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ABSTRACT 
 
Mitochondrial steroidogenic cytochrome P450 (CYP) enzymes rely on electron transfer from the 
redox partner ferredoxin for catalytic activity. Previous in vitro data suggests these co-factors are 
key regulators of CYP enzyme activity. However, this has never been studied in vivo. Zebrafish 
have emerged as model to study human steroidogenesis as they have conserved steroidogenic 
genes, molecular mechanisms and endocrine tissues. This project aimed to establish zebrafish as 
an in vivo model for endocrine development and its disorders, and to investigate the influence of 
mitochondrial redox regulation on steroid hormone production. This study involved the 
identification and characterisation of zebrafish mitochondrial steroidogenic CYP enzymes and 
their ferredoxin co-factors. Through implementation of recent genomic editing methods 
including Transcription Activator-Like Effector Nucleases (TALENs) and the Clustered 
Regulatory Interspaced Short Palindromic Repeat Cas9 nuclease (CRISPR/Cas9) system, and 
steroid hormone analysis from whole zebrafish extracts by liquid chromatography/tandem mass 
spectrometry, essential mitochondrial redox components required for zebrafish glucocorticoid 
production were identified. Overall, this work has helped established zebrafish as a model to 
study the pathophysiological consequences of steroid hormone disease and provided insights into 
the mechanism of mitochondrial redox regulation of steroid hormone production. 
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WT1  Wilms tumour suppressor 1 
 
 
 1 
 
  
Chapter One 
 
 
General Introduction 
 
 
Chapter one: General Introduction: Redox regulation of steroid hormone synthesis 
 
2 
 
 GENERAL INTRODUCTION 1.0
Part One: Redox regulation of steroid hormone synthesis 
1.1 Steroid hormones 
Steroid hormones are essential for vertebrate development and normal physiology. The main 
classes of steroid hormones include glucocorticoids, mineralocorticoids, the sex steroids 
encompassing androgens (testosterone, dihydrotestosterone), oestrogens (oestrone, oestradiol) 
and progestins (progesterone), and the calciferols (1,25-dihydroxy vitamin D). These five classes 
of steroid hormones (Miller and Auchus, 2011) and the closely related 1,25-dihydroxy vitamin D 
(a sterol) (Feldman et al., 2014) are involved in many physiological processes including 
development, sex differentiation and maintaining homeostasis throughout life. Endogenous 
steroid hormones are produced in steroidogenic tissues and secreted into the circulation to act in 
an endocrine fashion. Steroid hormones modulate many physiological processes through 
genomic and non-genomic pathways. Classically they bind specific receptors in target tissues to 
modulate gene transcription to influence cellular processes (Table 1.1). Specifically, 
glucocorticoids, such as cortisol, have key roles in maintaining metabolic homeostasis in response 
to stress by binding the glucocorticoid receptor (GR). Individual sex steroids function through 
specific receptors to modulate sex differentiation, sexual maturation and reproductive functions. 
Aldosterone is the main mineralocorticoid and acts via the mineralocorticoid receptor (MR) to 
control osmoregulation and blood pressure (Miller and Auchus, 2011). Finally, 1,25-dihydroxy 
vitamin D binds the vitamin D receptor to regulate bone health and immunity (Feldman et al., 
2014).  
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Table 1.1 Principal steroid hormones in humans 
 Mineralocorticoids Glucocorticoids Sex Steroids Calciferols 
Steroids Aldosterone Cortisol Testosterone, 
Oestradiol,  
Progesterone 
1,25-dihydroxy 
vitamin D  
Origin Zona glomerulosa Zona fasciculata Gonads 
Placenta,  
Zona reticularis 
Liver/Kidney 
Function Blood pressure 
Cardiovascular 
effects 
Protein, 
carbohydrate, lipid 
and nucleic acid 
metabolism 
Stress and immune 
modulation 
Sexual 
development 
Behavior 
Reproduction 
Bone 
mineralisation 
Immune 
modulation 
Receptor Mineralocorticoid 
receptor (MR) 
Glucocorticoid 
receptor (GR) 
Androgen 
receptor (AR)  
Estrogen receptor 
(ER)  
Progesterone 
receptor (PR) 
Vitamin D 
receptor (VDR) 
 
 
1.2 Steroid hormone biosynthesis 
Steroidogenesis is a biochemical process to synthesise active steroid hormones from cholesterol 
via a network of sequential enzymatic reactions (Figure 1.1). These enzymes fall into two families: 
cytochrome P450 (CYP) enzymes and hydroxysteroid dehydrogenase (HSD) enzymes. The inter-
conversion of steroids by these enzymes involves oxidation-reduction (redox) reactions and often 
requires electron transporter co-factors for enzymatic activity.  
 
Cholesterol taken up from the circulation via cholesterol receptors, or produced de novo from 
acetic acid, is transported to the inner mitochondrial membrane by an evolutionary conserved 
transport mechanism involving Steroid Acute Regulatory protein (StAR) and the mitochondrial 
translocator protein (Fan and Papadopoulos, 2013, Miller and Auchus, 2011). Subsequently, the 
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first and rate limiting step of steroidogenesis involves the conversion of cholesterol to 
pregnenolone in the mitochondrial matrix by the CYP enzyme P450 side-chain cleavage 
(CYP11A1; P450scc). From here the pathway diverges to produce mineralocorticoids, 
glucocorticoids and sex hormones, depending on the presence of steroidogenic enzymes in 
specific cells. Pregnenolone is translocated to the endoplasmic reticulum for further catalysis by 
17-hydroxylase (CYP17A1), 3β-hydroxysteroid dehydrogenase (3βHSD2) and 21-hydroxylase 
(CYP21A2). 
 
Mineralocorticoid production initially requires the activities of 3β-HSD2 and CYP21A2 to 
convert pregnenolone to progesterone and 11-deoxycorticosterone, respectively. Then 
11-deoxycorticosterone is transferred to the mitochondria where the enzyme aldosterone 
synthase (CYP11B2) catalyses the production of aldosterone. Glucocorticoid production relies on 
the conversion of pregnenolone to 11-deoxycortisol by consecutive CYP17A1, 3βHSD2 and 
CYP21A2 activities. Following this 11-deoxycortisol is translocated back to the mitochondria 
where it undergoes 11-hydroxylation by the enzyme 11β-hydroxylase (CYP11B1) to generate 
cortisol. The synthesis of sex steroids requires the 17, 20 lyase activity of CYP17A1 to convert 
17-hydroxypregnenolone to dehydroepiandrosterone (DHEA), the major precursor for both 
female and male sex steroids (Miller and Auchus, 2011). 
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Figure 1.1 Human steroid biosynthesis pathway 
Physiologically active steroid hormones are derived from the common precursor cholesterol. 
After cholesterol is transported across the mitochondrial membrane by the Steroid Acute 
Regulatory protein (StAR), it is converted to pregnenolone in the first step of steroidogenesis. 
Subsequent conversion into either glucocorticoids, mineralocorticoids or the sex steroids 
involves sequential enzymatic reaction catalysed by either cytochrome P450 (CYP) or 
hydroxysteroid dehydrogenase (HSD) enzymes. Steroids elicit physiological changes by 
binding to their receptor (MR, Mineralocorticoid receptor; GR, glucocorticoid receptor; AR, 
androgen receptor; ER, oestrogen receptor). Genes coding steroidogenic enzymes are shown 
in grey. CYP11A1, P450 side-chain cleavage enzyme; CYP17A1, 17-hydroxylase; HSD3B2, 
3β-hydroxysteroid dehydrogenase type two; CYP21A2, 21-hydroxylase; CYP19A1, P450 
aromatase; HSD17B, 17β-hydroxysteroid dehydrogenase; CYP11B1, 11β-hydroxylase; 
CYP11B2, aldosterone synthase; SRD5A2, steroid 5α reductase; Dehydroepiandrosterone, 
DHEA; 11-deoxycorticosterone, DOC.  
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1.3 Classical steroid hormone producing tissues 
Steroidogenic tissues are defined by their ability to convert cholesterol into pregnenolone. It was 
previously believed this attribute was restricted to the endocrine cells of the adrenal cortex and 
the gonads; specifically the Leydig cells in the testis and the Theca and Granulosa cells in the 
ovary (Miller and Auchus, 2011). More recently, the detection of steroidogenic enzymes in 
peripheral target tissues has led to the insight that the conversion of steroid precursors may be 
occurring locally in other tissues (Labrie et al., 1998, Labrie et al., 2000, Thiboutot et al., 2003).  
 
1.3.1 The adrenal cortex 
The adrenal cortex is the main site of steroid hormone production in humans. The adrenal glands 
are located above the kidneys and consist of two parts; the outer adrenal cortex and the inner 
adrenal medulla. While epinephrine and norepinephrine are secreted by the chromaffin cells in 
the medulla, the adrenal cortex is responsible for the secretion of corticosteroids; that is the 
glucocorticoids and mineralocorticoids and androgens (Figure 1.2). The cortex is subdivided into 
the outer zona glomerulosa, the middle zona fasciculata and the inner zona reticularis. Through a 
combination of enzyme and receptor expression each zone of the adrenal cortex is responsible 
for specific steroid production. While production of pregnenolone via CYP11A1 expression is 
common to all three zones, the zona glomerulosa cells are positive for CYP11B2 to facilitate 
aldosterone production. The middle zona fasciculata produces cortisol through CYP11B1 
expression and the zona reticularis secrete DHEA and androstenedione by expression of 
CYP17A1 (Simpson and Waterman, 1988).  
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Figure 1.2 Functional zones of the human adrenal cortex 
The adrenal cortex is the major site of steroid hormone production in humans. The outer 
zona glomerulosa expresses CYP11B2 to facilitate aldosterone production in response to 
angiotensin II (AngII) binding to the angiotensin II receptor (AT1R) and potassium ions 
(K+). The zona fasciculata generates cortisol in an adrenocorticotropic hormone (ACTH) 
dependent manner by expressing melanocortin II receptor (MC2R) which regulates CYP11B1 
expression. Adrenal androgens dehydroepiandrosterone (DHEA) and androstenedione are 
synthesised from the inner zona reticularis. Expression of CYP11A1 which generates 
pregnenolone required for all steroid hormone production is common to all three zones of 
the adrenal cortex.  
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1.4 Regulation of steroid hormones and actions  
1.4.1 Hypothalamus-pituitary-adrenal axis 
Glucocorticoid production in the adrenal cortex is regulated by the hypothalamus-pituitary-
adrenal (HPA) axis (Simpson and Waterman, 1988) (Figure 1.3). Under periods of stress or as 
part of the diurnal rhythm, the hypothalamus secretes corticotropin-releasing hormone (CRH), 
which signals the pituitary to transcribe the pro-opiomelanocortin (POMC) gene. The POMC 
preprotein is cleaved to adrenocorticotropic hormone (ACTH). ACTH promotes glucocorticoid 
production by binding its receptor on the adrenal cortex. Finally, circulating cortisol provides 
feedback to the hypothalamus and inhibits pathway stimulation, completing the HPA axis. 
 
 
 
Figure 1.3 Regulation of glucocorticoid production by the HPA axis 
The hypothalamus-pituitary-adrenal (HPA) regulates the production of cortisol. During 
stress or as part of the diurnal rhythm, the hypothalamus secretes corticotropin-releasing 
hormone (CRH), which signals the pituitary to secrete adrenocorticotropic hormone 
(ACTH). ACTH binds receptors on the adrenal cortex which signal cortisol production. 
Circulating cortisol provides negative feedback to the hypothalamus and pituitary gland to 
inhibit pathway stimulation, completing the HPA axis. 
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ACTH promotes steroidogenesis by binding to the melanocortin II receptor (MC2R) on the zona 
fasciculate, which in turn activates the protein kinase A (PKA) pathway via cyclic AMP (cAMP). 
PKA phosphorylation of StAR causes the mobilisation of cholesterol into the mitochondria for 
conversion to active steroid hormones, generating an acute response to ACTH stimulation 
(Arakane et al., 1997, Clark et al., 1995, Stocco, 2001). Prolonged ACTH stimulation increases 
adrenal cortex expression of steroidogenic enzymes (mainly StAR, CYP17A1, CYP21A2 and 
CYP11B1) and electron transfer co-factors through cAMP element binding protein (CREB) and 
steroidogenic factor 1 (SF-1) transcription factors (Manna et al., 2009). This response can occur 
over hours or days, thus providing a sustained response to the ACTH. Chronic exposure to 
ACTH (weeks to months) can promote adrenal hyperplasia, excessive production of 
glucocorticoids and in extreme cases it can result in Cushing’s syndrome (Nelson et al., 1958). 
 
1.4.2 Renin-angiotensin-aldosterone system 
Aldosterone is a component of the renin-angiotensin-aldosterone system (RAAS) and is required 
for blood pressure regulation and water balance homeostasis (Figure 1.4). Low blood volume is 
detected by the juxtaglomerular cells in the kidneys causing them to secrete renin. Renin 
metabolises angiotensinogen to angiotensin I which is converted to angiotensin II by the 
angiotensin-converting enzyme (ACE). Angiotensin II binds the angiotensin II receptor type one 
(AT1R) which activates the downstream signalling pathways to increase blood pressure and 
volume (Guo et al., 2001). Additionally, angiotensin II increases CYP11B2 expression from the 
zona glomerulosa to increase aldosterone synthesis (Bader, 2010). In turn, aldosterone stimulates 
sodium and water reabsorption by the kidneys though its actions via the mineralocorticoid 
receptor to further increase blood volume.  
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1.4.3 Mechanisms of action of steroid hormones 
The classical model of hormone action involves the steroid molecules eliciting physiological 
changes by binding receptors expressed by specific tissues. Nuclear steroid receptors show 
considerable homology to each other and consist of a carboxyl-terminal ligand binding domain; a 
variable amino-terminal domain that is predicted to modulate transactivation; and a central 
cysteine-rich domain for DNA binding (Kumar and McEwan, 2012). Ligand binding induces a 
conformational change in the receptor, exposing the DNA binding domain. Translocation into 
the nucleus enables the steroid-receptor complex to recognise and bind specific palindromic 
hormone response elements on genomic DNA. Regulation of steroid responsive genes is initiated 
through the receptor-ligand complex interacting with basal transcription complexes, activators, 
 
 
Figure 1.4 Regulation of aldosterone production by the RAAS 
Aldosterone production in the zona glomerulosa is controlled by renin and angiotensin II 
through the renin-angiotensin-aldosterone system (RAAS). In response to blood pressure 
fluctuations, the kidney secretes renin; an enzyme which cleaves angiotensinogen into 
angiotensin I. Angiotensin converting enzyme (ACE) subsequently produces angiotensin II 
which signals to the adrenal gland to produce aldosterone. Aldosterone controls the 
reabsorption of sodium ions and water and secretion of potassium by the kidneys to restore 
blood pressure.   
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repressors and transcription regulators (Beato and Klug, 2000). Steroid hormones also elicit rapid 
non-genomic actions. These effects involve the generation of second messengers (such as 
cAMP), and the activation of signalling cascades and ion fluxes to provide a dynamic response to 
steroid hormone signalling (Losel and Wehling, 2003). 
 
1.5 Cytochrome P450 enzymes and steroid hormone 
production 
CYP enzymes are a diverse family of proteins which catalyse the oxidative activation or 
inactivation of endogenous and exogenous chemicals. This, in turn, has impact on normal and 
disease physiology. Typically, these evolutionary conserved enzymes are about 55 kDa in size, 
contain a single haem group and derive their name from their ability to absorb light maximally at 
450 nm (Gonzalez, 1988). Eukaryotic CYP enzymes can be classified into two distinct groups 
based on their location within the cell. Class I CYP enzymes are located within the mitochondria 
and class II reside in microsomes. Along with their different cellular location, each class of CYP 
enzyme relies on different electron transfer systems for their catalytic activity. The microsomal 
type II enzymes receive electrons from nicotinamide adenine dinucleotide phosphate (NADPH) 
through P450 oxidoreductase (POR) and sometimes in conjunction with cytochrome b5 (Miller, 
2005). Conversely, all mitochondrial type I CYP enzymes receive electrons from NADPH via the 
redox co-factors ferredoxin reductase (FDXR) and ferredoxin (FDX1). It is the redox regulation 
of mitochondrial CYP enzymes which is the focus of this study and will be discussed in detail 
below.  
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1.5.1 Mitochondrial steroid hormone synthesis 
Of the nine CYP enzymes involved in the synthesis of steroid hormones and 1,25-dihydroxy 
vitamin D, five are located in the mitochondria and rely on the ferredoxin electron transport 
chain for activity. The first reaction in steroid hormone production is catalysed by CYP11A1 and 
occurs in the mitochondria. Additionally, the final steps of glucocorticoid and mineralocorticoid 
synthesis are achieved by the mitochondrial CYP enzymes CYP11B1 and CYP11B2, respectively 
(Miller, 2013). As these reactions are essential for glucocorticoid and mineralocorticoid 
production it is imperative that the activity of these enzymes is tightly regulated to maintain 
normal physiology.  
 
1.5.2 CYP11A1: The Cholesterol Side Chain-Cleavage Enzyme 
P450scc or CYP11A1 is a mitochondrial P450 enzyme which catalyses cholesterol to 
pregnenolone in the first step of steroid synthesis (Figure 1.5). Cholesterol is transported to the 
inner mitochondrial matrix by StAR before CYP11A1 catalyses three sequential monooxygenase 
reactions to generate pregnenolone. P450scc catalyses two hydroxylation reactions of cholesterol 
to produce 22R-hydroxycholesterol and then 20α,22R-dihydroxycholesterol. The final step 
involves the cleavage of the side chain to produce pregnenolone. Each reaction requires two 
electrons as reducing equivalents which are received from NADPH via the ferredoxin electron 
transport chain (Section 1.5.5) P450scc is encoded by the CYP11A1 gene located on 
chromosome 15q23. Regulation of CYP11A1 expression and P450scc activity is of particular 
importance for normal physiology. Expression of CYP11A1 is stimulated by ACTH in all zones 
of the adrenal cortex, with additional regulation by angiotensin II in the zona glomerulosa. 
Cholesterol conversion to pregnenolone by CYP11A1 is a slow reaction which contributes to it 
being the rate-limiting step of steroid hormone production (Miller, 2013). 
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1.5.3 CYP11B1: The steroid 11β-hydroxylase enzyme 
CYP11B1 is a mitochondrial CYP enzyme which catalyses the final steps of cortisol synthesis 
(Figure 1.6). It is encoded by the CYP11B1 gene and is located on chromosome 8q22, adjacent to 
its isozyme CYP11B2. CYP11B1 is the more abundant of the two CYP11B isozymes found in 
humans, and it is expressed in the zona fasciculata and somewhat in the zona reticularis of the 
adrenal cortex. It primarily converts 11-deoxycortisol to cortisol, but can also generate 
corticosterone from 11-deoxycorticosterone. Expression of CYP11B1 is induced by ACTH via 
cAMP and can be supressed by glucocorticoids.  
 
 
 
 
 
Figure 1.5 Catalytic activity of Cholesterol P450 side chain-cleavage enzyme 
Cholesterol side-chain cleave enzyme (CYP11A1) catalyses the conversion of cholesterol to 
pregnenolone in three subsequent reactions. Initially, hydroxylation of cholesterol produces 
22R-hydroxycholesterol and then 20α,22R-dihydroxycholesterol.  The final step involves the 
cleavage of the side-chain to produce pregnenolone. Each monooxygenase step requires two 
electrons which are transferred from NADPH via the ferredoxin redox chain involving 
ferredoxin reductase (FDXR) and ferredoxin (FDX1).  
Chapter one: General Introduction: Redox regulation of steroid hormone synthesis 
 
14 
 
 
 
 
1.5.4 CYP11B2: Aldosterone synthase 
The mitochondrial CYP enzyme aldosterone synthase is, as its name suggests, required for 
aldosterone production. It is localised to the zona glomerulosa of the adrenal cortex where it 
catalyses the final three steps in aldosterone synthesis; 11β-hydroxylation of 
11-deoxycorticosterone to corticosterone, followed by 18-hydroxylation and 18-oxidation to 
produce aldosterone (Figure 1.7). Aldosterone synthase is encoded by the CYP11B2 gene located 
40 kb away from CYP11B1 gene. These two human isozymes share 93 % amino acid identity, but 
unlike CYP11B1, expression of CYP11B2 is regulated by potassium and angiotensin II. 
 
 
 
Figure 1.6 Catalytic activity of 11β-hydroxylase enzyme  
The CYP enzyme 11β-hydroxylase converts 11-deoxycortisol into cortisol within the 
mitochondrial of cells in the zona fasciculate. For this reaction it requires electrons which are 
transferred from NADPH via the ferredoxin reductase (FDXR) and ferredoxin (FDX1).   
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1.5.5 The mitochondrial redox electron transport chain 
Redox partner proteins are required for the transfer of electrons from NADPH to the haem 
centre of CYP enzymes. In vitro studies conclude that electron transfer co-factors regulate CYP 
catalytic activities by more than just their electron transfer. Since mitochondrial CYP enzymes 
rely on their redox partners for activity the nature of this interaction is of considerable 
importance for normal physiology. 
 
1.5.5.a. Ferredoxin Reductase 
Human ferredoxin reductase (FDXR; adrenodoxin reductase; ADXR) is a 54-kDa flavoprotein 
which forms the first component of the electron transport to mitochondrial CYP enzymes. It is 
encoded by the FDXR gene on chromosome 17q24-q25 (Sparkes et al., 1991) and is alternatively 
spliced to generate two mRNA transcripts that differ by 18 nucleotides, but only the protein 
 
 
Figure 1.7 Catalytic activity of aldosterone synthase 
The mitochondrial CYP enzyme aldosterone synthase (CYP11B2) catalyses the final three 
reactions required for mineralocorticoid synthesis. Two successive hydroxylations of 
deoxycorticosterone produce corticosterone and 18-hydroxycorticosterone. Subsequently, 
CYP11B2 oxidase activity converts 18-hydroxycorticosterone to aldosterone. Each step 
requires electrons from NADPH via the mitochondrial redox co-factors ferredoxin reductase 
(FDXR) and ferredoxin (FDX1). 
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encoded by the shorter mRNA is active in steroidogenesis (Brandt and Vickery, 1992). Although 
it is ubiquitously expressed, highest levels of expression occur in classical steroidogenic tissues, 
namely, the adrenal cortex, gonads and placenta (Brentano et al., 1992).  
 
Unlike most steroidogenic genes, the promoter for FDXR contains the SP1 transcription binding 
sites which are typically found in “housekeeping genes” (Lin et al., 1990, Miller and Auchus, 
2011). Additionally, cAMP from ACTH stimulation does not regulate transcription of the FDXR 
gene (Brentano et al., 1992). This suggests that dynamic changes in FDXR expression are not 
required for acute steroid hormone production. The electron transfer pathway begins when 
FDXR receives a pair of electrons from NADPH via its flexible carboxyl-terminal flavin adenine 
dinucleotide (FAD) domain (Kimura and Suzuki, 1967, Ziegler et al., 1999). It is loosely 
associated with the inner mitochondrial membrane where it interacts with ferredoxin, the second 
component of the mitochondrial redox chain.  
 
 
 
Figure 1.8 The mitochondrial electron transfer system 
NADPH donates a pair of electrons (e-) to the FAD moiety of ferredoxin reductase (FDXR). 
FDXR interacts with ferredoxin 1 (FDX1) via charge-charge interactions and subsequently 
reduces it by transferring electrons to its Fe/S cluster. FDX1 then dissociates from FDXR and 
interacts via the same region with the mitochondrial cytochrome P450 enzyme. The electrons 
are transferred to the haem ring of the P450 enzyme, allowing it to mediate its catalytic 
conversion of the bound substrate. (IMM: Inner mitochondrial membrane). 
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1.5.5.b. Ferredoxin 
Ferredoxins are iron-sulphur proteins which act as electron donors for a variety of fundamental 
reactions catalysed by mitochondrial CYP enzymes. The human ferredoxin 1 (FDX1; 
adrenodoxin; ADX) is a small (14 kDa) protein which resides in the mitochondrial matrix or 
closely associated with the inner mitochondrial membrane. It is involved in various metabolic 
processes including the synthesis of steroid hormones, vitamin D and bile acids (Meyer, 2008). 
The FDX1 gene is located on chromosome 11q22 and spans over 30 kb. In humans, FDX1 is 
ubiquitously expressed; however, it is most abundant in steroidogenic tissue including the adrenal 
gland and the gonads (Picado-Leonard et al., 1988). Humans have two ferredoxin genes, FDX1 
and FDX2 (previously termed fdx1-like) however, only FDX1 activity supports steroidogenic 
mitochondrial CYP enzymes (Sheftel et al., 2010). Electron transfer from FDX1 is critical for the 
catalytic activity of all mitochondrial CYP enzymes including CYP11A1, CYP11B1 and 
CYP11B2 (Miller and Auchus, 2011). Therefore, it is hypothesised that FDX1 plays a key role in 
regulating the steroid hormone producing capacities of a cell.  
 
1.5.6 Regulation of the mitochondrial electron transfer chain 
Currently little is known about the physiological importance of mitochondrial redox partner 
interactions in regulating steroid hormone production. Since this electron transfer mechanism 
was discovered in 1965 (Kimura and Suzuki, 1965, Suzuki and Kimura, 1965), the effects of 
FDX1 on CYP enzymatic activity has been the focus of several in vitro studies. Cumulatively, 
these studies show the amino acid sequence, redox potential, concentration of FDX1 as well as 
its amiability to phosphorylation can influence CYP enzyme activity (Figure 1.9).  
 
The concentration of FDX1 in the mitochondria is hypothesised to influence the activity of CYP 
enzymes. Lambeth and Kriengsiri (1985) suggested CYP11A1 reduction was not dependent on 
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FDX1 concentration. However, more recent studies show a correlation between increasing 
FDX1 concentrations and increasing CYP enzyme activity (Beckert and Bernhardt, 1997). 
Discrepancies between these results is not clear, but it is suggested different reaction conditions 
and advances in data processing allow for more sensitive evaluation of measurements in the 
recent study (Ewen et al., 2011). Both FDX1 and FDXR transcription is regulated by SF1 
(Imamichi et al., 2013, 2014) the main transcription factor regulating steroid hormone 
production; however, only FDX1 expression is up-regulated upon treatment of ovarian 
Granulosa cells with cAMP indicating FDX1 is required for dynamic changes in steroid hormone 
production (Imamichi et al., 2013). Given the similarity in transcriptional regulation between 
FDX1 and steroidogenic CYP enzymes, together with the latest functional activity data, it is likely 
that increases in FDX1 is a mechanism to increase CYP450 functional activity via the promotion 
of electron transfer.  
 
 
 
 
Figure 1.9 Modulation of Fdx1 dependent CYP enzymatic reactions in vitro 
The ability to transfer electrons is critical for FDX1 function. In vitro data suggests increased 
concentrations of FDX1 can directly affect the catalytic rate of CYP enzymes. In addition 
phosphorylation, amino acid sequence and redox potential are all capable of modifying FDX1 
binding behaviour to its redox partners, and subsequently alters CYP activity.  
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Moreover, the efficiency of the interaction between redox partners can influence the catalytic rate 
of mitochondrial CYP enzymes. The transfer of electrons occurs during the protein-protein 
interaction between the electron donor and acceptor (Beratan et al., 1992). Using stop flow 
kinetic studies to determine the rate of electron transfer, the limiting step of the of the 
FDXR/FDX1/CYP11A1 redox chain was the interaction between FDX1 and CYP11A1 
(Schiffler et al., 2011); highlighting the importance of this interaction. The bovine FDX1 
Ser112Trp mutant has increased affinity to CYP11A1 and causes enhanced pregnenolone 
production from cholesterol (Schiffler et al., 2001). Furthermore, phosphorylation of bovine 
FDX1 at Thr71 causes enhanced affinity for CYP11A1, but not CYP11B1, which in turn 
improves pregnenolone production in vitro (Bureik et al., 2005). Given CYP11A1 is the first and 
rate limiting step of steroidogenesis, its interaction with FDX1 is likely to have consequences for 
in vivo steroid hormone production.  
 
Finally, changes in redox potential can also influence CYP catalytic activity. The redox potential 
of a protein refers to its ability to acquire and donate electrons. FDX1 mutants with differing 
redox potentials can affect CYP catalytic activity in vitro. The bovine mutants FDX1 4-114 and 
FDX1 4-108 display increased electron transfer properties. Through their interaction with 
CYP11B2, these mutants increase the synthesis of corticosterone and aldosterone (Cao and 
Bernhardt, 1999). Furthermore, many in vitro studies (including the ones performed in this study) 
are routinely used with a mutant form of bovine adrenal Fdx1 (Fdx1 4-108) (Uhlmann et al., 
1994). The truncation causes Fdx1 to have a more negative redox potential which results in 
increased CYP catalytic activity and improved substrate conversion (Ewen et al., 2012). The 
redox potential of ferredoxins is a critical factor in their ability to shuttle electrons from FDXR to 
mitochondrial CYP enzymes. All-in-all comprehensive in vitro studies have shown modulation of 
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FDX1 can influence the catalytic activity of CYP enzymes. However, the physiological in vivo 
consequences of FDX1 interactions remain undetermined. 
 
1.6 Deregulation of mitochondrial steroid production causes 
disease 
1.6.1 CYP11A1 deficiency 
CYP11A1 deficiency is an autosomal recessive condition caused by mutations in the CYP11A1 
gene. Several patients have been described with CYP11A1 mutations rending partial or complete 
inactivity of P450scc (Hiort et al., 2005, Kandari et al., 2006, Katsumata et al., 2002, Kim et al., 
2008, Parajes et al., 2012, Parajes et al., 2011, Rubtsov et al., 2009, Sahakitrungruang et al., 2011, 
Tajima et al., 2001). These patients suffer from impairment of glucocorticoid and 
mineralocorticoids synthesis causing adrenal insufficiency. Interestingly, CYP11A1 deficiency is 
the only inborn error of steroidogenesis leading to adrenal atrophy, even in partial deficiencies 
(Parajes et al., 2011), rather than to hyperplasia of the adrenal cortex (Kim et al., 2008, Parajes et 
al., 2012, Parajes et al., 2011). Since the electron transfer between FDX1 and CYP11A1 in vitro is 
only 66 to 75 % efficient (Miller and Auchus, 2011) it is hypothesised the remaining electrons 
contribute to reactive oxygen generation. This reactive oxygen species production is predicted to 
induce apoptosis of the adrenal cortex and is likely to represent an exaggerated form of adrenal 
ageing. However, such mechanism cannot be determined by in vitro studies, and require in vivo 
analysis.  
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1.6.2 CYP11B1 deficiency and deregulation 
Functionally disrupting CYP11B1 mutations are the second most common cause of congenital 
adrenal hyperplasia in most populations (approximately 5–8% of all cases) (White et al., 1994). A 
lack of cortisol production in these patents results in an up regulation of the HPA axis, causing 
increased cortisol steroid precursors which are metabolised to adrenal androgens. The excess 
production of androgens leads to abnormalities in sexual development. Conversely, genetic 
variation in CYP11B1 has also been linked with hypertension and primary hyperaldosteronism 
(Freel et al., 2008, Zhang et al., 2010). Patients with elevated levels of cortisol have been 
associated with cardiovascular risk factors such as components of metabolic syndrome (Fraser et 
al., 1999, Whitworth et al., 2005), accelerated atherosclerosis (Dekker et al., 2008), depression and 
subsequent increases in morbidity and mortality (Rosmond, 2005).  
 
1.6.3 CYP11B2 deficiency and deregulation  
Deficiencies in aldosterone synthases from mutations within CYP11B2 cause excessive sodium 
excretion and potassium retention resulting in hyponatremia, hyperkalaemia and metabolic 
acidosis. The complete absence of aldosterone synthases generally results in salt-wasting crisis in 
infancy (Peter et al., 1995), whereas patients with partially inactivating mutations in CYP11B2 
present with milder phenotypes in childhood or adulthood (Hui et al., 2014, Kayes-Wandover et 
al., 2001). Conversely, the excessive production of aldosterone is implicated in the pathogenesis 
of hypertension and heart disease. The CYP11B2 C344T polymorphism (rs1799998) is associated 
with higher levels of aldosterone production, hypertension and primary aldosteronism (Kumar et 
al., 2003). Primary aldosteronism is due to an excessive and autonomous secretion of aldosterone 
and is associated with a significant increase in cardiovascular morbidity and mortality in 
hypertensive patients. Therefore, specific inhibition of CYP11B2 is being investigated as a 
potential target for the treatment of hypertension, renal disease and heart failure (Liu et al., 2014).  
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1.6.4 Mitochondrial redox co-factors in disease 
To date there have been no patients described with FDX1 or FDXR deficiencies. Furthermore, 
knockout mouse models have not been generated, limiting in vivo studies thus far. Drosophila 
knockouts of the FDXR homologue gene dare undergo developmental arrest due to lack of 
steroid hormone production; supporting the idea the mitochondrial redox pathway is functionally 
important for early development (Freeman et al., 1999). It is suggested that a human foetus 
deficient in FDX1 would result in spontaneous abortion around six to seven week gestation, due 
to loss in pregnenolone synthesis (Miller, 1998). However, given CYP11A1 deficient patients 
have survived, it is feasible that FDX1 mutations leading to partial loss of function would be 
compatible with life.  
 
Mutations in the electron donor of microsomal CYP enzymes, POR, are known to result in 
multiple clinical manifestations (Pandey and Fluck, 2013). Although POR knockout mice are 
embryonic lethal (Otto et al., 2003), humans with complete POR deficiency can present with a 
disorder of steroidogenesis associated with Antley-Bisler skeletal malformation syndrome. 
Additionally, mild POR mutations were present in phenotypically normal adults with infertility 
(Scott and Miller, 2008). The identification of mutations in POR highlights the importance of 
redox cofactors in disease and normal physiology.  
 
Numerous in vitro studies have shown that modulation of FDX1 can influence steroid hormone 
production through modifying CYP enzymatic activity, suggesting the deregulation of redox 
co-factors may have pathophysiological consequences. Indeed, FDX1 has been identified in 
whole genome association studies as a genetic risk factor of obesity (Xu et al., 2013b). 
Furthermore, it is hypothesised the deregulation in FDX1 may be a cause of common disease 
such as hypertension or cardiac disease though increased production 18-hydroxycorticosterone 
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and aldosterone (Cao and Bernhardt, 1999). However, the precise impact of how this 
mitochondrial redox protein impacts physiological or pathological conditions requires further in 
vivo studies.  
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Part Two: Zebrafish - An emerging model for endocrine disease 
1.7 Zebrafish 
The zebrafish (Danio rerio) is a small tropical freshwater fish naturally found in rivers throughout 
South Asia. It is a member of the teleost class along with other bony fish such as the medaka 
(Oryzias latipes), the three-spined stickleback (Gasterosteus aculeatus) and pufferfish species (Takifugu 
rubripes and Tetraodon nigroviridis). Zebrafish have commonly been used in developmental biology 
studies, however its popularity has now extended into other fields including translational 
research, cancer, toxicology and drug discovery (Ablain and Zon, 2013).  
 
1.7.1 Advantages of zebrafish as a vertebrate model system 
Zebrafish have several advantages lending it to be amenable for biomedical research. Particularly, 
external fertilisation prevents many of the problems associated with other in vivo models which 
develop in utero and provides easy collection of fertilised eggs for genetic manipulation by 
microinjection. Additionally, offspring can be generated in large numbers compared to other 
vertebrate models, making them particularly ideal for high throughput screening studies. 
Pharmacological studies can be easily performed by altering media conditions (Zon and Peterson, 
2005) and embryos are small enough to fit in 96-well or 384-well plates facilitating high 
throughput screening of chemical libraries (Peterson et al., 2000, Xu et al., 2013a). Moreover, 
embryos are transparent making them ideal for visualisation studies, and by fluorescently marking 
specific cells, researchers can track precise cells during development. Finally, zebrafish have rapid 
organ development and tissue maturation, with the majority of systems functional within the first 
48 hours post fertilisation (hpf). With the exception of few tissues (notably lungs, prostate and 
mammary gland) most organs in humans are present in zebrafish making them ideal for 
developmental and translational studies (Kari et al., 2007). 
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1.7.2 Studying vertebrate gene function in zebrafish 
To effectively translate zebrafish studies to human development and disease it is important to 
recognise how zebrafish genes relate to orthologous human genes. Analysis of the zebrafish 
genome sequence revealed 70 % of human genes have counterparts in zebrafish (Howe et al., 
2013). Between 305 and 450 million years ago, the common teleost ancestor underwent a whole 
genome duplication (Amores et al., 1998, Postlethwait et al., 1998, Woods et al., 2000). This 
resulted in 26 % of zebrafish genes being present as a duplicate copy (Howe et al., 2013). During 
evolution, these paralogues can undergo subfunctionalisation (Force et al., 1999), where duplicate 
genes diverge in function or expression (Kassahn et al., 2009). Often the combined mechanisms 
of the zebrafish paralogues are equivalent to the single orthologue in other vertebrates (Schartl, 
2014). Studying duplicated genes, either via changes in regulatory control or via changes in 
protein function, can contribute to the understanding of how genes evolve and provide insight 
into regulatory mechanisms or new functional adaptations. Additionally, subfunctionalisation can 
also allow for the study of genes involved in disease development in adult fish without effecting 
early development.  
 
1.7.2.a. Antisense morpholino knockdown strategies 
Gene knockdown by antisense RNA interference is a technique commonly used both in in vitro 
and in vivo model systems. The most widely used method to study a gene function in zebrafish is 
by antisense morpholino. Morpholinos are 25 base-pair oligonucleotides typically designed to 
inhibit protein translation by binding the region surrounding the start methionine codon, or 
disrupt splicing of the precursor mRNA by binding a splice junction site (Figure 1.10). 
Commonly, morpholinos are injected into single cell embryos where they effectively bind RNA 
transcripts during development. As the cells divide and the embryo rapidly grows the morpholino 
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becomes diluted and subsequently less effective, resulting in a transient knockdown. However, as 
most tissues, including the endocrine system is developed with the first few days after fertilisation 
(Lohr and Hammerschmidt, 2011), transient knockdown is usually sufficient to investigate gene 
function. A major advantage of using morpholino to study gene function is their ease of use. 
Coupled with the high fecundity of zebrafish, morpholinos can be easily injected into several 
hundred embryos for a single experiment making high throughput gene analysis studies possible. 
 
 
 
 
Despite their prevalence among zebrafish researchers, morpholinos often elicit off-target effects 
which are not associated with the loss of the targeted gene. These artefacts are difficult to 
separate from those caused by the binding the specific RNA (Eisen and Smith, 2008), and often 
present as developmental delay, pericardial oedema, neural toxicity, or craniofacial defects (Bedell 
 
 
Figure 1.10 Mechanism of action by antisense morpholino oligonucleotides 
Antisense morpholino oligonucleotides (shown in red) knock-down gene expression 
disrupting splicing of the pre-mRNA or blocking translation of mRNA into functional 
protein. Morpholinos are 25 nucleotides long and are designed to bind over intron-exon splice 
junctions or over the ATG start codon of the targeted gene.  
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et al., 2011, Schulte-Merker and Stainier, 2014). Often specificity of a phenotype is confirmed by 
comparing with a separate morpholino targeting the same gene, injection of a control 
morpholino or by rescuing the phenotype with co-injection of targeted mRNA.  However, even 
with stringent controls several morpholino studies do not correlate with zebrafish harbouring a 
loss-of-function genetic mutation (den Broeder et al., 2009, Law and Sargent, 2014, Nichols et al., 
2013). In light of these studies and the recent development of alternative reverse genetic 
approaches (Section 1.7.2.b), many researchers are opting for the generation of specific genetic 
knockouts over the transient knockdown morpholino approach (Schulte-Merker and Stainier, 
2014). 
 
1.7.2.b. Genomic editing in zebrafish  
Over the past decade major advances have been made in the area of genome engineering 
techniques. These methods have allowed for fast, easy and efficient modification of endogenous 
genes in a range of cell types and model organisms. To date, several classes of adaptive DNA 
binding tools have been developed, including: Zinc-finger nucleases (ZFNs) developed from 
eukaryotic transcription factors (Bibikova et al., 2003, Urnov et al., 2005), transcription activator-
like effector nucleases (TALENs) (Cermak et al., 2011, Huang et al., 2011, Sander et al., 2011) 
(Chapter 5.0) and the more recently developed clustered regulatory interspaced short palindromic 
repeat (CRISPR)/Cas9-based RNA-guided DNA endonucleases (Jiang et al., 2013, Pattanayak et 
al., 2013b) (Chapter 6.0). These technologies are now widely available to researchers and are 
rapidly becoming routine molecular biology techniques.  
 
All of the available genome engineering methods rely on the principal of making targeted 
chromosomal breaks. In an effort to maintain chromosomal integrity these breaks are repaired 
via endogenous cellular repair mechanisms: non-homologous end joining (NHEJ) or homology 
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directed (HD) repair to generate desired genetic modifications (Figure 1.11) (Wyman and Kanaar, 
2006). NHEJ is the major chromosomal repair pathway in mammals and involves the ligation of 
chromosomal ends without a homologous template (Liang et al., 1998). This repair method is 
error prone and can lead to the insertion/deletion (commonly termed indels) of nucleotides 
which disrupt the translational reading frame of a protein or interrupt the binding site for trans-
acting factors within their promoters. Subsequently, an out-of-frame mutation rendering a non-
functional protein or impaired gene expression creates a null allele. Alternately to NHEJ, HD-
medicated repair uses recombination with an exogenously supplied donor template carrying the 
specific insertion or mutation. HD has traditionally been used to generate knockin and knockout 
animal models by altering the genome of embryonic stem cells. Still, with the efficiency of 
recombination being low (one in 106 to 109) (Capecchi, 1989), large scale applications of gene 
targeting is challenging. Chromosomal breaks increase the efficiency HD-mediated repair in 
mammalian cells (Choulika et al., 1995). Genomic editing methods are now being used to create 
genomic insertions of functional elements in zebrafish; including loxP recombination sites (Bedell 
et al., 2012) and fluorescent proteins (eGFP) (Zu et al., 2013). Therefore, targeted chromosomal 
breaks in combination with donor templates can facilitate precise modifications of genomic 
regions in zebrafish.  
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1.7.3 Translational research and modelling genetic diseases in zebrafish 
Zebrafish are becoming an increasing prevalent model for human genetic diseases due to the high 
degree of conservation of molecules and pathways between the two species. Genome analysis 
showed more than 75 % of human genes implicated in disease have counterparts in the zebrafish. 
This has allowed zebrafish to be a valuable model for a number of human genetic conditions 
including, neurological and psychiatric disorders, cancer, heart defects, foetal alcohol syndrome 
and kidney disorders (Phillips and Westerfield, 2014). Only recently has the benefit of zebrafish 
 
 
 
 
Figure 1.11 Cellular repair mechanisms of chromosomal breaks  
Double stranded DNA breaks (DSB) can be repaired by two mechanisms; non-homologous 
end joining (NHEJ) and homology directed (HD) repair. NHEJ is error prone and generates 
insertions or deletions (red) which generate out-of-frame mutations to disrupt protein 
function. HR requires a homologous donor template which guides the repair. By providing an 
exogenous donor template with a specific mutation (green) flanked by homologous ends, 
specific sequences can be inserted at precise loci within the genome.  
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been used to study endocrine physiology and disease. Characterisation of the endocrine system 
between humans and zebrafish revealed it is well conserved (McGonnell and Fowkes, 2006). 
Importantly, the development of the endocrine system is complete and functional by five days 
post fertilisation (dpf). Therefore, it is possible to model human endocrine diseases and 
developmental physiology, taking full advantage of this in vivo model system. Even with the 
apparent differences between zebrafish and humans, using zebrafish for disease modelling, 
chemical screening and gene function discovery is becoming more prevalent and generating new 
insights in understanding pathogenesis of human disease at a molecular and cellular level.  
 
1.8 Conservation of steroid hormone pathway in zebrafish  
1.8.1 Glucocorticoid production in zebrafish  
Like humans, cortisol is the main glucocorticoid in zebrafish and its production relies on 
conserved steroidogenesis genes. Glucocorticoid synthesis begins with the import of cholesterol 
into the mitochondria where the zebrafish P450scc enzymes, Cyp11a1 or Cyp11a2 produce 
pregnenolone (Hsu et al., 2006, Parajes et al., 2013). Successively, the 17α-monooxygenase 
isozymes (Cyp17a1 and Cyp17a2), the 3β-hydroxysteroid dehydrogenase (3βHsd1 and 3βHsd2) 
and the single cytochrome 21-hydroxylase enzyme produce 17-pregnenolone, 17-
hydorxypregnenolone and 11-deoxycortiol, respectively. A final step catalysed by the single 11β-
hydroxylase isozyme converts 11-deoxycoritsol to cortisol (Mommsen et al., 1999) (Figure 1.12). 
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As in humans, cortisol in zebrafish is produced in response to stress and in a circadian rhythm 
under the regulation of the hypothalamus and the pituitary (Alsop and Vijayan, 2008, Fuzzen et 
al., 2011, To et al., 2007). The primary targets of cortisol are the gills, brain, intestine, muscles and 
liver to help mobilise energy stores to cope with stressors (Lin et al., 2011, Lohr and 
Hammerschmidt, 2011). Furthermore, GR null fish are chronically stressed and exhibit 
behavioural changes indicative of depression, suggesting glucocorticoids have additional roles in 
behaviour and brain function (Ziv et al., 2013). Like in a number of other species cortisol is 
present in unfertilised eggs and is necessary for development of the embryo (Nesan and Vijayan, 
 
 
Figure 1.12 The postulated pathway for glucocorticoid production in zebrafish 
Like humans, cortisol is the main glucocorticoid in zebrafish and it is synthesised from 
cholesterol. Many of the steroidogenic enzymes are duplicated in zebrafish, including the first 
step by the P450 side chain cleavage orthologues, Cyp11a1 and Cyp11a2. Pregnenolone is 
successively converted by the 17 hydroxylase enzymes (Cyp17a1 and Cyp17a2), the 
3β-hydroxysteroid dehydrogenase enzymes (Hsd3b1 and Hsd3b2) and the single 
21-hydroxylase enzyme (Cyp21a2). Cyp11c1 is the single 11β-hydroxylase enzyme which 
generates cortisol from 11-deoxycortiosl. Cortisol performs both glucocorticoid and 
mineralocorticoid actions though binding of glucocorticoid receptor (GR) and the 
mineralocorticoid receptor (MR) on targeted tissues, respectively. 11-deoxycorticosterone, 
DOC.  
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2013, Pikulkaew et al., 2011). Inhibition of early cortisol action leads to defects in mesoderm 
formation (Pikulkaew et al., 2011), muscle development (Nesan et al., 2012), craniofacial 
development (Hillegass et al., 2008) and cardiac performance (Nesan and Vijayan, 2012) in the 
developing zebrafish. Overall, studies have revealed that cortisol mechanisms of action are 
essential for embryonic development and adult life and it provides a useful model for further 
insight into the role of glucocorticoids in development and disease.  
 
In addition to its glucocorticoid actions, cortisol controls ionic and osmotic regulation in teleost 
fish. In order to maintain hypertonic body fluids in a fresh water environment, zebrafish absorb 
ions; a process thought to be regulated predominantly by cortisol (Kumai et al., 2012, Laurent 
and Perry, 1990, Lin et al., 2011). The human MR has two physiological ligands, aldosterone and 
cortisol (Fuller et al., 2012). It is generally accepted that teleost fish are unable to synthesise the 
mineralocorticoid aldosterone, despite having a highly conserved MR (Pippal et al., 2011). 
Although less potent than aldosterone and deoxycorticosterone (Colombe et al., 2000), cortisol 
can bind and activate the zebrafish MR in vitro suggesting this hormone can regulate 
mineralocorticoid physiological actions in zebrafish (Pippal et al., 2011). Conversely, others have 
hypothesised that 11-deoxycorticosterone might be the ligand for the teleost mineralocorticoid 
receptor (Bury and Sturm, 2007, Gilmour, 2005, Prunet et al., 2006, Sturm et al., 2005). 
Deoxycorticosterone is present in teleost fish in significant concentrations and binds the MR 
(Pippal et al., 2011, Sturm et al., 2005). However, the zebrafish’s adaption to hypertonic 
environments was not mediated by 11-deoxycorticosterone (McCormick et al., 2008). Regardless, 
teleost corticosteroids (cortisol and/or deoxycorticosterone) have critical roles in electrolyte 
homeostasis, possible roles in energy metabolism and ion regulation (Gilmour, 2005). However, 
evidence on the specific role of mineralocorticoids in zebrafish is considerably less than its 
glucocorticoids counterparts and requires further investigation. 
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1.9 The regulation of glucocorticoid production in zebrafish 
1.9.1 The zebrafish interrenal 
The zebrafish interrenal is the equivalent of the mammalian adrenal gland (Hsu et al., 2003, Liu, 
2007). Structurally, the interrenal is located within the anterior part of the zebrafish kidney. It is 
imbedded amongst the chromaffin cells within the kidney head, rather than a distinct organ on 
top of the kidneys like in the mammal. However, like the mammalian adrenal gland, the zebrafish 
interrenal shares its origins from the kidney and gonadal primordia under the regulation of 
Wilms’ tumour suppressor 1 (WT1) transcription factor (Bandiera et al., 2013, Hsu et al., 2003, 
Luo et al., 1994). WT1 causes differentiation of the interrenal cells through regulating expression 
of the transcriptional activator Ff1b, the homologue to the mammalian SF1. Both ff1b deficient 
zebrafish (Hsu et al., 2003) and SF1 knockout mice (Lala et al., 1995, Luo et al., 1995) fail to 
develop interrenal tissue or adrenal glands, respectively. Additionally, the functional role of the 
interrenal is also well conserved. It is the primary site of steroid synthesis in teleost fish (Grassi 
Milano et al., 1997). It expresses genes required for steroid hormone synthesis, including StAR, 
cyp11a2, and 3β-hsd which are required for interrenal function (Hsu et al., 2003, Keegan and 
Hammer, 2002, Parajes et al., 2013). Although the structural organisation of the endocrine gland 
is different between teleost fish and mammals, the development during organogenesis and 
functional capabilities are highly conserved. 
 
1.9.2 Hypothalamus-pituitary-interrenal axis 
Zebrafish have proved to be an excellent model to gain insights into the corticoid stress axis in 
vertebrates. In higher vertebrates, CRH from the hypothalamus drives POMC expression in the 
pituitary, giving rise to ACTH to regulate glucocorticoid production in the adrenal glands. 
Although two POMC genes have been identified in zebrafish (de Souza et al., 2005, Gonzalez-
Chapter one: General Introduction: Zebrafish – An emerging model for endocrine disease 
 
34 
 
Nunez et al., 2003b), only one is capable of generating ACTH (Gonzalez-Nunez et al., 2003a). 
Additionally, zebrafish have a single CRH gene capable of generating the mature CRH peptide 
which is highly conserved with the human orthologue (Chandrasekar et al., 2007) (Figure 1.13).  
 
1.9.3 Development of the hypothalamus-pituitary-interrenal axis 
Whole-mount in situ hybridisation of established markers for the hypothalamus and pituitary 
show these structures are present in the developing zebrafish larvae from 24 hpf (Alsop and 
Vijayan, 2009). Furthermore, by 97 hpf interrenal function is dependent of pituitary signals 
indicating a functioning HPI axis (Alsop and Vijayan, 2009, To et al., 2007). Upon stress (Alsop 
and Vijayan, 2009) or prior to the peak of cortisol during the diurnal rhythm (Dickmeis, 2009), 
CRH is secreted by the hypothalamus which signals the pituitary gland to produce ACTH (Alsop 
and Vijayan, 2009). Subsequent glucocorticoid synthesis occurs when circulating ACTH binds the 
MC2R on the surface of the interrenal cells (Alderman and Bernier, 2009, Alsop and Vijayan, 
2008). On the whole, the molecular mechanisms and development of the HPI axis in zebrafish is 
analogous to the mammalian HPA axis, and therefore zebrafish provide a suitable model to 
investigate the regulation of steroid hormone production.  
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Figure 1.13 Comparison of cortisol production between humans and zebrafish 
In humans, the hypothalamus and pituitary gland regulate cortisol production from the 
adrenal gland. Corticoid releasing hormone (CRH) is produced by the hypothalamus in the 
brain in response to stress. It signals to the pituitary gland which produces 
adrenocorticotropic hormone (ACTH).  ACTH signals to the adrenal gland to synthesise 
cortisol. Although structural different the same regulatory pathway is conserved in zebrafish. 
The zebrafish interrenal is the counterpart of the mammalian adrenal gland. It consists of 
endocrine cells imbedded within the kidney head.  
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1.10 The role of mitochondrial CYP genes in zebrafish 
Zebrafish are a comprehensive model which allows the in vivo investigation into gene function, 
development and disease. Despite the evolutionary distances between mammals and fish, the 
developmental programming, key enzymes and physiological functions of endocrine signalling are 
highly conserved (Chai et al., 2003, Hsu et al., 2003). Due to the whole genome duplication of the 
common teleost ancestor, many zebrafish steroidogenesis genes exist in two copies; however, to 
date there is limited information on expression or function of individual paralogues. 
 
1.10.1  Cholesterol Side Chain-Cleavage Enzyme 
In humans, P450scc (encoded by the CYP11A1 gene) converts cholesterol to pregnenolone 
during the first reaction of steroidogenesis. Zebrafish have duplicated CYP11A genes termed 
cyp11a1 and cyp11a2 (Goldstone et al., 2010). To date, work has largely focused on the cyp11a1 
paralogue (Hsu et al., 2006). This gene is expressed as a maternal transcript and by the zygote 
during embryonic development. Cyp11a1 facilitates the synthesis of pregnenolone which 
stabilises the microtubules. The dynamic changes in the microtubule network are essential for the 
coordinated movement of the blastoderm around the yolk during epiboly (Lee, 2014). 
Consequently, Cyp11a1 is essential for early zebrafish development (Hsu et al., 2006). Until this 
current study the functional capabilities and developmental role of Cyp11a2 remained unknown. 
We showed cyp11a2 expression coincides with the development of the interrenal tissue. 
Additionally, in adults, its expression is restricted to the steroidogenic tissues of the interrenal, 
gonads and brain. Furthermore, knockdown of cyp11a2 impairs de novo pregnenolone and 
subsequent cortisol production, which suggests Cyp11a2 is the functional orthologue of human 
CYP11A1 (Parajes et al., 2013) (Chapter 4.0).  
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1.10.2 Steroid 11β hydroxylase 
The relationship between zebrafish and human genes is often defined in terms of orthologues in 
which genes share the same ancestral gene. Zebrafish have a single identified Cyp11b-like gene, 
termed cyp11c1 (Goldstone et al., 2010). Studies suggest mammalian CYP11B1 evolved from 
cyp11c1 of fish (Nelson et al., 2013), however, zebrafish cyp11c1 does not share synteny with any 
tetrapod Cyp11b genes (Goldstone et al., 2010). With the exception of rainbow trout all teleost 
fish have retained a single cyp11c gene after the whole genome duplication event. Cyp11c1 is 
required for cortisol production, however, whether teleost Cyp11c1 has dual 11- and 18- 
hydroxylase activity for mineralocorticoid production remains undetermined. Located on 
chromosome 16, zebrafish cyp11c1 expression is up regulated between 24 and 48 hpf coinciding 
with the beginning of de novo steroidogenesis (Wang and Orban, 2007, Wilson et al., 2013). 
Furthermore, both the treatment of embryos with an 11β-hydroxylase inhibitor (Metyrapone) and 
morpholino knockdown of Cyp11c1 impair cortisol production in zebrafish embryos (Wilson et 
al., 2013).  
 
Most research to date on the functional characteristics of Cyp11c1 has focused on its role in 
androgen production. Cyp11c1 is required for the synthesis of 11-ketotestosterone, the main 
androgen in teleost fish (Fuzzen et al., 2011, Kusakabe et al., 2002). In zebrafish, testosterone is 
hydroxylated by 11β-hydroxylase to produce 11β-hydroxytestosterone, which is the substrate for 
11β-Hsd2 to produce 11-ketotestosterone (Figure 1.14). Cyp11c1 is implicated in gonadal 
differentiation and it is highly expressed in the androgen producing Leydig cells of the adult testis 
(Sreenivasan et al., 2008, Wang and Orban, 2007). 
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1.10.3 Mitochondrial electron transport chain 
It is well established that ferredoxins are evolutionary well conserved (Ewen et al., 2012), 
however information of this redox pathway in teleost fish is limited. A single study identified an 
adrenodoxin-like peptide in the interrenal of the closely related sea bass (Lates calcarifer) and tilapia 
(Sampath-Kumar, 1994). This suggests the mitochondrial redox co-factors involved in 
steroidogenesis are conserved in the teleost linage. Furthermore, gene expression profiling of 
zebrafish treated with androgen receptor antagonists (Flutamide and Vincolzolin), showed a 
 
 
Figure 1.14 Androgen production in zebrafish 
The principal androgen in zebrafish is 11-ketotestosterone. It is primarily synthesised in the 
testis from conversion of androstenedione to 11β-hydroxyandrostenedione and subsequent 
production of 11-ketoandrostenedione. 11-ketotestosterone and the less abundant 
testosterone are capable of binding and transactivating the androgen receptor (AR) and are 
predicted the most physiologically relevant androgens. Steroidogenic enzymes are shown in 
grey. Cyp11c1, 11β-hydroxylase; Hsd11b2, 11β-hydroxysteroid dehydrogenase type 2; 
Hsd17b, 17β-hydroxysteroid dehydrogenase. 
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significant suppression in fdx1 transcripts in males, along with other genes involved in androgen 
biosynthesis (Martinovic-Weigelt et al., 2011). This advocates a possible role in regulating sex 
steroid synthesis. To date the characterisation of the specific zebrafish paralogues and their 
functional roles has not been reported and will be one of the objectives of this current study. 
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Part Three: Project rational 
1.11 Rational for work 
The year 2015 will mark 50 years since the isolation of human FDX1, however, the detailed 
mechanisms of how this protein works are still poorly understood (Omura, 2011, Suzuki and 
Kimura, 1965). Furthermore, the significance of mitochondrial redox co-factor regulation in 
health and disease remains unknown. Given the dependence of mitochondrial CYP enzymes for 
electron transfer through FDX1, this interaction is of particular importance. In vitro discoveries 
have highlighted that FDX1 modifications can influence steroid hormone synthesis. In contrast, 
the impact of redox regulation on mitochondrial CYP enzymes has not been studied in vivo.  
 
The zebrafish represents a cost-effective vertebrate system to study for the first time the 
mitochondrial redox regulation of steroid hormone production. The high conservation of 
steroidogenic enzymes and pathways between zebrafish and humans make them ideal for 
investigating the regulation of steroidogenesis. The transparency of the embryo together with the 
ease of performing knockdown or knockout studies, mean zebrafish are an ideal model for 
studying specific gene functions and will help in understanding the pathogenesis of human 
endocrine diseases. 
 
1.11.1 Hypothesis and aims 
We hypothesise that FDX1 mutations or changes in its expression will have significant impact on 
steroid hormone production, which could lead to pathophysiological consequences. Furthermore, 
it is proposed that changes in the ferredoxin electron transport chain might be a cause of 
common diseases such as hypertension through influencing steroid hormone production. To test 
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this hypothesis, zebrafish will be used as an in vivo model system to investigate the mitochondrial 
redox regulation of steroidogenesis. The following objectives will be addressed: 
 
o To comprehensively characterise zebrafish mitochondrial steroidogenic CYP enzymes 
and their redox co-factors. 
o To establish zebrafish as an in vivo model for endocrine development and its disorders. 
o Investigate the influence of mitochondrial redox reactions on steroid hormone synthesis 
in vivo by using zebrafish as a vertebrate model system.  
 
The proposed project will support our understanding of the physiological processes regulating 
steroid hormone synthesis. Additionally, it will provide insights into zebrafish physiology and 
develop it as a translational model for human pathophysiology. These results will broaden the 
knowledge of CYP enzymes and co-factor regulation in general, and highlight the functional 
importance of redox regulation in health and disease. 
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 GENERAL MATERIALS AND METHODOLOGIES 2.0
Chemical reagents were supplied by Sigma Aldrich (Dorset, United Kingdom) unless otherwise 
stated. Restriction enzymes and T4 DNAse ligase were provided by New England Biolabs 
(Hitchin, United Kingdom). Oligonucleotides were synthesised by Sigma Aldrich at 0.025 μmol 
and purified by desalting. Dried oligonucleotides were resuspended in nuclease free water to a 
concentration of 100 μM and stored at -20 °C. 
 
2.1 Molecular biology materials and methodologies 
2.1.1 Standard solutions 
Luria Bertani (LB) media 12.5 g LB powder was made up to 500 mL with deionise water, 
and sterilised by autoclave. 
 
LB agar plates 7.5 g agar per 500 mL of LB media, sterilised by autoclave, poured 
into Petri dishes and cooled. 
 
1 X TBE 40 mM Tris-acetate (pH 8.3), 1 mM diamino ethanetetra-acetic 
acid, disodium salt (EDTA). 
 
DEPC treated water 0.1 % diethl pyrocarbonate (DEPC) water was treated overnight 
and autoclaved to remove DEPC.  
 
1M IPTG IPTG in 50 % ethanol, stored at -20 °C. 
 
20mg/ml X-Gal  200 mg X-Gal in 10 ml dimethylformamide, stored at -20 °C. 
 
 
2.1.2 Transformation of E. coli by heat shock 
The naturally occurring process of transformation allows bacteria to uptake circular plasmid 
DNA. Molecular biology techniques can manipulate this process by allowing competent bacteria 
to uptake plasmids containing genes of interest. As the bacteria replicate they make copies of the 
recombinant plasmid which can be purified for future work. 
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Typically, bronze efficiency competent DH5α Escherichia coli (E. coli) cells (Bioline; London, 
United Kingdom) were transformed by incubating with a recombinant plasmid and using a heat 
shock method. One microlitre of DNA was added to 40 µL of competent cells. The mixture was 
placed on ice for 20 minutes before heat shocking at 42 °C for one minute and then returned to 
ice for five minutes. Two hundred microlitres of LB media was added to the cells and incubated 
for 20 minutes at 37 °C. Finally, the cell suspension was plated onto LB agar plates containing the 
appropriate antibiotic for selection. The agar plates were incubated at 37 °C for 16 hours. 
 
2.1.3 Plasmid DNA preparation 
Plasmid DNA preparation is a method that allows the extraction and purification of plasmid 
DNA from bacteria. Plasmids were prepared using the QIAprep Spin Miniprep kit as per the 
manufacturer’s instructions (Qiagen; Venlo, Netherlands). This kit uses an alkaline lysis method 
of bacterial cells and allows the plasmids to bind onto a silica column. Typically, a single E. coli 
colony was used to inoculate 5 mL of LB media containing the appropriate antibiotic for 
selection. They were cultured at 37 °C for 16 hours at 250 rpm. The culture was centrifuged at 
3,000 rpm for five minutes to pellet the bacteria. The cells were then resuspended in 250 µL 
Qiagen Buffer P1 (50 mM Tris-Cl, pH 8.0; 10 mM EDTA; 100 µg/mL RNase A). The bacteria 
were lysed using 250 µL Qiagen Buffer P2 (200 mM NaOH, 1 % SDS [w/v]) and neutralised by 
adding 350 µL of acetate containing Qiagen Buffer N3. Samples were then centrifuged for 10 
minutes at 13,000 rpm. The remaining supernatant was added to the QIAprep Spin Column and 
centrifuged for one minute to allow plasmid DNA to bind to the column. The column was 
washed by adding 750 µL of ethanol containing PE Buffer and centrifuged for one minute. After 
centrifugation for an additional minute to remove residual wash buffer, the purified plasmid 
DNA was eluted by adding 50 µL of DEPC treated water to the column and centrifuged for one 
minute. Plasmid concentration and purity was determined and samples were stored at -20 °C. 
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2.1.4 Reverse transcription 
Reverse transcription (RT) is a methodology that allows for the generation of complementary 
DNA (cDNA) from a purified RNA sample. cDNA was prepared from total RNA using 
SuperScript III Reverse Transcriptase (Invitrogen). Before the RT reaction RNA was treated with 
DNAse to remove any residual genomic DNA contamination from the RNA purification. One 
microgram of RNA was combined in 1x DNAaseI buffer with 1 U of DNaseI amplification 
grade and incubated for one hour at 37 °C. DNase activity was inhibited by adding of 1 μL of 
25 mM EDTA solution and heating 10 minutes at 65 °C. One microlitre of Oligo(dT)20 primers 
and 1 μL of 10 mM dNTP mix was added to the pre-treated RNA in a final volume of 13 μL. 
Samples were incubated at 65 °C for five minutes and cooled on ice to allow annealing of the 
oligonucleotides to the RNA. Four microlitres of Invitrogen’s 5x First strand buffer was added to 
the RNA mix with 1 μL of 0.1 M DTT and 1 µL RNaseOUT Recombinant RNase Inhibitor to 
prevent RNA degradation by RNases. Finally, 1 µL of SuperScript III Reverse Transcriptase was 
added and the samples were incubated at 50 °C for one hour. The enzymes were inactivated by 
incubating at 70 °C for 15 minutes and stored at -20 °C until required.  
 
2.1.5 General expression plasmids 
2.1.5.a. pGEMt-easy 
The pGEM-T Easy vector system (Promega; Madison, United States of America) is a linearised 
vector with single three-prime terminal thymidine residues to allow easy cloning of PCR products 
with compatible deoxyadenosine overhangs. It contains both T7 and SP6 RNA polymerase 
promoters flanking the multiple cloning site. It is amenable for blue/white screening due to the 
presence of the β-galactosidase gene.  
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2.1.5.b. pcDNA6-V5/His 
The pcDNA6-V5 (Life Technologies; Carlsbad, United States of America) drives expression of 
cloned cDNA in mammalian cells via the human cytomegalovirus (CMV) promoter. Additionally, 
it contains a V5 epitope and a polyhistidine (His-tag) metal-binding peptide at the carboxyl-
terminal which allows detection of the protein via Western blot using appropriate antibodies. A 
T7 promoter site is located upstream of the multiple cloning site to permit RNA synthesis by T7 
polymerase.  
 
2.1.5.c. pCS2+ 
The pCS2+ plasmid is a multipurpose expression vector which was primarily used for in vitro 
RNA transcription. It contains a SP6 promoter, upstream of the first multiple cloning site 
followed by a poly-A signal. By directionally cloning cDNA into the first multiple cloning site, 
SP6 RNA polymerase can be used to synthesise messenger RNA in vitro. A second multiple 
cloning site is located after the poly-A signal and permits vector linearisation prior to mRNA 
transcription which prevents transcription of the full plasmid.  
 
2.1.5.d. pET22b+ 
The pET22b+ vector (Merck Millipore; Billerica, United States of America) was used for 
bacterial expression for protein purification. This plasmid has an amino terminal pelB signal 
sequence for periplasmic localisation of the desired protein and an additional carboxyl terminal 
His-tag sequences for protein purification. It contains a T7 RNA polymerase promoter upstream 
of the multiple cloning site for RNA synthesis.  
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2.1.6 Quantification of nucleic acids 
Purified DNA and RNA samples were all quantified using the NanoDrop ND-1000 
spectrophotometer (Thermo Fisher Scientific; Waltham, United States of America). Typically, 
DEPC water was used to determine a background level and then 2.0 µL of sample was applied 
onto the spectrophotometer. For nucleic acid samples, a ratio of A260/280 was used to 
determine purity. A ratio between 1.8 and 2.2 was considered acceptable to use in future 
experiments. 
 
2.1.7 DNA sequencing 
DNA sequencing was performed by the sequencing facility at the Genomics Facility at the School 
of Biosciences within the University of Birmingham (United Kingdom). Typically, 6.4 pmol of 
sequence primer and 400-1000 ng of double stranded plasmid DNA were supplied in 10 µL of 
DEPC water. At this facility they perform BigDye terminator sequencing and the samples are run 
on the capillary sequencer ABI 3730 to produce read lengths up to 1,000 base-pairs. Assembled 
sequence data was viewed and analysed by CLC Main workbench software (Qiagen). Standard 
vector primers were routinely used for sequencing plasmids and are shown in Table 2.1. 
 
 
Table 2.1 Standard vector primers used for sequencing and colony PCR screens 
Primer 
Sequence 
(5-prime to 3-prime) 
T7 TAATACGACTCACTATAGGG 
SP6 ATTTAGGTGACACTATAG 
T7 pIRES GTACTTAATACGACTCACTATAG 
M13 Forward GTAAAACGACGGCCAGT 
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2.1.8 Agarose gel electrophoresis 
Electrophoresis of DNA was carried out at room temperature using 0.7 - 3.0 % (w/v) TBE 
agarose gels. Agarose gels were prepared by heating and dissolving the required amount of 
agarose in TBE buffer. After the solution was cooled to approximately 50 °C, 1x SYBR® Safe 
DNA gel stain (Life Technologies) was added for visualisation of DNA products under 
ultraviolet (UV) excitation. The DNA samples where mixed with DNA loading buffer (Thermo 
Fisher Scientific) and electrophoresis carried out in 1x TBE buffer at 100 volts. Samples where 
run concurrently with Hyperladder I or Hyperladder V (Bioline) as a molecular weight marker for 
product size determination. The DNA bands were visualised under UV transillumination at 
300 nm. 
 
2.1.9 Enzymatic restriction digests 
Bacterial restriction enzymes cut double stranded DNA at specific recognition sites. Restriction 
digest reactions were performed to confirm ligation of cDNA into plasmids or to linearise 
plasmids prior to mRNA transcription. One to 6 µg of plasmid DNA or purified PCR product 
was incubated in 10 or 50 µL reactions with the appropriate buffer. Reactions were carried out 
using 1 U of enzyme per microgram of DNA. Samples were typically incubated at 37 °C for at 
least one hour to ensure complete digestion. After digestion samples were either purified by 
QIAquick PCR Purification Kit (Qiagen) or run on an agarose gel to with undigested control to 
confirm complete digestion. 
 
2.1.10 Alkaline phosphatase treatment of linarised vectors 
Linarised plasmids were dephosphorylated using calf intestinal alkaline phosphatase (CIP) (New 
England Biolabs) to avoid recirculation after restriction digestion. For this purpose, 10 U CIP 
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was added to the restriction digestion reaction and incubated for one hour at 37 °C. Enzyme 
deactivation was performed by incubating the mix at 75 °C for ten minutes.  
 
2.1.11 DNA purification  
Purification of DNA from enzymatic reactions such as PCR or restriction digests was carried out 
using the QIAquick PCR Purification Kit according to the manufactures instructions (Qiagen). 
Briefly, five volumes of Buffer PB were added to one volume of reaction mix. To ensure correct 
pH for DNA binding to the silica column, 10 µL of 3 M sodium acetate was also added. The mix 
was added to the QIAquick silica column and centrifuged 13,000 rpm to bind the DNA. The 
column was washed adding 750 µL of Buffer PE and centrifuging 13,000 rpm for one minute. 
An additional centrifugation for one minute was performed before the DNA was eluted in 40 µL 
of DEPC water. Samples were stored at -20 °C until required. 
 
2.1.12 Agarose gel DNA purification 
Purification of DNA fragments from agarose gels fragments was performed by QIAquick Gel 
Extraction Kit (Qiagen). After samples were separated by agarose gel electrophoresis, the desired 
DNA fragment was excised from the gel using a scalpel and transferred to a 1.5 mL 
microcentrifuge tube. Samples were weighed and three volumes of Buffer QG were added for 
each volume of gel slice. To help the Buffer QG solubilises the agarose gel, samples were 
incubated at 50 °C for ten minutes. Optimal pH for DNA binding the silica column was achieved 
by adding 10 µL of 3 M sodium acetate (pH 5.0). Subsequently, one volume of isopropanol was 
added and the samples were mixed. The DNA was bound to the QIAquick silica column by 
centrifuging at 13,000 rpm for one minute. The column was washed in 750 µL of Buffer PE and 
centrifuged at 13,000 rpm for one minute. After an additional centrifugation for a minute to 
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remove residual wash solution, the samples were eluted in 40 µL of DEPC water. Samples were 
stored at -20 °C until required. 
 
2.1.13 T4 DNA ligation  
The T4 DNA ligase enzyme catalyses the formation of a phosphodiester bonds between the five-
prime phosphate and three-prime hydroxyl termini of DNA, allowing the joining of double 
stranded DNA fragments. Typically, a ratio of five moles of insert to one mole of vector was 
used for ligation reactions. Ten microlitre reactions containing, digested and purified plasmid and 
an insert with compatible ends, were combined with 1x T4 DNA Ligase buffer and 1 µL of T4 
DNA ligase enzyme. Reactions were mixed gently and incubated overnight at 4 °C. The 
following day, 10 µL ligation reactions were used to transform 50 µL of gold efficiency 
competent DH5α E. coli cells (Bioline) by the standard transformation protocol. 
 
2.1.14 pGEMT-easy ligation  
The pGEM-T Easy vector system (Promega) allows for cloning of PCR products with three-
prime adenosine overhangs. A ratio of five moles of insert to one mole of pGEM-Teasy vector 
was used in 1x ligase buffer with 3 U of T4 DNA ligase enzyme. Reactions were mixed gently 
and incubated overnight at 4 °C. The following day, 10 µL ligation reactions were used to 
transform 50 µL of gold efficiency competent DH5α E. coli cells (Bioline) by the standard 
transformation protocol.  
 
2.1.15 Colony Polymerase Chain Reaction 
Colony PCR is a method to screen transformed bacteria for presence of a specific plasmid DNA 
construct. The initial melting step of the PCR bursts the bacteria, making the plasmid DNA 
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available to act as a template for primers. Twenty-five microlitre reactions were performed using 
BIOTAQ DNA polymerase (Bioline). Briefly, a mix of 1x NH4 reaction buffer, 4 mM MgCl2, 
1 mM of dNTPs, and 0.2 μM each of forward and reverse oligonucleotides were used. Either 
gene specific oligonucleotides were used or if direction specificity of the insert was required, a 
vector targeting oligonucleotide (Table 2.1) with a gene specific oligonucleotide was used. Using a 
pipette tip, individual colonies were scraped off the LB agar plates and combined with the PCR. 
The pipette tip was left to inoculate 100 µL of LB media. PCR consisted of an initial 10 minutes 
at 94 °C followed by 35 cycles of 94 °C for 30 seconds, a 30 second anneal step and a 72 °C 
extension step. A final seven minute extension step completed the PCR. Reactions were then run 
on an agarose gel to determine positive clones. Once positive clones were identified the 
corresponding 100 µL of LB media was used as a starter culture for plasmid purification  
 
2.1.16 RNA extraction 
RNA extraction is a procedure which allows for the isolation of RNA from a biological sample 
and therefore providing a snapshot of the genes being actively transcribed at that the respective 
time point. RNA was isolated from dissected zebrafish tissues or a pool of zebrafish embryos 
using TRI-Reagent. Samples were washed in phosphate buffered saline (PBS) before 1 mL of 
TRI-Reagent was added. Tissues were homogenised using a micropestle (Eppendorf; Hamburg, 
Germany). Two hundred microlitres of chloroform was added to the samples and they were 
mixed vigorously. Samples were incubated at room temperature for 10 minutes and centrifuged at 
13,000 rpm for 20 minutes. The upper aqueous phase containing the RNA was transferred to a 
fresh microcentifuge tube. The RNA was precipitated at -20 °C overnight using 500 μL of cold 
isopropyl alcohol. The following day, RNA was pelleted by centrifugation at 13,000 rpm for 10 
minutes at 4 °C and washed in 70 % ethanol. After a further centrifugation step at 13,000 rpm 
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for 10 minutes at 4 °C the supernatant was removed and the RNA was allowed to dry. RNA was 
then resuspended in RNase-free water, quantified and stored at -20 °C. 
 
 
 
2.1.17 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
Semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) was used to 
investigate gene expression by using Megamix-Blue (Microzone Ltd; West Sussex, United 
Kingdom). Typically, 0.6 μM of specific forward and reverse oligonucleotides were combined 
with 1.5 μL of cDNA in a 25 μL reaction volume of Megamix-Blue. Reactions were run with an 
initial denaturing step of 95 °C and then 40 cycles consisting of a 95 °C for 30 seconds, 
30 seconds for annealing at the appropriate temperature for the primers and extension at 72 °C 
for one minute per 1,000 base-pairs of product. A final extension of 72 °C for seven minutes 
completed the PCR. For visualisation of PCR products, 12 µL of the reactions were run on DNA 
agarose gel. 
 
For amplification of full length coding sequences of zebrafish genes, Expand High Fidelity PCR 
System (Roche; Basel, Switzerland) was used. Specific oligonucleotides were designed typically with 
endonuclease restriction sites for direct cloning into the required plasmid. Fifty microlitre reactions 
consisted of 1x Expand High Fidelity PCR system buffer, 2 mM MgCl2, 0.4 μM of dNTPs, 0.3 μM of 
each forward and reverse oligonucleotides, 1.5 μL of cDNA and 2.6 U of polymerase mix. Reactions 
were performed using a single denaturing step at 94 °C for five minutes, 40 cycles consisting of 94 °C 
for 30 seconds, annealing temperature between 52 °C and 58 °C (depending on the oligonucleotide 
melting temperature) and an extension time of one minute per 1,000 base-pairs at 68 °C. A final 
extension of 72 °C for seven minutes completed the PCR cycle. 
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2.2 In silico protein analysis 
2.2.1 Multiple sequence alignments 
Multiple protein alignments and homology analyses were performed using ClustalW2 software 
under default parameters (URL: http://www.ebi.ac.uk/Tools/msa/clustalw2/). Typically, 
ENSEMBL (version Zv9) protein sequences were imported in FASTA format for analysis. 
Phylogenetic analyses of protein sequences were performed with the PhyML software under the 
SH-like likelihood-Ratio test parameters (URL: http://www.phylogeny.fr/) (Dereeper et al., 
2008). Scaled phylogenetic tree was drawn with TreeDyn software. 
 
2.3 Zebrafish husbandry and methodologies  
2.3.1 Zebrafish nomenclature 
Nomenclature used throughout this thesis is consistent with the current guidelines based on the 
Trends in Genetics Genetic Nomenclature Guide for Zebrafish (Mullins, 1995). Typically, zebrafish 
genes are named after the mammalian orthologue and written italicised and in lower case. 
Zebrafish protein symbols are the same as the gene symbol, but not italicised and the first letter is 
uppercase. A comparison between different species naming conventions is shown in Table 2.2. 
 
Table 2.2 Zebrafish and mammalian naming conventions 
Species Gene Protein 
zebrafish fdx1 Fdx1 
human FDX1 FDX1 
mouse/bovine Fdx1 FDX1 
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2.3.2 Standard solutions 
E3 Media 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4 
made up in dionised water and supplemented with 2 µg/mL 
gentamycin. 
 
DNA extraction buffer  10 mM Tris-HCl (pH 8.0), 1.0 mM EDTA and 200 µg/mL 
Proteinase K. 
 
Phenylthiourea (PTU) 0.003 % 1-phenyl 2-thiourea in E3 media. 
 
Pronase solution Protease Type XIV from Streptomyces greiseus was diluted in DEPC 
water to a concentration of 10 mg/mL and stored at -20 °C. 
 
Rhodamine dextran soltuion 4 % (w/v) 10,000 MW rhodamine dextran in 0.2 mol/L potassium 
chloride. 
 
 
2.3.3 Zebrafish maintenance 
All zebrafish work was performed under project licence PPL 40/3681 and personal licence 
ICB7ED2A1 in accordance with the HOME Office Animal (Scientific Procedures) Act 1986. 
The zebrafish wild-type AB strain was maintained in a recirculating system (Tecniplast; Kettering, 
United Kingdom) at 28.5 ºC with a 10:14 hour dark:light photoperiod. Adults were fed three 
times per day with granule fish food and brine shrimp (ZMSystems; Hampshire, United 
Kingdom). Embryos were obtained by natural spawning and incubated at 28.5 ºC in E3 medium. 
To prevent pigment formation embryos required for imaging were incubated with E3 medium 
supplemented with PTU from 24 hours post fertilisation (hpf). The developmental stages were 
determined according to hpf and morphological features as previously described by Kimmel et al. 
(1995). 
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2.3.4 Breeding strategy to generate knockout zebrafish lines 
To generate several zebrafish lines harbouring mutations in specific steroidogenic genes I used 
Transcription Activator-Like Effector Nucleases (TALENs) (Chapter 5.0) or the Clustered 
regularly interspaced short palindromic repeats and Cas9 nuclease (CRISPR/Cas9 system) 
(Chapter 6.0). The following strategy was used to generate knockout embryos (Figure 2.1). The 
TALEN or CRISPR/Cas9 RNA was injected into single-cell embryos. During cleavage and 
blastula phases, the RNA and subsequent protein is dispersed throughout the blastomere. The 
mutations generated from the TALENs or CRISPR/Cas9 is different in each cell, creating 
mosaic embryos which were raised to adulthood. Adult zebrafish harbouring mutations within 
the germ-cells, and therefore capable of transmitting mutations to the next generation (F1), were 
identified by out-crossing to a wild-type and screening the off-spring for genomic disruption. 
Embryos from positive clutches were raised to adults. These adults were genotyped from fin clips 
and sequenced to identify the specific mutation. Once adults harbouring a mutation were 
identified they were out-crossed to wild-type zebrafish, producing the F2 generation which would 
contain embryos heterozygous for the same mutation (50 % of embryos with Mendelian 
inheritance). These embryos were raised to adults. Heterozygous adults were identified by 
genotyping fin clips, and were in-crossed to produce the F3 generation. With Mendelian 
inheritance, 25 % of F3 embryos were expected to be homozygous for the specific mutation.  
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Figure 2.1 Breading strategy to generate homozygous mutant zebrafish lines 
To generate knockout stable lines single-cell embryos were subjected to genome editing by 
injecting TALEN or CRISPR/Cas9 RNA. As the blastomere grows and divides the genome 
editing occurs. Adults raised from these injections are mosaic for different mutations (m). 
Out-crossing injected adults identifies fish capable of germ-line transmission of genetic 
mutations. F1 generation siblings may have different mutations (m1 or m2) as the parent is 
mosaic. Out-crossing of individual F1 adults produces the F2 generation which are 
heterozygous (+/m2) for the same mutation. In-crossing of two heterozygotes will generate 
embryos homozygous for the mutation (m2/m2). 
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2.3.5 Embryo collection  
For zebrafish embryo collection, a sexually mature male and female adult were placed in three 
litre breading tanks separated by a baffle. Each breading tank has an internal raised tank with a 
latticed bottom which allowed externally fertilised eggs to fall through to the bottom of the tank 
preventing adult fish from consuming them and ensuring easy collection. Zebrafish naturally 
spawn shortly after dawn and each female can produce 100 to 300 eggs each week. To make 
spawning as natural as possible, the following morning the baffles were removed shortly after the 
facility lights were turned on. Upon detection of eggs, adult zebrafish were transported to a new 
tank and the eggs were collected in a small sieve and transferred to a petri dish with a Pasteur 
pipette. The collected eggs were sorted and checked for fertilisation and vitality under a 
dissection microscope and incubated in E3 Media at 28.5 °C until the desired time point was 
reached.  
 
2.3.6 Dechorionation of zebrafish embryos 
Naturally, zebrafish develop inside a chorion, which is a tough outer membrane that protects the 
developing embryo for the first three days of development. Observations of zebrafish 
development can be made through the chorion; however, for some techniques such as imaging, it 
is beneficial to remove the chorion. When raised at 28.5 °C in E3 medium embryos can develop 
normally outside of their chorion. After 18 hpf chorions can be removed manually by using 
Dumont No. 5 forceps to tear it and allowing the embryo to fall out.  
 
Chorions can also be chemically digested using pronase. Single cell embryos were placed in a 
Petri dish and incubated in pronase solution. When the chorions begin to collapse, embryos were 
transferred to a one litre glass beaker containing fish water. Embryos were gently washed at least 
four times in one litre of fish water to remove excess pronase and chorions. Finally, using a 
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transfer pipette embryos were placed in agarose coated Petri dishes contain E3 medium. 
Dechorionated embryos were continually submerged in media, as exposure to air causes the 
embryos to burst.  
 
2.3.7 In vitro mRNA synthesis 
In order to perform rescue experiments, full length coding sequences were cloned into the pCS2+ 
plasmid. The SP6 RNA polymerase promoter allows for in vitro transcription of sequences cloned into 
the polylinker one site. It also generates a polyadenylation tail (pA) via the SV40 polyadenylation site 
down steam of the cloned gene. In a 50 µL reaction, 5 µg of pCS2+ plasmids was linearised by a 
unique restriction enzyme in polylinker two. This linearisation prevents continuous mRNA 
synthesis of plasmid DNA by the RNA polymerase. Complete digestion was confirmed by 
running 2 µL of the reaction on a 1 % DNA agarose gel and the remainder was purified using 
QIAquick PCR Purification Kit (Qiagen).  
 
In vitro mRNA synthesis was performed using mMessage mMachine Kit (Life Technologies). The 
20 µL transcription reactions were assembled at room temperature using 1 µg of linarised DNA 
template, 1x SP6 transcription buffer, 1x NTP/CAP ribonucleotides, and 2 µL of SP6 RNA 
polymerase. After mixing, reactions were incubated at 37 °C for two hours. Subsequent treatment 
at 37 °C for 15 minutes with 1 µL of TURBO DNase removed the DNA template.  
 
In vitro derived mRNA was then purified using the GenElute Mammalian Total RNA Miniprep 
Kit (Qiagen). Elution solution was used to make the final volume RNA mix to 100 µL. Three 
hundred and fifty microlitres of fresh lysis Solution/2-mercaptoethanol mixture was added and 
the solution mixed thoroughly. Subsequently, 250 µL of 100 % ethanol was added to the 
solution. After mixing, the RNA sample was added to the RNA binding column and centrifuged 
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at 13,000 rpm for 15 seconds. The binding column was transferred to a new tube and washed 
twice with Wash 2 solution by centrifuging at 13,000 rpm. After a final centrifugation to remove 
residual wash solution, the RNA was eluted into a fresh tube by adding 30 µL of nuclease-free 
water to the column and centrifuging at 13,000 rpm for one minute. Typically, the concentration 
and quality was determined by spectrophotometer and running the samples on an agarose gel, 
respectively. Aliquots of RNA were stored at -80 °C until required.  
 
2.3.8 In vivo knockdown by antisense morpholino 
Antisense morpholino oligonucleotides were synthesised by Gene Tools, LLC (Philomath, 
United States of America). Morpholinos are synthetic oligonucleotides similar to DNA 
oligonucleotides, except they have a morpholine ring and a non-charged phosphorodiamidate 
backbone, making them resistant to nucleases (Nasevicius and Ekker, 2000). They were designed 
to bind either the initiating methionine codon on mRNA to block formation of translational 
machinery or over splice site junctions to disrupt correct splicing of mRNA. Each morpholino 
comprised of a 25 base-pair antisense sequence of approximately 50 % guanine/cytosine 
nucleotide content without any predicted internal hairpins. Candidate sequences were then 
screened for representation elsewhere in the zebrafish genome by performing a BLASTn 
database search (URL: http://www.ncbi.nlm.nih.gov/BLAST/). Control morpholinos were also 
synthesised by creating a five nucleotide mismatch to the targeting site to determine off-target 
effects. Morpholinos were resuspended in DEPC water to a concentration of 1 mM and stored at 
-20 °C until required.  
 
2.3.9 Morpholino microinjection of single cell zebrafish embryos 
The morpholino stock solution was diluted to working concentrations of 0.5 - 6 ng/nL in DEPC 
water containing 0.05 % phenol red. Two microlitres of 4 % rhodamine dextran was also added 
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to the 10 µL injection mixes as a fluorescent tracer. Approximately 2 nL of the working solution 
was microinjected into the yolk of single cell embryos. Phenol red served as a visible marker for 
injections. Approximately, four hours after injection embryos were screened for rhodamine 
dextran fluorescence to identify effectively injected embryos using a 554 nm laser on a 
fluorescence microscope (SMZ1500-P-FLA2, Nikon UK Limited; Surrey, United Kingdom).  
 
2.3.10 Fin clipping adult zebrafish 
Adult zebrafish were anesthetised by immersion in 0.004 % in Tricaine Methanesulfonate 
(MS-222) pH 7.2 until gill movement is slowed and the fish had stopped swimming. Fish were 
transferred to a Petri dish and the fin was clipped using a sterile scalpel. The fish was immediately 
transferred to a tank containing 1.5 L of fresh system water and monitored while swimming 
ability was regained. Post fin clipping, fish were housed in individual holding tanks while genetic 
DNA was isolated for the purposes of genotyping.  
 
2.3.11 Genomic DNA extraction 
The extraction of genomic DNA from either pooled embryos or adult fin clips was performed to 
determine genomic alterations after genome editing or for sequencing specific loci. Embryos or 
fin clips were incubated overnight in 30 µL of DNA extraction buffer. Subsequently, the 
proteinase K was inactivated by heating samples to 95 °C for 15 minutes. Debris was pelleted by 
centrifuging 4,000 rpm for 10 minutes. The supernatant containing the genomic DNA was 
transferred to a clean microcentrifuge tube and stored at -20 °C until required. 
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2.4 Cell biology materials and methodologies 
2.4.1 Standard solutions 
5x SDS Loading Buffer 250 mM Tris-HCl pH 6.8, 50 % glycerol, 10 % sodium dodecyl 
sulphate (SDS), 1 % β-mercaptoethanol, 0.25 % bromophenol 
blue. 
 
PBST PBS with 0.1 % Tween 20.  
 
Blocking buffer 10 % skim milk in PBST. 
 
RIPA buffer   150 mM sodium chloride, 1.0 % Triton X-100, 0.5 % sodium 
deoxycholate, 0.1 % SDS (sodium dodecyl sulphate), 50 mM Tris, 
pH 8.0.  
 
2.4.2 Mammalian cell culture 
The COS-7 cell line was isolated from the kidney of the African Green Monkey (Cercopithecus 
aethiops) and is commonly used for enzyme activity assays. Cells were grown in Dulbecco's 
Modified Eagle's medium (DMEM) high glucose and glutamine (4 mM) (Life Technologies), 
supplemented with 10 % foetal bovine serum, 100 U/mL penicillin and 0.1 mg/mL 
streptomycin. Cells were maintained at a density of 2 x 103 to 1 x 104 cells/cm2 in a 5 % carbon 
dioxide, 37 C humidified incubator. Harvesting of the cells was performed using trypsin 
digestion using Tryple Express (Life Technologies) and cells subcultured using a 1:4 to 1:8 split.  
 
2.4.3 Transfection of mammalian cell lines 
Transfection is a process whereby DNA is deliberately introduced into a eukaryotic cell. Often in 
molecular biology, transfection of a plasmid containing a cloned cDNA sequence allows the 
over-expression of the gene by a highly expressing promoter. Twenty-four hours before 
transfection, cells were seeded at 300,000 cells per well of a six-well plate. A ratio of 3 μL of 
X-treameGene HP Reagent to 1 μg of plasmid DNA was mixed in 100 µL of DMEM. After 
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incubation at room temperature for 15 minutes to form transfection complexes, 100 μL was 
added drop-wise to each well. Subsequently, fresh media with bovine serum and antibiotics was 
added after six hours.  
 
2.4.4 In vitro enzyme activity assay 
2.4.4.a. 22R-hydroxycholesterol conversion assay 
The enzyme activity of the zebrafish Cyp11a1 and Cyp11a2 was assessed by measuring the 
conversion of 22R-hydroxycholesterol into pregnenolone. The intermediate product 
22R-hydroxycholesterol does not rely on StAR-mediated transport to enter the mitochondria; 
therefore, enzymatic activity can be measured independent of StAR activity. Forty-eight hours 
after transfection cells were subjected to conversion assays. Cells were incubated for four or 24 
hours at 37 °C with 1,000 µL of DMEM containing 2 µM 22R-hydroxycholesterol and 200 µM of 
NADPH. Ethanol was added to cells as a negative control. After the incubation, media was 
collected separately in sylinised test tubes (Fisher Scientific; Loughborough, United Kingdom) 
and subjected to cell media steroid extraction.  
 
2.4.4.b. 11-deoxycortisol conversion assay 
Enzymatic activity of zebrafish Cyp11c1 was assessed by measuring the conversion of 
11-deoxycortisol to cortisol. Functional activity assays were performed 48 hours after 
transfection. Cells were treated with 1,000 μL of 2.5 μM of 11-deoxycortisol, 5 μM of 
18β-glycyrrhetinic acid (an 11β-hydroxysteroid dehydrogenase inhibitor to prevent the 
11β-hydroxysteroid dehydrogenase type 2 activity endogenous to COS7 cells), and 200 µM of 
NADPH and incubated for six or 24 hours at 37 °C in a humidified incubator. Ethanol was 
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added to cells as a negative control cells. After the incubation steroid were extracted from cell 
media.  
 
2.4.5 Protein extraction 
Media was aspirated and COS7 cells were washed twice in 10 mL ice-cold PBS before being 
harvested. Cells were harvested in 1 mL of Radio Immunoprecipitation Assay buffer (RIPA 
buffer) supplemented with a protease inhibitor (Complete Mini Tablets; Roche). Cells were 
removed by scraping and collected in a microcentrifuge tube. The cell solution was vortexed for 
10 seconds followed by incubation at –20 °C for 30 minutes. Debris was pelleted by 
centrifugation at 13,000 rpm for ten minutes at 4 °C. The supernatant containing the proteins 
was then collected in a fresh microcentrifuge tube for protein quantification. 
 
2.4.6 Protein quantification 
Protein concentrations were determined the Bio-Rad DC Protein Assay according to the 
manufactures instructions (Bio-Rad Laboratories, Inc.; Hercules, United States of America). Prior 
to the assay, a small aliquot of harvested protein was diluted in distilled water. A fresh mix was 
made containing 20 µL of Reagent S for each millilitre of Reagent A required of the assay. Five 
microlitres of each sample was added to a well of a 96-well plate followed by 25 µL of Reagent A 
(supplemented with Reagent S). Then 200 µL Reagent B was added and the plate was mixed. 
Finally, after 15 minutes absorbance were read at 750 nm using the Victor3 plate reader (Perkin 
Elmer; Turku, Finland) using Wallac 1420 software (Perkin Elmer). Concentrations of proteins 
were derived by comparison of a standard curve ranging from 0.2 mg/mL to 2.0 mg/mL of 
protein using bovine serum albumin diluted in the same buffer as the proteins. Blank samples 
containing no bovine serum albumin were also used to determine background absorbance.  
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2.4.7 SDS Poly Acrylamide Gel Electrophoresis 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis or SDS PAGE, is a method that 
allows for the separation of proteins based on size. Typically, 10 µg of protein sample was mixed 
with 1x loading buffer in a final volume of 20 µL. Samples were heated at 95 °C for five minutes 
and cooled on ice. Samples were loaded on a 10 % NuPAGE Novex Tris-Bis precast gel 
(Invitrogen) and run at 200 volts for one hour in 1x NuPAGE Buffer (Invitrogen).  
 
2.4.8 Protein transfer using the iBlot Blotting System 
Upon completion of gel electrophoresis proteins were transferred to nitrocellulose membranes 
using the iBlot 7-Minute Blotting System (Invitrogen) consisting of the iBlot Gel Transfer Device 
and iBlot Gel Transfer Stacks. SDS PAGE gels were rinsed in deionised water and placed on top 
of the iBlot Anode Stack containing the nitrocellulose membrane. Filter paper pre-soaked in 
deionised water was placed on top of the acrylamide gel and any air bubbles were removed. The 
iBlot cathode stack was positioned with the electrode side facing up. After completion of the Gel 
Transfer Stack a seven minute dry transfer at 23 volts was performed using the iBlot Gel Transfer 
Device.  
 
2.4.9 Western Blot 
Western Blot is a technique that uses specific antibodies to detect proteins of interest which have 
previously been separated based on their size by SDS PAGE. Antibodies used for western 
blotting analysis were purchased from Abcam (Cambridge, United Kingdom) and are detailed in 
Table 2.3. 
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Table 2.3 Antibodies for Western Blotting 
Antibody dilution Catalogue number 
mouse-anti-V5 1:1000 ab9137 
mouse-anti-β-actin-HRP 1:1000 ab20272 
Anti-mouse-HRP 1:20,000 ab97046 
 
 
Initially, nitrocellulose membranes were blocked for one hour at room temperature in blocking 
buffer. The membranes were incubated overnight at 4 °C with primary antibody (mouse-anti-V5) 
at the required dilution in blocking buffer. The following day the membranes were washed three 
times for five minutes in PBST. The secondary antibody (Anti-mouse-HRP) was diluted to the 
appropriate concentration in blocking buffer and incubated with the membrane for one hour. 
Finally, the membrane was washed three times for five minutes in PBST. Following antibody 
incubation, the blot was developed using ECL detection kit (GE health care; Little Chalfont, 
United Kingdom) according to the manufactures instructions and developed on Kodak film. To 
establish equal loading mouse anti-β-actin-HRP was used 1:20,000 dilution. After blocking, 
membranes were incubated with the antibody for one hour, washed and develop as described 
above. 
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2.5 Biochemical materials and methods 
2.5.1 Standard Solutions 
Internal Standards Deuterated cortisol (Cortisol-d4), 11-deoxycortisol (11-
deoxycortisol-d2), corticosterone (corticosterone-d8), testosterone 
(testosterone-d3), Dihydroxytestosterone (DHT-d3), 
Dehydroepiandrosterone (DHEA-d6), 17-hydroxyprogesterone 
(17OHP-d8), progesterone (progesterone-d9), pregnenolone 
(pregnenolone-d4), and 17-hydroxypregnenolone (17OHPreg-d3) 
were combined to make a stock solution containing 1 µg/mL of 
each steroid. 
 
 
2.5.2 Steroid hormone extraction from zebrafish 
To determine the steroid hormone profiles of zebrafish embryos, a steroid hormone extraction 
method was developed to quantify cortisol and pregnenolone by liquid chromatography/tandem 
mass spectrometry (LC-MS/MS). Typically, 300 zebrafish embryos were collected for each time 
point of development. Dechorionated embryos and larvae were gently washed twice in 1x 
Dulbecco’s modified PBS and kept in 1 mL 1x Dulbecco’s modified PBS at -20 ºC until required. 
 
To extract steroid hormones, zebrafish embryos were thawed at 55 ºC, followed by addition of 
10 ng of deuterated steroid internal standards. After samples were frozen and thawed three more 
times, they were homogenised for one minute using a PowerGen 125 homogeniser using small 
stainless-steel blades (Fisher Scientific Ltd.; Leicestershire, United Kingdom). Between samples, 
blades were rinsed with 1 mL 1x Dulbecco’s modified PBS, which was combined with the 
homogenised samples. Steroid hormones were extracted via liquid/liquid extraction four times 
from the homogenates in 5 mL dichloromethane. Organic phases were combined and dried 
under a nitrogen stream at 55 ºC. Samples were resuspended and vortexed in 400 µL of a 1:3 
methanol:water solution. Samples were passed through a Phree phospholipid removal plate 
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(Phenomenex; Cheshire, United Kingdom) to remove residual proteins and lipids. Each Phree 
phospholipid extraction column was equilibrated with 1.2 mL methanol containing 0.1 % formic 
acid. Zebrafish extracts were subsequently added to the columns and the plate was vortexed for 
two minutes. Using a vacuum manifold the solutions passed through the columns under pressure. 
The eluent containing the steroid fraction was collected and evaporated to dryness under a 
nitrogen stream at 55 ºC. Samples were then reconstituted in 125 µL of 50:50 methanol:water for 
LC-MS/MS analysis. 
 
2.5.3 Steroid hormone extraction from cell media 
To analyse specific enzyme catalytic activity, COS7 cells were transfected with the specific 
enzyme of interest and subjected to steroid hormone treatments. All steroids were extracted 
using a liquid/liquid extraction regardless of the substrate. Typically, 1 mL of culture media was 
transferred to a silynised test tube. Twenty nanograms of deuterated internal standard stock were 
added to each sample prior to extraction. Three millilitres of MTBE was then added and the 
samples were vortexed. Samples were then frozen for at least an hour at -20 °C. Using a glass 
Pasture pipette, the top layer was transferred to 96-well plate (Thermo-Fisher Scientific) and 
allowed to evaporate to dryness at 55 °C under nitrogen stream in a 96-well plate evaporator 
(TurboVap, Biotage, United Kingdom). Samples were reconstituted in 125 µL of 50:50 
methanol:water for analysis. 
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2.5.4 Liquid Chromatography/Tandem mass spectrometry (LC-
MS/MS) System Setup 
Steroids were identified and quantified using a Waters Xevo TQ mass spectrometer with an 
ACQUITY ultra high-pressure liquid chromatography (uPLC) system, fitted with a HSS T3 
1.8 μm 2.1 x 50 mm column (Waters Corporation, Milford, United States of America). The 
Waters Xevo was fitted with an electrospray ionisation source, operated in positive mode. 
Twenty microlitres of each sample was injected into the mass spectrometer for analysis. Steroid 
hormones were eluted from the column using a methanol/water gradient system, solvent A was 
water with 0.1 % formic acid, and B was methanol with 0.1 % formic acid. Three different 
gradient systems were used in these experiments for the analysis of cortisol, pregnenolone-oxime 
and the analysis of zebrafish androgens. For positive identification of a steroid within a sample, 
two identical mass transitions and an identical retention time in comparison to an authentic 
steroid standard was required (Table 2.4). To quantify each steroid each method included a 
calibration series ranging from 0.5 to 500 ng/mL. TargetLynx software was used to process the 
mass spectrometry data (Masslynx 4.1; Waters Corporation). 
 
2.5.4.a. Cortisol analysis by LC-MS/MS 
Cortisol analysis was completed using a gradient system starting at 45 % methanol (0.1 % formic 
acid), followed by four linear increases to 47 % at one minute, 57 % at two minutes, 70 % at 2.5 
minutes and 98 % at four minutes. Detection of cortisol in a zebrafish sample relative to an 
authentic steroid standard can be seen in Figure 2.2. 
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Table 2.4 LC-MS/MS parameters for the detection and quantification of cortisol and 
pregnenolone-oxime, androgen and their internal standards cortisol-d4 and 
pregnenolone-oxime-d4. 
 
&Qualifier ions 
 
 
 
Steroid 
Retention 
Time 
(min) 
Mass Transitions 
Cone 
Voltage 
(CV) 
Collision 
Energy 
(CE) 
Cortisol 1.26 
363 > 121 
363 > 97& 
26 
26 
30 
23 
Cortisol-d4 1.24 
367 > 121 
367 > 331& 
24 
24 
24 
16 
Pregnenolone-oxime 2.66 
332 > 86 
332 > 300& 
36 
36 
26 
24 
Pregnenolone-oxime-d4 2.66 
336 > 90 
336 > 304& 
36 
36 
26 
24 
11-ketoandrostenedione 1.70 
303 > 121 
302 > 265& 
30 
30 
24 
18 
11-ketotestosterone 1.48 
303 > 121 
303 > 91& 
34 
34 
26 
50 
11-βOH androstenedione 2.66 
303 > 267 
303 > 145& 
26 
26 
18 
26 
11-βOH testosterone 2.66 
305 > 269 
305 > 121& 
26 
26 
16 
22 
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2.5.4.b. Pregnenolone Analysis by LC-MS/MS: Oxime Derivatisation 
To increase LC-MS/MS sensitivity to lipophilic pregnenolone, an oxime derivatisation method 
was used. Following cortisol analysis, the samples and calibration series were evaporated to 
dryness under nitrogen at 55 ºC. Oxime derivatisation was conducted by adding 100 µL 
2 % hydroxylamine hydrochloride solution in pyridine (w/v) to the dried samples. The mixture 
was vortexed then incubated at 60 ºC for one hour. Oxime-derivatised samples were 
 
 
Figure 2.2 LC-MS/MS detection of cortisol in whole zebrafish extracts 
 
Representative chromatogram showing positive identification of cortisol from whole 
zebrafish embryo extracts. Top is authentic reference standard, and bottom is cortisol from 
zebrafish embryos. The chromatogram is a sum of the two mass transitions defined in Table 
2.4. 
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subsequently dried under nitrogen at 55 ºC then reconstituted in 125 µL of 50:50 methanol:water. 
Reconstituted samples were analysed by LC-MS/MS and quantified as described in Section 2.5.4. 
 
The optimised chromatography method started at a gradient of 50 % methanol (0.1 % formic 
acid) which was held for one minute. Following this, there were three linear increases to 55 % 
methanol (0.1 % formic acid) at one minute, 70 % at two minutes and 90 % at five minutes. 
Detection of pregnenolone-oxime in a zebrafish sample relative to an authentic steroid standard 
can be seen in Figure 2.3. 
 
2.5.4.c. Androgen analysis by LC-MS/MS 
Androgen analysis was completed using a gradient system starting at 45 % methanol (0.1 % 
formic acid), followed by four linear increases to 47 % at one minute, 57 % at two minutes, 70 % 
at 2.5 minutes and 98 % at four minutes. These chromatographic conditions allowed for 
simultaneous detection of the zebrafish androgens (see Chapter 6.0).  
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2.5.5 Statistical analysis of steroid hormone measurements 
2.5.5.a. Whole zebrafish extracts 
Steroid measurements from whole zebrafish extracts are expressed as the mean in pg per embryo 
or larva  standard deviation (SD).  Experiments were performed in triplicate, unless stated 
otherwise and plotted using GraphPad Prism v.6.0 software (GraphPad Software, Inc.; La Joya, 
United States of America).  Comparison between steroid profiles of morpholino knockdowns 
and controls were performed using unpaired student t-test. Rescue experiments were compared 
 
 
Figure 2.3 LC-MS/MS detection of pregnenolone-oxime in whole zebrafish extracts 
Representative chromatogram showing positive identification of pregnenolone-oxime from 
whole zebrafish embryo extracts. Top is authentic reference standard, and bottom is 
pregnenolone-oxime from zebrafish embryos. The chromatogram is a sum of the two mass 
transitions defined in Table 2.4. 
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using one-way analysis of variance (ANOVA) following Dunnett's multiple comparisons test. 
Statistically significant differences are noted with asterisks. 
 
2.5.5.b. Enzymatic assays 
Enzymatic assays were performed in triplicate and data is presented from three independent 
experiments. Enzyme activities are expressed as percentage of the appropriate human orthologue 
and are represented as the mean ± SD and plotted using GraphPad Prism v.6.0 software. 
Statistical significance was determined by ANOVA following Dunnett's multiple comparisons 
test. Statistically significant differences are noted with asterisks.  
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 THE DUPLICATED MITOCHONDRIAL FERREDOXIN FDX1B 3.0
REGULATES GLUCOCORTICOID PRODUCTION IN 
ZEBRAFISH 
3.1 Introduction 
Ferredoxins are iron-sulphur (Fe/S) proteins which act as electron donors for a variety of 
fundamental reactions catalysed by mitochondrial CYP enzymes. The human ferredoxin 1 
(FDX1; adrenodoxin; ADX) is a 14 kDa protein loosely associated with the inner mitochondrial 
membrane and is involved in various metabolic processes including the synthesis of steroid 
hormones (Meyer, 2008), bile acids and vitamin D (Ewen et al., 2012). In these biochemical 
pathways, the flavoprotein ferredoxin reductase (FDXR) receives electrons from nicotinamide 
adenine dinucleotide phosphate (NADPH) and in turn reduces FDX1. FDX1 then transfers 
these electrons to CYP enzymes allowing them to perform their catalytic functions (Miller, 2005, 
Miller and Auchus, 2011). In steroidogenic tissues, FDX1 transfers electrons to the P450 side-
chain cleavage enzyme, CYP11A1, which facilitates the conversion of cholesterol into 
pregnenolone first step of steroid hormone biosynthesis (Miller and Auchus, 2011). In addition, 
the mitochondrial CYP enzymes 11β-hydroxylase (CYP11B1) and aldosterone synthase 
(CYP11B2) also require FDXR/FDX1 election transfer to catalyse the reactions required for 
glucocorticoid and mineralocorticoid synthesis, respectively.  
 
Currently, little is known about the physiological importance of mitochondrial redox partner 
interactions or their ability to modulate steroid hormone production in the adrenal glands. In vitro 
studies show that modifying the available concentrations of FDX1 or FDX1 mutants harbouring 
different redox potentials can influence CYP catalytic activity (Bureik et al., 2005, Grinberg et al., 
2000). However, to date there are no FDX1 human mutations identified or Fdx1 knockout 
animals to investigate the whole system consequences of such changes. 
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3.2 Rational for work 
Previous in vitro studies established FDX1 can influence steroid hormone production through 
regulating CYP enzymatic activity. However, the in vivo impact of these changes remains 
undetermined. My project aimed to develop zebrafish as an in vivo model to study mitochondrial 
redox reactions. Additionally, we intended to investigate the influence of redox reactions on 
mitochondrial CYP enzymes and establish the effect on a whole-system. The objective of this 
current study was to characterise the FDX1 paralogues in zebrafish and determine, in vivo, how 
ferredoxin deficiency affects embryonic development and influences steroidogenic capacity. 
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3.3 Methods 
3.3.1 PCR amplification and cloning of zebrafish ferredoxin paralogues 
The fdx1 and fdx1b coding sequences were amplified and sequenced from cDNA derived from an 
ovary of an adult female zebrafish. Oligonucleotides were designed based on sequences 
annotations from ENSEMBL Zv9 genomic database. For the amplification of fdx1, all 
oligonucleotides were designed with BamHI restriction sites to allow direct cloning into pCS2+ 
and pCDNA6-V5. Reverse oligonucleotides were used to generate products with (XR-BamHI) 
and without (R-BamHI) a stop codon to allow the three prime end to be tagged with a V5 
epitope. The same strategy was implemented for amplification of fdx1b, except primers were 
designed with flanking EcoRI restriction sites (Table 3.1). RT-PCR was performed using a high 
fidelity polymerase. After PCR purification, digestion of the PCR product and ligation into the 
required plasmid were performed using the standard protocols. Directionally of insert was 
screened using T7 vector primer with an appropriate insert primer.  
  
 
Table 3.1 Oligonucleotides for cloning of zebrafish ferredoxin paralogues 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
fdx1 fdx1-F-BamHI TACCGAGCTCGGATCCATGTCTGCGTGTGTTTTAAGAG 
 fdx1-XR-BamHI a CTGGACTAGTGGATCCTTATATTTTGGGTGGGGCTGT 
 fdx1-R-BamHI CTGGACTAGTGGATCCTATTTTGGGTGGGGCTGTG 
fdx1b fdx1b-F-EcoRI CAGTGTGGTGGAATTCATGGCATATCGTATGTGTGTGC 
 fdx1b-XR-EcoRI a GATATCTGCAGAATTCTCATTTGCTGCTCACAGCCT 
 fdx1b-R-EcoRI GATATCTGCAGAATTCCATTTGCTGCTCACAGCCT 
a Reverse oligonucleotides contain a stop codon. 
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3.3.2 PCR amplification and cloning of zebrafish mitochondrial redox 
partners for expression assays 
For protein expression and purification of the zebrafish mitochondrial redox proteins, each 
coding sequence was cloned into pET22b vector. The sequences were amplified in the mature 
form without the predicted mitochondrial targeting sequence (mitochondrial targeting sequences 
were predicated by alignment conservation). Oligonucleotides used for amplification and ligation 
are listed in Table 3.2.  
 
  
Table 3.2 Oligonucleotides for cloning of zebrafish mitochondrial redox partners into 
pET22b 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
fdx1 
p.46-F-NdeI CAGTGTGGTGGCATATGTCACATAGGGCTGAAGAGAAG 
XR-EcoRI CCATCGATTCGAATTCCTTTGGGTGGGGCTGTG 
fdx1b 
 p.46-F-NdeI CAGTGTGGTGGCATATGGGTTCTTCAAGCTCTAAAGTGCT 
XR-EcoRI CCATCCGATTCGAATTCCTTTGCTGCTCACAGCCT 
cyp11a1 
p.36-F ATGCAAAACTCCACTGTCCAGCC 
R GCATCTCTGCTTTCTGCTGGCA 
cyp11a2 
p.36-F ATGCAAGACTCCACTGTACGGC 
R TCTCTGCTTTCTGCTGGAG 
cyp11c1 
p.138-F-NdeI CAGTGTGGTGGCATATGCAAAGCTCAGATCCGCTG 
R-EcoRI CCATCGATTCGAATTCGAGTGCTGGTGTGTGAGTGT 
fdxR 
p.56-F-NdeI CAGTGTGGTGGCATATGCAGCTACTGAAGGCTCGA 
R-NotI CCATCGATTCGCGGCCGCGGACCAGGCGATCTTCAG 
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Zebrafish cyp11a1 and cyp11a2 were cloned within NdeI and EcoRI sites of pET22b via blunt end 
cloning due to the presences of an NdeI site in the coding sequences. Cloning into the NdeI 
restriction site was required for all genes as it removes the pelB signal sequence required for 
periplasmic localisation. fdxR and cyp11c1 were also cloned into NdeI and EcoRI using restriction 
digest of the PCR product and direct ligation into the vector. All cytochrome P450 enzymes and 
FdxR were cloned in-frame with the carboxyl polyhistadine tag to purification of the protein. 
Mature fdx1 and fdx1b were directionally cloned using NdeI and EcoRI restriction sites without 
the carboxyl terminal polyhistadine tag as it was predicated to interfere with redox potential. 
 
3.3.3 Alignment and phylogenetic analyses of zebrafish Fdx isozymes 
Coding sequences were used to infer Fdx1 and Fdx1b protein sequences. Zebrafish Fdx1 and 
Fdx1b protein sequences were then compared to vertebrate Fdx1 protein sequences, including 
human (Homo sapiens; ENSP00000260270), gorilla (Gorilla gorilla gorilla; ENSGGOP00000023526), 
bovine (Bos Taurus; ENSBTAT00000033850), mouse (Mus musculus; ENSMUSP00000034552), 
medaka (Oryzias latipes; ENSORLP00000005248), and stickleback (Gasterosteus aculeatus; 
ENSGACP00000018745). Alignment and homology analyses were performed as described in 
Section 2.2.1. 
 
3.3.4 Characterisation of Fdx1 and Fdx1b expression  
The spatial and temporal expression of fdx1 and fdx1b were determined by RT-PCR. A 694 
nucleotide fragment of the fdx1 gene was amplified using 3' UTR F and R primers (Table 3.3) and 
25 ng of cDNA as previously described under the following conditions: initial denaturation at 
95 ºC for five minutes, followed by 40 cycles at 95 °C for 30 seconds, 58 °C for 40 seconds and 
72 °C for 40 seconds; and a final incubation at 72 °C for 7 minutes. To define the expression of 
fdx1b, a 159 nucleotide fragment was amplified with e3 F and e5 R primers (Table 3.3) under the 
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conditions described above. As a control for cDNA quality and equal loading, a 102 nucleotide 
fragment of the β-actin gene (actb1, ENSEMBL Gene ID ENSDARG00000037746) was 
amplified using e4 F and e4 R primers (Table 3.3). 
 
 
Table 3.3 Oligonucleotides for RT-PCR expression analysis of the fdx1 and fdx1b genes. 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
fdx1 3' UTR F AGTCAAACCAGAGCGTTTCC 
 3' UTR R CAGCTACAGGCATATCTGCAA 
fdx1b e3 F GAGCAGCGTATTTGTCACAGA 
 e5 R ACCATTGGCTCCAGTTTGTCA 
actb1 e4 F CGAGCAGGAGATGGGAACC 
 e4 R CAACGGAAACGCTCATTGC 
 
 
 
3.3.5 Zebrafish fdx1b knockdown studies 
To analyse the role of the two zebrafish ferredoxin paralogues during development I performed 
transient knockdowns with specific anti-sense morpholinos as previously described in Section 
2.3.9. Translation of fdx1 mRNA was blocked using 9 ng morpholino per embryo directed to the 
start ATG codon (fdx1-ATGMO). Additionally, a five base-pair mismatched control morpholino 
(fdx1-CtlMO) and 9 ng of fdx1-SplMO targeting the splice acceptor site of exon two were also used. 
For fdx1b disruption, 6 ng of ATG morpholino (fdx1b-ATGMO), and 6 ng of a splice morpholino 
(fdx1b-SplMO) targeting the splice acceptor site of exon four were used. A five base-pair mismatch 
of the ATG morpholino was injected as a control (fdx1b-CtlMO). Sequences of the morpholinos 
and mismatch controls are listed in Table 3.4. 
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Table 3.4 Sequences of the anti-sense morpholinos used for the transient knockdown of 
fdx1 and fdx1b genes 
 
Gene Morpholino 
Sequence 
(5-prime to 3-prime) 
fdx1 fdx1-ATGMO a CTCTTAAAACACACGCAGACATTGC 
 fdx1-CtlMO CTGTTAAAAGACACGGACACATTCC 
 fdx1-SplMO TCTCTTCAGCCCTGCATAGAAACAC 
fdx1b fdx1b-ATGMO a GCACACACATACGATATGCCATGCT 
 fdx1b-CltMO GCAGACAGATACGTTATGCGATGGT 
 fdx1b-SplMO b GCTCCTAATATAGACACACACATGC 
aATG morpholinos impair initiation of mRNA translation 
bSplice morpholinos induce abnormal splicing of the mRNA 
Underlined letters highlight base-pair mismatches between ATG or splice morpholinos and 
controls. 
 
 
3.3.6 mRNA rescues of fdx1 and fdx1b morphants 
To confirm specificity of the phenotype of fdx1 and fdx1b morpholino knockdown, co-injection 
with mRNA of fdx1 or fdx1b was performed. Five-prime oligonucleotides were designed 
containing five base-pair synonymous mutations with the morpholino binding site and a T7 
polymerase recognition sequence. A reverse oligonucleotide was designed to include a 
polyadenylation signal (Table 3.5). PCR was performed using high fidelity polymerase using the 
methodology previously described and using previously cloned fdx1 or fdx1b as a template. After 
purification of the PCR product, mRNA was synthesised containing a 7-methyl guanosine five 
prime cap and a polyadenylated tail by in vitro transcription as detailed in Section 2.3.7. 
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Table 3.5 Oligonucleotides for the amplification of fdx1 and fdx1b coding sequences with 
T7 polymerase recognition sequences and a polyadenylation signal 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
fdx1 T7-mm F 
GAAGGTAATACGACTCACTATAGGGAGAGCAATGTCAGCCTG
TGTATTGAGGG 
fdx1b T7-mm F 
GAAGGTAATACGACTCACTATAGGGAGAATGGCTTACCGAAT
GTGCGTCC 
 R-polyA TCACTAAAGGGAACAAAAGTGG 
Underlined letters highlight base-pair mismatches between ATG morpholinos and amplified 
mRNA. 
 
 
3.3.7 Phenotypic classification of embryos and larvae 
After morpholino injection of fdx1-ATGMO, fdx1-SplMO or fdx1-CtlMO embryos were screened for 
rhodamine incorporation into the embryo proper between 64 and 572 cell stages. At 10 hpf 
embryos were scored based on the percentage of epiboly completed and detection of embryonic 
shield (Table 3.6).  
 
 
Table 3.6 Classification of the phenotype of fdx1 morphants at 10 hpf 
Class I Class II Class III Class IV 
normal epiboly 
movement 
delay in epiboly 
serve delay in epiboly 
and no shield 
dead 
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Similarly, embryos injected with fdx1b-ATGMO and fdx1b-SplMO and fdx1b-CtlMO were screened for 
rhodamine incorporation into the embryo after injection. At 120 hpf, larvae were classified into 
four groups based on the inflation of the swim bladder, the size of the yolk sac, oedema of the 
pericardial sac and size of the head (Table 3.7). 
 
 
Table 3.7 Phenotypic classification of the fdx1b morphants at 120 hpf 
Phenotype Class I Class II Class III Class IV 
Swim bladder inflated inflated none none 
Yolk sac normal enlarged enlarged enlarged 
Pericardial sac normal normal normal oedema 
Head normal normal small shortened snout 
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3.4 Results 
3.4.1 Zebrafish Fdx1 and Fdx1b homology with other vertebrate 
Ferredoxins  
Two FDX1 paralogues were identified in zebrafish and these are termed fdx1 and fdx1b. Protein 
sequences of our zebrafish wild-type strain were deduced by directly sequencing RT-PCR 
products amplified from ovary cDNA. No polymorphisms were identified in either gene when 
compared to the annotated sequences on the ENSEMBL genome database (Zv9). Protein 
sequence analysis was performed in silico to determine evolutionary conservation of the two 
identified ferredoxin paralogues. The pre-processed zebrafish ferredoxins; Fdx1 and Fdx1b are 
175 and 168 amino acids in length, respectively, and share 43 % protein identity. Additionally, the 
predicted mature proteins (after cleavage of the mitochondrial signalling peptide) share 60 % 
protein identity. Fdx1 was most similar to other teleost species with 57 % and 51 % identity with 
medaka and stickleback.  
 
Conservation of known functional amino acids and motifs was observed in both zebrafish 
paralogues. Motif one and motif three collectively contain the four cysteine residues required for 
Fe/S binding and are present in both zebrafish paralogues. The negatively charged motif two, 
which contains amino acids required for the interaction with redox partners, was also conserved. 
Many other functionally important amino acids were identified, including, Gly26, His56 and 
Pro108 (Grinberg et al., 2000) which are present in all vertebrate ferredoxins, and Thr49 
(Hannemann et al., 2001) and Thr54 (Uhlmann and Bernhardt, 1995) which are both involved in 
modulating the redox potential of the protein. Notably, at amino acid 14, Fdx1b has a glutamine 
amino acid rather than the well conserved arginine. Additionally, at the corresponding amino 
acids for Thr71 in motif two, Fdx1 has a serine and Fdx1b contains a valine (Figure 3.1).  
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Figure 3.1 Phylogenetic analysis of ferredoxin proteins 
The protein sequence of human, gorilla, bovine, mouse, medaka, stickleback, and zebrafish 
Fdx1 paralogue enzymes were aligned using ClustalW under default parameters. The three 
motifs common to all hydroxylase ferredoxins are shown. Motif 1 is a loop that contains 
three of the cysteine residues involved in Fe/S cluster binding (highlighted in purple). Motif 
2 contains a cluster of negatively charged amino acids which are important for binding to 
CYP450 and FDXR (highlighted in red). Motif 3 contains the conserved sequence around 
the fourth cysteine residue required for cluster binding. The signalling peptide targets the 
ferredoxin to the mitochondria and is cleaved to form the mature protein. Other known 
functionally important amino acids as shown in grey. Zebrafish-I and Zebrafish-Ib refers to 
Fdx1 and Fdx1b, respectively. 
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3.4.2 Tissue distribution and temporal expression of fdx1 and fdx1b 
The expression of fdx1 and fdx1b genes was investigated during early zebrafish development and 
in adult fish. fdx1 was expressed as a maternal transcript (present from one-cell stage) and is 
sustained by the zygote throughout development (Figure 3.2). Expression of fdx1b started weakly 
during late segmentation period (28 hpf) and became prominent from 32 hpf up to 120 hpf 
(Figure 3.2A). In adults, fdx1 expression was detected in all tissues tested including the gonads, 
kidney, brain, liver, intestine and heart. Zebrafish fdx1b expression was identified in the kidney 
head, brain, ovary and testis (Figure 3.2). No sexual dimorphism in the expression pattern of 
either gene was observed. 
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Figure 3.2 Temporal expression and tissue distribution of zebrafish fdx1 and fdx1b 
transcripts. 
Expression of fdx1 and fdx1b was characterised in zebrafish embryos and larvae (A) and in 
adult tissues (B). Beta actin was used as a loading control. 
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3.4.3 Defining the role of Fdx1 in early zebrafish development 
To determine the role of Fdx1 in zebrafish development transient knockdown studies were 
performed using anti-sense morpholinos. Microinjection of the fdx1-ATGMO resulted in a 
phenotype during the gastrula phase consisting of delayed epiboly and a grainy cellular 
appearance. An initial titration injection of 3 ng, 6 ng and 9 ng of fdx1-ATGMO per embryo was 
performed to establish the toxicity of the morpholino. Increasing concentration showed 
increased severity of the phenotype observed at 10 hpf (Figure 3.3). As there were no adverse 
effects with the fdx1-CtlMO at any concentration (data not shown), 9 ng was used for subsequent 
experiments. By 10 hpf, 69 % of fdx1 morphants showed a class II phenotype consisting of a 
delay in epiboly (the movement of cells over the yolk during gastrulation) and a thickening of the 
dorsal blastoderm. Additionally, 18 % of fdx1 morphants showed a class III phenotype where a 
severe delay in epiboly was observed, together with a grainy appearance of the cells of the 
blastoderm and no shield was detected. In contrast, 97 % of control injected embryos showed a 
typical Class I phenotype with normal developmental progression through epiboly. The observed 
phenotype in the fdx1-ATGMO injected embryos was partially reproduced by injecting with the 
fdx1 splice disrupting morpholino (fdx1-SplMO), with 40 % of embryos showing either Class II 
(19 %), Class III (9 %) or failing to thrive (12 %) by 10 hpf. Furthermore, co-injection of the fdx1 
five base-pair mismatched mRNA with fdx1-ATGMO partially restored the mutant phenotype. Of 
the rescued embryos, 65 % showed a normal Class I phenotype compared 8 % of fdx1-ATGMO 
injected embryos (Figure 3.3).  
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Figure 3.3 Morphological phenotype of embryos injected with Fdx1 morpholino at 
9 hpf  
 
(A) Embryos injected with fdx1-ATGMO, fdx1-SplMO or fdx1-CtlMO were classified based on 
their progression of epiboly at 9 hpf. Class I represents a normal epiboly, and class II and 
class III represent delayed movement as indicated by the black arrow. (B) A titration of 
fdx1-ATGMO of 3 ng, 6 ng and 9 ng showed increasing in the severity of morphological 
phenotype. (C) Injection of 9 ng of fdx1-CtlMO showed 95 % of the normal Class I 
phenotype compared to fdx1-ATGMO injected embryos which had 68.9 % Class II and 18 % 
Class III. Embryos injected with 9 ng with fdx1-SplMO to target zygotic transcripts had 40 % 
of embryos with Class II, Class II or failing to thrive. Co-injection of with fdx1 mRNA with 
fdx1-ATGMO partially restored embryos to a Class I phenotype.  
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3.4.4 Pregnenolone synthesis in Fdx1 morphants 
To determine if Fdx1 was required for early pregnenolone steroid synthesis in the developing 
embryo, steroids were extracted and analysed by LC-MS/MS at 10 hpf from fdx1-ATGMO and 
fdx1-CtlMO injected embryos. No difference was observed in pregnenolone concentration 
between fdx1 morphants and controls. Pregnenolone concentrations of fdx1-ATGMO injected 
embryos were 0.65 pg per embryo compared fdx1-CTLMO embryos with 0.64 pg per embryo 
(Figure 3.4).  
 
 
 
 
 
 
 
Figure 3.4 Pregnenolone concentrations of fdx1 morphants and controls at 10 hpf 
Embryos were injected with either fdx1-CtlMO (black) or fdx1-ATGMO (grey) and pregnenolone 
concentrations were calculated from amounts measured by LC-MS/MS in zebrafish extracts. 
fdx1-ATGMO injected embryos had 0.65 (± 0.32) pg per embryo while fdx1-CTLMO injected 
embryos had 0.64 (± 0.20) pg per embryo. Graph represents mean ± SD from three 
independent experiments. 
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3.4.5 Identifying the role of Fdx1b during zebrafish development 
The expression of fdx1b was disrupted by injecting an anti-sense morpholino targeting its 
transcriptional start codon (fdx1b-ATGMO). Injected embryos developed normally up to 48 hpf. A 
late onset phenotype was observed from 52 hpf and was most obvious at 120 hpf. fdx1b 
morphants showed a delay in the absorption of the yolk sac, smaller heads, jaw malformations 
and cardiac oedema when compared to control injected embryos (Figure 3.5). At 120 hpf, the 
majority fdx1b-ATG morphants showed Class II (54 %) morphology consisting of a large yolk sac 
and no inflation of the swim bladder, or Class III (27 %) which had additional jaw malformation. 
In comparison, the majority of fdx1b-CtlMO injected larvae showed a normal Class I phenotype 
(94 %). To determine the specificity of the morphological phenotype, mRNA rescues were 
performed by co-injection of fdx1b-ATGMO and fdx1b mRNA. A partial rescue of the 
morphological phenotype was observed with 47 % of larvae having a Class I phenotype at 120 
hpf compared with 18 % of larvae injected with fdx1b-ATGMO only. However, there was an 
increase in the severe Class IV morphology with 6 % of mRNA rescued larvae compared to 1 % 
of fdx1b-ATGMO only.  
 
A second morpholino targeting exon four splice acceptor site of fdx1b (fdx1b-SplMO) was used to 
confirm gene disruption by RT-PCR. At 72 hpf, fdx1b transcript could not be detected in 
fdx1b-SplMO injected larvae using the primer pair fdx1b e3F and e3R (Figure 3.6). By 96 hpf 
transcript levels begin to be detected and by 120 hpf no difference can be seen between the 
control and the fdx1b-SPLMO injected larvae. These morphants showed a similar, but less 
prominent, morphology compared to the translational blocking morpholino with 30 % and 18 % 
of larvae having a Class II or Class III phenotype, respectively.  
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Figure 3.5 Morphological characterisation of fdx1b morphants at 120 hpf. 
(A) At 120 hpf larvae were categorised into four different classes depending on inflation of 
the swim bladder (black arrow), size of the yolk sac (blue arrow), head size (black asterisks) 
and pericardial oedema (red arrow) (Table 3.7). Class I represents a wild-type phenotype. (B) 
The phenotypic spectrum observed in fdx1b-CtlMO, fdx1b-ATGMO and fdx1b-SplMO injected 
embryos. Additionally, embryos co-injected with fdx1b-ATGMO and fdx1b mRNA were also 
assessed for phenotypic abnormalities.  
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Figure 3.6 The fdx1b splice morpholino (fdx1b-SplMO) effectively disrupts the fdx1b 
mRNA transcript 
 
(A) The fdx1b-SplMO binds to the splice acceptor site of exon 4, causing inclusion of the 
enclosed intron in the fdx1b mRNA. (B) RT-PCR analysis confirmed disruption of the fdx1b 
mRNA in the splice morphants but not in embryos injected with the control morpholino 
(fdx1b-CtlMO). Black arrows indicate the binding sites of the primers used for RT-PCR 
analysis to confirm missplicing of fdx1b mRNA; grey line represents fdx1b-SplMO binding site 
at the splice acceptor site of exon 4. Beta actin was used as a loading control. 
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3.4.6 The effects of fdx1b deficiency on zebrafish steroidogenesis 
Pregnenolone and cortisol concentrations were measured in fdx1b-ATGMO and fdx1b-CtlMO 
injected embryos at five developmental stages to investigate the influence of Fdx1b on the 
zebrafish steroidogenic pathway (Figure 3.7). No differences in pregnenolone concentrations 
were observed between fdx1b-ATG morphants and controls at 10 hpf or 24 hpf. At 72 hpf, 
fdx1b-ATG morphants had pregnenolone concentrations of 0.42 pg per larva compared to 
0.65 pg per larva in the controls. Fdx1b morphants maintained lower pregnenolone 
concentrations at 72 hpf and 96 hpf and at 120 hpf were detected having 0.73 pg in contrast to 
the control injected embryos with 1.10 pg.  
 
As a measure of steroid hormone biosynthesis capabilities, cortisol was determined from both 
fdx1b-ATG and fdx1b-Ctl morphants during development. At 10 hpf and 24 hpf there was no 
difference in cortisol concentrations between fdx1b-ATG and fdx1b-Ctl embryos. However, at 
72 hpf cortisol levels were undetectable in fdx1b-ATGMO injected larvae while control larvae were 
detected having 2.5 pg of cortisol per larva. By 120 hpf fdx1b-ATG morphants regained some 
steroidogenic capacity producing 0.9 pg cortisol per larva, but still remained drastically reduced 
compared to 15.25 pg in the controls (Figure 3.8). Additionally, embryos injected with fdx1b-
SplMO were analysed at 72 hpf and showed cortisol concentrations of 0.4 pg per larva, 3.6 times 
less than control larvae at the same time point (data not shown).  
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Figure 3.7 Pregnenolone concentrations of Fdx1b morphants and controls during 
development 
 
Pregnenolone concentrations were measured over development in fdx1b-ATGMO (grey) and 
fdx1b-CtlMO (black). Picograms of pregnenolone per embryo or larva were calculated from 
concentrations measured by LC-MS/MS in zebrafish extracts. Data represents concentrations 
from at least two independent experiments and was plotted against developmental stages as 
mean ± SD.  
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Figure 3.8 Cortisol concentrations of Fdx1b morphants and controls during 
development 
 
Cortisol concentrations were measured over development in zebrafish injected with fdx1b-
ATGMO (grey) or fdx1b-CtlMO (black). Picograms of cortisol per embryo or larva were 
calculated from concentrations measured by LC-MS/MS in zebrafish extracts. Data 
represents concentrations from at least two independent experiments and was plotted against 
developmental stages as mean ± SD.  
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3.4.7 mRNA and steroid rescues of fdx1b deficient embryos 
Rescue experiments were performed with the co-injection of five base-pair mismatched Fdx1b 
mRNA with fdx1b-ATGMO and steroid extraction was performed at 72 hpf. Co-injection of 
mRNA partially restored pregnenolone concentrations to 0.60 (SD ± 0.21) pg per larvae, which 
were similar to control injected embryo levels of 0.65 (SD ± 0.09) pg per larvae, however this 
change was not significant. Additionally, cortisol levels remained undetected in larvae co-injected 
with fdx1b-ATGMO and fdx1b mRNA (Figure 3.9). To further elucidate the role of Fdx1b in 
zebrafish steroidogenesis, zebrafish injected with fdx1b-ATGMO were supplemented with 
pregnenolone or vehicle (ethanol) and cortisol was measured at 72 hpf. Despite there being an 
excess pregnenolone detected in the embryos (1.92 pg - data not shown), cortisol levels remained 
undetected (Figure 3.9). 
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Figure 3.9 Pregnenolone and cortisol measurements in fdx1b rescued larvae. 
Steroids concentrations were measured in embryos injected with fdx1b-CtlMO, fdx1b-ATGMO, 
fdx1b mRNA and fdx1b-ATGMO with fdx1b mRNA. (A) Pregnenolone concentrations of 
embryos showed no difference between the injected groups. (B) Cortisol concentrations were 
similar in embryos injected with fdx1b mRNA compared to control injected embryos. In 
comparison, co-injection of fdx1b-ATGMO and fdx1b mRNA could not restore cortisol levels. 
Additionally, incubation of embryos with 50 nM pregnenolone also failed to synthesise 
cortisol. Concentrations were measured at 72 hpf from three independent experiments. 
Concentrations are expressed as picograms per larva (mean ± SD), calculated from 
concentrations measured by LC-MS/MS. Statistical analysis was performed using one-way 
ANOVA followed by Dunnett's multiple comparisons test. ** P<0.01 
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3.5 Discussion and prospective studies 
3.5.1 Evolutionary conservation of the ferredoxin electron transport 
system 
It is well established that ferredoxins are evolutionary well conserved (Ewen et al., 2012). 
Interestingly, zebrafish is the only teleost that retained both duplicated ferredoxin genes after the 
genome duplication of the common teleost ancestor. This provides a unique opportunity to 
investigate amino acid changes in the duplicated genes and correlate these with functional 
capabilities. Although the zebrafish ferredoxin pre-proteins share 43 % amino acid identity, there 
are notable differences which may provide insights into functionally important amino acids of 
ferredoxins.  
 
Post translational modifications of ferredoxins can alter activities of the interacting CYP 
enzymes. Thr71 is located within the interaction domain which is the interface for redox partner 
recognition. In vitro, phosphorylation of bovine FDX1 at position Thr71 increases CYP11A1 
enzymatic activity, but not CYP11B1 activity (Bureik et al., 2005) suggesting an important 
regulatory mechanism impacting on mitochondrial CYP enzyme function. Interestingly, zebrafish 
Fdx1 has a serine at this position which is capable of being phosphorylated, whereas Fdx1b has a 
valine residue, which is not amenable to phosphorylation. The mechanistic importance of 
phosphorylation of redox partners during in vivo steroidogenesis has not yet been elucidated. It 
would be hypothesised phosphorylation of zebrafish Fdx1 at Ser71 would improve the 
interaction and catalytic activity of some its redox CYP enzymes. Fdx1 is predicted to be the 
mitochondrial redox partner of Cyp11a1 during early zebrafish embryo development. Therefore, 
phosphorylation may be an important mechanism for regulating pregnenolone production during 
zebrafish development. Importantly, phosphorylation capability at this position has no effect on 
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interactions with FDXR (Bureik et al., 2005) suggesting that both Fdx1 and Fdx1b can interact 
with the single zebrafish FdxR protein independent of their phosphorylation status.  
 
Another notable difference in amino acid conservation is the replacement of Arg14 with a polar 
uncharged glutamine residue in the zebrafish Fdx1b protein. The biochemical properties of this 
amino acid position is highly conserved in bacterial, plant and vertebrate ferredoxins and typically 
carries a positive charged amino acid (arginine, lysine or histidine) (Grinberg and Bernhardt, 
1998). In the mature bovine FDX1, crystallography studies show amino acid Arg14 forms a 
hydrogen bond with the conserved Pro108. Elimination of this hydrogen bond decreases stability 
of the protein at physiological temperatures, but has no effect on redox potential or protein 
interactions (Grinberg and Bernhardt, 1998). The zebrafish Fdx1b protein is likely to have 
decreased stability compared to other ferredoxins due to a glutamine residue at position 14; 
however, the significance of this currently remains unknown. In silico sequence comparison of the 
two zebrafish FDX1 proteins suggests differences in regulation and stability. However, further 
studies are required to determine the protein stability of each zebrafish paralogue and to gain 
insights into their individual functional roles during zebrafish development.  
 
3.5.2 The role of Fdx1 in zebrafish development 
Expression analysis of the zebrafish fdx1 revealed it was present from the one-cell stage as a 
maternal transcript and was maintained by the zygote during zebrafish development. In 
concordance with human FDX1 (Picado-Leonard et al., 1988, Voutiainen et al., 1988) zebrafish 
fdx1 expression was detected in all tissues tested. Knockdown of Fdx1 by antisense morpholino 
showed a strong cellular defect with abnormal epiboly. Further analysis is required to determine if 
these cellular defects are cellular necrosis, apoptosis, from a general developmental delay in the 
embryo. To confirm the phenotype of fdx1 knockdown, the fdx1-SplMO was used. This 
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morpholino also caused epiboly delay and similar cellular defects; however, it was less severe, as 
splice disrupting morpholinos only affect zygotic pre-RNA (i.e. not maternally derived mRNA). 
Co-injection of fdx1-ATGMO with fdx1 mRNA could restore 65 % of the embryos to the normal 
Class I phenotype, suggesting the morphological and developmental changes observed resulted 
from the loss of Fdx1 protein in the developing embryo. Additionally, rescue with fdx1b mRNA 
(data not shown) could also restored the phenotype suggesting functional conservation between 
the two paralogues. However, the functional role of Fdx1 in the developing zebrafish embryo 
remains undetermined.  
 
Morpholino knockdown of Cyp11a1 causes a delay in epiboly resulting from decreased 
pregnenolone synthesis and subsequent destabilisation of microtubules (Hsu et al., 2006). It was 
hypothesised that Fdx1 would be the redox partner of Cyp11a1 in the yolk syncytial layer. To 
address this, pregnenolone was measured by LC/MS-MS in fdx1-ATGMO and fdx1-CtlMO injected 
embryos and no difference was observed. To fully excluded that Fdx1 does not have a role in 
pregnenolone production, it would be recommended to incubate fdx1-ATGMO with media 
supplemented with 50 nM pregnenolone as previously described (Hsu et al., 2006, Parajes et al., 
2013), to determine if the epiboly phenotype can be restored. It cannot be exclude that Fdx1 is 
interacting with other mitochondrial CYP enzymes at this developmental stage. Although, data 
from transcript microarray profiling of zebrafish CYP enzymes during development, suggest 
Cyp11a1 is the most likely candidate based on its high expression levels during cleavage and 
gastrula stages (Goldstone et al., 2010). 
 
In addition to the epiboly phenotype, a distinct, yet uncharacterised, cellular phenotype was 
observed in Fdx1 deficient embryos. It is hypothesised that disruption of the mitochondrial 
electron chain, through loss of Fdx1 causes cellular damage. Electron leakage from the 
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mitochondrial CYP redox chain can contribute to reactive oxygen species (ROS) production 
(Hanukoglu, 2006). At low concentration ROS is involved in many cellular processes, however, 
imbalances in the oxidative state of a cell can lead to cell damage and cell death (Prasad et al., 
2014). Additionally, changes in redox homeostasis within the adrenal cortex can affect 
steroidogenesis and has implications for steroidogenic disease (Meimaridou et al., 2012). It 
remains undetermined if a knockdown of electron transport chain proteins, such as in the fdx1 
morphants, causes cellular defects from the production of mitochondrial ROS. Further 
investigations are required into the fdx1 morphant phenotype to identify if the loss of ferredoxin 
can generate ROS and how the mitochondrial redox pathway affects cellular processes.  
 
3.5.3 Fdx1b expression is required for steroid hormone synthesis in the 
adult zebrafish 
Alternative to fdx1, fdx1b expression was restricted to steroidogenic tissues of the kidney head 
(containing the interrenal gland), brain, ovary and testis. Additionally, fdx1b transcripts were 
up-regulated between 24 and 28 hpf, coinciding with the development of the interrenal gland. 
(Chai et al., 2003, To et al., 2007). This expression mirrors that of zebrafish cyp11a2, the side-
chain cleavage enzyme facilitating de novo interrenal steroidogenesis in larvae and adults (Parajes et 
al., 2013) (Chapter 4.0). Therefore, it was hypothesised that Fdx1b is the ferredoxin regulating 
mitochondrial steroid hormone production in the interrenal.  
 
Transient loss of Fdx1b using morpholino knockdown showed a late on-set phenotype 
characterised by increased yolk size, small heads, jaw malformations along with a delay in 
inflation so the swim bladder. This phenotype is consistent with other studies of adrenal 
insufficiency and glucocorticoid resistance, including the transient knockdown of cyp11a2 (Parajes 
et al., 2013) (Chapter 4.0), ff1b (orthologue of mammalian steroidogenic factor 1, SF1) (Hsu et al., 
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2003), the SF1 transcriptional regulator dax1 (Zhao et al., 2006) and glucocorticoid receptor 
(Pikulkaew et al., 2011). This consistency in the morphological phenotype supports the 
hypothesis that Fdx1b is the ferredoxin regulating glucocorticoid synthesis in the interrenal of 
larvae and adults. 
  
To determine if fdx1b morphants were capable of synthesising glucocorticoids, cortisol 
measurements were assessed over the first five days of development. Similar to control embryos, 
fdx1b-ATGMO injected embryos showed maternal cortisol stores in the yolk were almost depleted 
after 24 hpf. In wild-type embryos, de novo cortisol synthesis begins at 48 hpf (Alsop and Vijayan, 
2008). Cortisol synthesis was observed in fdx1b-CTLMO larvae. However, fdx1b-ATGMO injected 
embryos fail to synthesise cortisol at 72 hpf and 96 hpf. Minimal cortisol was detected by 120 
hpf, but was still 98 % less than the concentrations observed in the control larvae. This lack of 
cortisol production at 72 hpf was also observed in the fdx1b-SplMO larvae. The inability of Fdx1b 
deficient embryos to produce cortisol is similar to larvae deficient in Cyp11a2 (Parajes et al., 
2013) (Chapter 4.0).  
 
3.5.4 Fdx1b is essential for cortisol synthesis through interactions with 
Cyp11c1 and possibly Cyp11a2  
The regulation of cortisol synthesis is highly conserved between zebrafish and mammals. In the 
adult interrenal gland zebrafish have two mitochondrial CYP enzymes required for glucocorticoid 
production, Cyp11a2 and Cyp11c1. Cyp11a2 is required for the first step of steroidogenesis when 
pregnenolone is produced from cholesterol (Parajes et al., 2013). To determine if Fdx1b was 
affecting pregnenolone synthesis, pregnenolone was measured in fdx1b-ATGMO injected embryos 
and larvae. Compared to control injected embryos, Fdx1b deficient embryos had less 
pregnenolone synthesis after interrenal steroid synthesis beings at 48 hpf. This suggests Fdx1b is 
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interacting with Cyp11a2 in the interrenal gland to impair pregnenolone synthesis. Pregnenolone 
concentrations were higher in Fdx1b deficient embryos (0.73 pg per larva at 120 hpf) when 
compared to Cyp11a2 morphants (0.33 pg per larva at 120 hpf). Although this is likely due to 
different efficacies of the individual morpholinos, it cannot be excluded that the ubiquitously 
expressed Fdx1 may be capable of supplying electrons, although with less efficiency, to partially 
restore Cyp11a2 activity. Further studies are required to investigate the efficiencies of interaction 
and electron transfer between the different ferredoxin and CYP enzymes.  
 
Cyp11c1 is the only identified Cyp11b-like enzyme identified in zebrafish (Goldstone et al., 
2010). It is required for cortisol (Wilson et al., 2013) and androgen (de Waal et al., 2008) synthesis 
in zebrafish. To establish the requirement of Cyp11c1 on electron transport from Fdx1b, Fdx1b 
deficient embryos were incubated with pregnenolone (to restore any loss resulting from disrupted 
Cyp11a2 activity) and the subsequent cortisol level was measured. Despite pregnenolone 
substitution, Fdx1b morphants failed to produce cortisol, suggesting Fdx1b regulates 
glucocorticoid production through Cyp11c1. As the Fdx1b deficient larvae morphologically 
resembles glucocorticoid resistance zebrafish models, the phenotype of fdx1b morphants is likely 
from impaired glucocorticoid synthesis during development rather than androgen synthesis 
deficiency.  
 
3.5.5 Stability of zebrafish ferredoxin proteins and mRNA 
Ferredoxins are regulated at many levels including the stability of at the mRNA and protein 
levels. In humans the functional FDX1 gene on chromosomal 11q22 encodes several 
alternatively splice transcripts which differ in their three-prime untranslated region, and predicted 
to have different mRNA half-lives (Picado-Leonard et al., 1988). Additionally, vertebrate 
ferredoxin proteins are known to have extremely low conformational stability. Studies show 
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bovine FDX1 has low thermodynamic stability (ΔdG = 21 kJ/mol at 25°C and pH 8.5) (Burova 
et al., 1995), compared to most of globular proteins (ΔdG values of 25 – 60 kJ/mol) (Privalov, 
1979). It is likely that the general lack of protein stability of ferredoxins and possible mRNA 
instability makes mRNA rescues technically challenging. Additionally, a lack of zebrafish specific 
antibodies, makes determining individual paralogue protein concentrations difficult. Currently, 
nothing is known about the stability of the zebrafish paralogues. However, it would of interest to 
compare the related paralogues, especially in contrast with the loss of Arg14 in Fdx1b as 
mentioned above. 
  
3.5.6 Investigating the interaction between zebrafish ferredoxins and 
CYP enzymes 
We have shown that the zebrafish ferredoxin, Fdx1b, is involved in the production of cortisol in 
the zebrafish larvae, most likely through electron transfer with Cyp11c1 and possibly Cyp11a2. 
One major question that remains is the efficiency of interaction and electron transfer between 
each ferredoxin paralogue and specific CYP enzymes. In collaboration with Professor Rita 
Bernhardt (Institute of Biochemistry, University of the Saarland, Germany) the interaction 
affinities and stability of the zebrafish redox proteins will be investigated. Professor Bernhardt’s 
laboratory established a method to express and purify bovine ferredoxin (Uhlmann et al., 1992), 
which has since been optimised and modified to investigate the interactions and structure of 
these proteins. I have cloned mature forms of zebrafish fdx1 and fdx1b, together with cyp11a1, 
cyp11a2, cyp11c1 and the only identified fdxr gene into pET22b for bacterial expression and 
purification. In vitro analysis will provide further information about efficiency of electron transfer 
between these proteins as well as specific protein-protein interactions. Furthermore, specific 
functional differences between the ferredoxin paralogues will provide information on how 
mitochondrial steroidogenesis can be influenced by redox partners.  
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Forward 
Results from this chapter were published in the May 2013 issue of the journal Endocrinology. 
This chapter outlines the work which I completed as part of this project. The full publication can 
be found in Appendix One (page 224).  
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 REDEFINING CYTOCHROME P450 SIDE-CHAIN CLEAVAGE 4.0
ACTIVITY IN ZEBRAFISH DEVELOPMENT  
4.1 Introduction 
The human CYP11A1 gene encodes the P450 side-chain cleavage enzyme (P450scc; CYP11A1) 
which catalyses the first and rate limiting step of steroidogenesis. Many of the key enzymes for 
steroid hormone synthesis and signalling are conserved in zebrafish, including CYP11A1 
reactions. A zebrafish gene encoding cyp11a1 was identified on chromosome 25 and consists of 
nine coding exons and two five-prime located non-coding exons (Hsu et al., 2009). Several 
studies show cyp11a1 is expressed in zebrafish embryos and larvae (Chai et al., 2003, Hsu et al., 
2002, Hu et al., 2004, To et al., 2007, Xie et al., 2008). Consistently, zebrafish cyp11a1 has shown 
to be expressed as a maternal transcript and maintained in the yolk syncytial layer. Functionally, 
this early expression of cyp11a1 facilitates pregnenolone synthesis, which stabilises microtubules 
via accessory proteins and promotes the epiboly movement required for zebrafish development 
(Hsu et al., 2006, Weng et al., 2013). 
 
During larva development, expression of cyp11a1 was shown in the interrenal primordial cells and 
has been suggested to be present between 24 and 120 hours post fertilisation (hpf) (Chai et al., 
2003, Hsu et al., 2003, To et al., 2007, Xie et al., 2008). However, others failed to demonstrate 
cyp11a1 expression in zebrafish larvae between three to 14 days post fertilisation (dpf) (Hsu et al., 
2002, Hu et al., 2004), despite reported de novo steroidogenesis at these stages (Alsop and Vijayan, 
2008). Whole transcriptome microarray analysis focusing on the expression of cytochrome P450 
enzymes in zebrafish identified a second cyp11a gene; cyp11a2 (Goldstone et al., 2010). The 
cyp11a2 gene consists of nine coding exons and is also located on chromosome 25, approximately 
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9 Kb upstream of the cyp11a1 gene. This newly proposed cyp11a paralogue remained 
uncharacterised in terms of function and expression in the zebrafish.  
 
4.2 Rational for work 
Zebrafish are becoming an increasingly popular model to study steroid hormone synthesis, 
signalling and action. In order to investigate the redox interactions between the ferredoxin and 
mitochondrial CYP proteins in zebrafish we first had to comprehensively characterise these 
enzymes. Therefore, we aimed to determine the functional roles of each zebrafish Cyp11a 
paralogue during zebrafish development.  
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4.3 Methodology  
4.3.1 PCR amplification of zebrafish cyp11a1 and cyp11a2 
The nucleotide sequences for zebrafish cyp11a1 and cyp11a2 were determined by amplifying the 
cDNA sequences from the ovary of an adult AB female. Oligonucleotides were designed based 
on sequences annotations from ENSEMBL Zv9 genomic database (Table 4.1) and RT-PCR was 
performed using a high fidelity polymerase. After PCR purification, the PCR product was ligated 
into pGEM-T Easy vector using the standard protocols and sequenced.  
 
Table 4.1 Oligonucleotides for PCR amplification P450scc cDNA 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
cyp11a1 cyp11a1-F GTGATGGCCCTCTGGAATG 
 cyp11a1-XRa CATCTCTGCTATCTGCTGGCA 
cyp11a2 cyp11a2-F CAATGGCCCTCTGGAGTC 
 cyp11a2-XRa GTACCGACCCAAACTGTACCG 
a Reverse oligonucleotides contain a stop codon 
 
 
4.3.2 Alignment and phylogenetic analysis of Cyp11a sequences 
Amplified PCR sequences were used to infer amino acid sequences of the Cyp11a paralogues. 
Zebrafish Cyp11a1 and Cyp11a2 protein sequences were compared to vertebrate Cyp11a1 
protein sequences from the ENSEMBL database, including human (Homo sapiens; 
ENSP00000268053), gorilla (Gorilla gorilla gorilla; ENSGGOP00000006378), tilapia 
(Oreochromis niloticus; ENSONIP00000019362), fugu (Takifugu rubripes; 
ENSTRUP00000035273), tetraodon (Tetraodon nigroviridis; ENSTNIP00000011253), and 
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stickleback (Gasterosteus aculeatus; ENSGACP00000006220). Alignment and homology analyses 
were performed using ClustalW2 software as previously described. 
 
4.3.3 PCR amplification and cloning of zebrafish P450-scc paralogues 
The cyp11a1 and cyp11a2 coding sequences from AB, Tubingen, Casper and Nacre wild-type 
strains were amplified and sequenced from an ovary of an adult female. For both genes, 
oligonucleotides were designed with BamHI restriction sites to allow direct cloning into pCS2+ 
and pCDNA6-V5. Additionally, reverse oligonucleotides were used to generate products with 
(XR-BamHI) and without (R-BamHI) a stop codon to allow the three-prime end to be tagged 
with a V5 epitope (Table 4.2). RT-PCR was performed using Expand High Fidelity PCR system. 
After PCR purification, digestion of the PCR product and ligation into the required plasmid was 
performed using the standard protocols. The correct directionality of the insert was screened by 
colony PCR using T7 vector primer with an appropriate insert primer.  
 
 
 
Table 4.2 Oligonucleotides for the PCR amplification and cloning of P450scc cDNA 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
cyp11a1 cyp11a1-F-BamHI TACCGAGCTCGGATCCGTGATGGCCCTCTGGAATG 
 cyp11a1-XR-BamHI a CTGGACTAGTGGAATCCCATCTCTGCTATCTGCTGGCA 
 cyp11a1-R-BamHI CTGGACTAGTGGATCCGCATCTCTGCTTTCTGCTGGCA 
cyp11a2 cyp11a2-F-BamHI TACCGAGCTCGGATCCCAATGGCCCTCTGGAGTC 
 cyp11a2-XR-BamHI a CTGGACTAGTGGATCCGTATCTCTGCTATCTGCTGGAG 
 cyp11a2-R-BamHI CTGGACTAGTGGATCCGTATCTCTGCTTTCTGCTGGAG 
a Reverse oligonucleotides contain a stop codon. 
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4.3.4 Characterisation of cyp11a1 and cyp11a2 expression 
The spatial and temporal expression of cyp11a1 and cyp11a2 was determined by RT-PCR as 
previously described. Specifically, a 76 nucleotide fragment of the cyp11a1 gene was amplified 
using MegaMix-Blue reaction mix containing cyp11a1 e9F and e9/10R primers. To characterise 
cyp11a2 expression, a 902 nucleotide fragment was amplified with e1F and e3R primers (Table 
4.3). As a control for mRNA quality, a 102 nucleotide fragment of the β-actin gene was amplified 
using e4F and e4R primers (Table 3.3Table 3.3 Oligonucleotides for RT-PCR expression analysis 
of the fdx1 and fdx1b genes.). 
 
 
Table 4.3 Oligonucleotides for RT-PCR expression analysis of the cyp11a paralogue 
genes 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
cyp11a1 e9F GCAATGAGTCTTCCAAGGTTC 
 e9/10R GAACTAAAGTCCCTGCTGGAA 
cyp11a2 e1F GAGCACCTGCAATCGGACT 
 e3R TCCCCTGCACCTTCGGAG 
 e5/6R TGTTATAGCCGTCGTGTCCACT 
 
 
 
4.3.5 Transient knockdown of cyp11a1 and cyp11a2 in zebrafish embryos 
To analyse the role of each zebrafish P450scc enzyme during development, transient 
knockdowns were performed with specific anti-sense morpholinos. The cyp11a1 morpholino was 
previously described by Hsu et al. (2006) and was directed to the transcriptional start codon 
(cyp11a1-ATGMO). A five base-pair mismatched morpholino (cyp11a1-CtlMO) was used as a 
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control. For cyp11a2, two different morpholinos were designed to disrupt gene expression; an 
ATG morpholino (cyp11a2-ATGMO), and a splice morpholino (cyp11a2-SplMO) against the splice 
acceptor site of exon four. A five base-pair mismatch for the translation blocking morpholino 
(cyp11a2-CtlMO) and the splice morpholino (cyp11a2-Ctl2MO) were used as controls. Sequences of 
the morpholinos and mismatch controls are listed in Table 4.4 
 
 
Table 4.4 Sequences of the anti-sense morpholinos used for the transient knockdown of 
cyp11a paralogs 
 
Gene Morpholino 
Sequence 
(5-prime to 3-prime) 
cyp11a1 cyp11a1-ATGMO a GCCATCACACTCTCTCTCTCTACTT 
 cyp11a1-CtlMO GCGATGACACTGTCTCTCTGTAGTT 
cyp11a2 cyp11a2-ATGMO a GCCATTGCACTCTCTCTGTCTCTGC 
 cyp11a2-CltMO GCGATTCCACTCTGTGTGTGTCTGC 
 cyp11a2-SplMO b ATTGGAAGACGTTGCTTACTTCAGC 
 cyp11a2-Ctl2MO ATTGCAAGAGGTTGGTTACATCACC 
 
a ATG morpholinos impair initiation of mRNA translation 
bSplice morpholinos induce abnormal splicing of the mRNA 
Underlined letters highlight base-pair mismatches between ATG or splice morpholinos and 
controls. 
 
 
4.3.6 Phenotypic characterisation of cyp11a morphants 
Zebrafish embryos injected with 3 ng of morpholino were raised to the desired developmental 
stage and observed on a stereomicroscope. At 10 hpf all morphants and controls were 
categorised into three classes based on normal epiboly, abnormal epiboly or dead. At 5 dpf 
cyp11a2-Spl morphants and cyp11a2-Ctl2 larvae were categorised into four classes depending on 
the observed morphology. Class I were considered to have normal development and Class IV 
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were the most severe. Class I larvae were subdivided into Class Ia and Class Ib, depending on 
inflation or no inflation of the swim bladder, respectively.  
 
 
Table 4.5 Classification of the phenotype of cyp11a2-Spl morphants at 120 hpf. 
Phenotype Class Iaa Class Iba Class II Class III Class IV 
Swim bladder inflated none inflated none none 
Yolk sac normal normal enlarged enlarged enlarged 
Pericardial sac normal normal normal normal oedema 
Head normal normal normal small 
shortened 
snout 
a Phenotype of class Ia and Ib zebrafish larvae represent the wild-type phenotype. 
 
 
 
4.3.7 Rescue experiments of cyp11a2 morphants with pregnenolone 
At 10 hpf zebrafish cyp11a2-Spl morphants were incubated in E3 media supplemented with 
50 nM pregnenolone or vehicle (ethanol). Treatments were changed every 24 hours over the first 
five days of development. At 120 hpf, the morphological phenotype was assessed based on the 
classifications outlined in Table 4.5 In addition, 300 larvae injected with cyp11a2-SplMO that were 
treated with pregnenolone or ethanol and were collected at 72 hpf for cortisol analysis. Rescue 
experiments with pregnenolone were performed in duplicate and represented as mean ± SD for 
each embryo treatment. 
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4.4 Results 
4.4.1 Homology of Cyp11a isozymes with vertebrate orthologues 
Protein sequence comparison between the two identified Cyp11a isozymes and other vertebrate 
orthologues was performed in silico to elucidate the evolution and conserved functional domains 
of the recently identified Cyp11a2 enzyme (Goldstone et al., 2010). Zebrafish were the only 
vertebrate with two identified cyp11a genes. Evolutionary analysis revealed that teleost Cyp11a 
enzymes grouped together on their own clade distinct from other mammals. The phylogenetic 
analysis indicates both zebrafish Cyp11a isozymes share a common ancestor with other teleost 
fish (Figure 4.1). 
 
 
 
 
 
Figure 4.1 Evolution of Cyp11a paralogues 
Maximum likelihood phylogenetic analyses of vertebrate Cyp11a protein sequences were 
conducted using the PhyML software under the SH-like likelihood-Ratio test parameters. 
Scaled phylogenetic tree was drawn with TreeDyn software. Branch support values are 
represented in %. Zebrafish-I and Zebrafish-II refer to Cyp11a1 and Cyp11a2 isozymes, 
respectively. 
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Comparison between the two zebrafish Cyp11a proteins showed 80 % protein sequencing 
identity. Cyp11a1 and Cyp11a2 have 509 and 512 amino acids, respectively, and both share 
typical cytochrome P450 functional domains. Notably, the redox-interaction domain is 
conserved, as well as the oxygen-binding and substrate binding domains, ExxR motif and the 
meander sequence (Hasemann et al., 1995, Strushkevich et al., 2011). Alignment of the protein 
sequences showed zebrafish Cyp11a2 has higher homology with other vertebrate cytochrome 
P450scc enzymes than its paralogue enzyme Cyp11a1. Specifically, in comparison to other teleost 
fish, Cyp11a2 had highest identity with stickleback and tetraodon (73 %), followed by fugu and 
tilapia (72 %). Alternatively, Cyp11a1 had most identity with stickleback and fugu (66 %) 
followed by tetraodon (65 %) and tilapia (64 %). In comparison to mammalian orthologues 
Cyp11a2 showed 46 % identity with human and gorilla and 44 % identity with rat and mouse. 
Cyp11a1 had 45 % identity with human, gorilla, rat and mouse.  
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Figure 4.2 ClustalW alignment of Cyp11a paralogs 
The protein sequence of human, gorilla, rat, mouse, tilapia, fugu, tetraodon, stickleback, zebrafish 
Cyp11a enzymes were aligned using ClustalW under default parameters. Black lines and arrows 
annotate -helixes and -sheets, respectively, of the secondary protein structure of human 
CYP11A1, based on the crystallographic structure (http://www.rcsb.org/pdb/home/home.do, 
PDB code 3NA0). The haem-binding domain is highlighted in red, the oxygen-binding domain in 
brown, the meander in light grey, and the ExxR in blue. Residues from the substrate-binding 
domain are coloured in green (residues directly binding to the substrate) and yellow (residues 
stabilizing the 3-hydroxyl of cholesterol). Residues participating in redox interaction are 
coloured in orange. Zebrafish-I and Zebrafish-II refers to Cyp11a1 and Cyp11a2, respectively. 
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4.4.2 Identification of polymorphisms in zebrafish cyp11a1 and cyp11a2 
genes 
The cyp11a1 and cyp11a2 full length cDNA was amplified from wild-type AB fish by high fidelity 
polymerase and sequenced to confirm PCR amplification without mutations. Comparison of our 
amplified sequences to the annotated ENSEMBL database sequences identified eight 
non-synonymous single nucleotide polymorphisms (SNPs) in the amplified cyp11a1. These 
included F8L, E165D, L328M, Y273C, I297V, F390Y, T392N and K437D. Repeat amplification 
and sequencing confirmed the presence of these SNPs. To compare the prevalence of these 
mutations, cyp11a1 coding sequences were amplified from other wild-type strains including 
Nacre, WIK and Casper, and compared to the available Tubingen sequence and the previously 
published cyp11a1 sequence (Hsu et al., 2009). A ClustalW alignment the corresponding proteins 
were used to compare the amino acid sequences. Each Cyp11a1 contained several mutations 
which are summarised in Table 4.6.  
 
Similarly, the cloned cyp11a2 sequence from wild-type AB fish had three non-synonymous SNPs 
when compared to the ENSEMBL reference sequence. These point mutations were confirmed 
by repeat amplification of the cyp11a2 cDNA, suggesting it was not PCR error. These mutations 
included T191N, N341H and K402N (Table 4.7). As there was no other annotated sequences for 
cyp11a2 the presence of the missense mutation was confirmed by repeating the amplification 
from other wild-type zebrafish. Only the T191N mutation was not present in other strains. 
However, the conservation of a polar uncharged amino acid at this position across all vertebrates, 
and the high polymorphic variability of these genes I continued with functional testing our AB 
Cyp11a2 sequence.  
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Table 4.6 Missense mutation identified in Cyp11a1 in different wild-type strains 
Mutation Referencea ABb WIKc Hsud Tubb Nacreb Casperb 
F8L F L L L F F F 
E165D E D D D E E E 
K197R K K K R K K K 
Y273C Y C C C Y Y Y 
I297V I V V I I I I 
L328M L M M L L L L 
F390Y F Y Y Y F F F 
T392N T N N T T T T 
K437N K N N N K K K 
Δ451L/452E LE LE LE LE Δ LE LE 
a ENSEMBL annotated sequence 
b PCR amplified from University of Birmingham stocks 
c NCBI annotated from sequence 
d Previously published by (Hsu et al., 2009) 
 
 
 
 
 
Table 4.7 Missense mutation identified in Cyp11a2 in different wild-type strains 
Mutation Referencea ABb Tubb Nacreb 
T191N T N T T 
N341H N H H N 
K402N K N N K 
 a ENSEMBL annotated sequence 
 b PCR amplified from University of Birmingham stocks 
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4.4.3 Functional in vivo assays of cyp11a1 and cyp11a2 paralogues 
Amplified cyp11a1 and cyp11a2 from the AB wild-type strain were directionally cloned into the 
pcDNA6-V5 mammalian expression vector. After transfection into COS7 cells, catalytic assays 
were used to determine the conversion of 22ROH-cholesterol to pregnenolone. The zebrafish 
Cyp11a2 showed 114 % (±11.1) activity of the human homologue, CYP11A1. In comparison, 
zebrafish Cyp11a1 only had 0.1 % (±0.03) of human CYP11A1 activity (Figure 4.3). To 
determine if this was from the identified mutations in the AB amplified sequence, cyp11a1 coding 
sequences from Tubingen and Nacre were also directionally cloned into the mammalian 
expression vector for functional testing. Similarly, the wild-type Tubingen and Nacre Cyp11a1 
had minimal conversion of 22ROH-cholesterol to pregnenolone. Additionally, AB cyp11a1 and 
cyp11a2 were cloned with a V5-tag to confirm protein levels. Western blot using a V5 antibody 
showed decreased Cyp11a1 protein compared to Cyp11a2. Beta-actin protein levels were used to 
confirm equal protein loading.  
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Figure 4.3 In vitro activity of zebrafish Cyp11a paralogues 
(A) COS7 cells were transfected with human CYP11A1, zebrafish cyp11a2 from AB strain or 
zebrafish cyp11a1 from AB, Tubingen or Nacre wild-type strains. Cells were then incubated 
with 22ROH-cholesterol for StAR independent conversion to pregnenolone. Zebrafish 
Cyp11a2 had 114% (±11.1) activity compared to human CYP11A1. All zebrafish Cyp11a1 
had 0.1% (±0.03) activity of the human paralogue. (B) Western blot of V5 tagged Cyp11a2 
and Cyp11a1 proteins show decreases in Cyp11a1 protein levels compared to Cyp11a2. 
Beta-actin was used to show equal loading. Experiments were performed in triplicate-
triplicate and the mean ± SD is shown for each paralogue. . Statistical analysis was performed 
using one-way ANOVA followed by Dunnett's multiple comparisons test. ** P<0.01 
. 
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4.4.4 Tissue distribution and temporal cyp11a expression  
The developmental expression of each cyp11a paralogue was determined by RT-PCR. cyp11a1 was 
expressed as a maternal transcript as it was detected at the single-cell stage. Expression was 
maintained to the segmentation periods (up to 22-24 hpf) with only residual expression being 
detected at 28 hpf. Alternatively, cyp11a2 transcripts were not detected at these early 
developmental stages and were only weakly detected during late segmentation period (28 hpf). By 
32 hpf expression of cyp11a2 became prominent and was maintained to 120 hpf (Figure 4.4).  
 
 
To determine spatial expression in adults, RT-PCR was performed using cDNA extracted from 
adult tissues. cyp11a1 expression was highest in the ovary, and was also detected in the testis 
kidney head (containing the interrenal gland), kidney and intestine. In contrast, cyp11a2 
expression was restricted to the kidney head, gonads and the brain. No sexual dimorphism in the 
expression pattern was observed (Figure 4.4).  
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4.4.5 Confirmation of cyp11a1 function during early zebrafish 
development 
To determine the specific roles of Cyp11a1 and Cyp11a2 during zebrafish development, each 
paralogue was knocked down using anti-sense morpholinos. Microinjection of cyp11a1-ATGMO 
resulted in a similar phenotype observed in previous studies (Hsu et al., 2006). At 10 hpf, 68 % of 
morphants (n = 300) had incomplete epiboly, and 29 % had died during these early 
 
 
Figure 4.4 Temporal expression and tissue distribution of zebrafish cyp11a1 and 
cyp11a2 genes 
Expression of cyp11a1 and cyp11a2 was characterised in zebrafish embryos and larvae (A) and 
in adult tissues (B). Beta-actin was used as a loading control. 
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developmental stages. In contrast, 97 % of cyp11a1-CtlMO injected embryos (n = 300) had 
completed epiboly. Pregnenolone concentrations were determined from 300 cyp11a1-CtlMO and 
surviving cyp11a1-ATGMO at 10 hpf. Control morphants had pregnenolone concentration of 
0.19 (± 0.05) pg per embryo. In comparison, cyp11a1 deficient embryos showed a decrease to 
0.1 (± 0.08) pg per embryo at 10 hpf (Figure 4.5). 
 
 
 
 
 
 
Figure 4.5 Pregnenolone concentrations in cyp11a1 deficient embryos at 10 hpf 
Pregnenolone concentrations were determined in cyp11a1-CtlMO (black) and cyp11a1-ATGMO 
(grey) injected embryos at 10 hpf.  Picograms of pregnenolone per embryo were calculated 
from concentration measured by LC-MS/MS from whole zebrafish extracts. cyp11a1-CtlMO 
injected embryos showed a pregnenolone concentration of 0.19 (± 0.05) pg per embryo. In 
comparison, cyp11a1-ATGMO embryos had 0.1 (± 0.08) pg per embryo. Mean ± SD from 
three independent experiments is shown.  
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Microinjection of cyp11a2-ATGMO resulted in a similar phenotype at 10 hpf. Of the injected 
embryos 45 % (n = 60) had not completed epiboly, with 18 % failing to thrive. In contrast, the 
cyp11a2-CtlMO did not alter normal development and allowed 93 % (n = 49) of embryos to 
complete epiboly by 10 hpf (Figure 4.6). Our expression data demonstrated that only cyp11a1 is 
expressed from one cell to 10 hpf. The cyp11a2 cDNA region which is targeted by the cyp11a2-
ATGMO has 72 % homology (18 out of 25 base-pairs) with cyp11a1 with the highest identity being 
around the ATG start codon. Unspecific binding of the cyp11a2-ATGMO to cyp11a1 mRNA would 
explain the abnormal epiboly observed in the cyp11a2-ATG morphants within the first 10 hours 
of development. Given the high nucleotide identity between the zebrafish cyp11a paralogues 
around the translation initiating start codon, it was not possible to design a specific morpholino 
blocking the ATG codon. The splice disrupting morpholino targeting cyp11a2 (cyp11a2-SplMO) did 
not recapitulate the epiboly delays observed with the cyp11a2-ATGMO injections, suggesting it was 
not targeting cyp11a1. The nucleotide identity between the cyp11a2-SplMO with cyp11a1 was 44 % 
(11 out of 25 base-pairs) and the mismatches are distributed over the entire morpholino binding 
region. Thus, unspecific binding of the cyp11a2-SplMO to cyp11a1 mRNA was not expected. 
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Figure 4.6 Morphological phenotype of Cyp11a morphants at 10 hpf 
(A) Abnormal epiboly (black arrow) was observed in cyp11a1-ATG and cyp11a2-ATG 
morphants at 10 hpf. Phenotype of cyp11a2-Spl morphants and controls was normal. (B) 
Frequency of normal development, abnormal epiboly and mortality in zebrafish morphants 
and controls at 10 hpf.  
*Abnormal epiboly refers to the inability of the blastoderm to move normally towards the 
vegetal pole of the embryo during gastrulation. 
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4.4.6 Determining the specific roles of cyplla2 during early development 
Confirmation of splice disruption of the cyp11a2 RNA transcript by the cyp11a2-SplMO was 
performed by RT-PCR. The injection of cyp11a2-SplMO into single-cell embryos efficiently 
induced abnormal splicing of cyp11a2 intron 2. Amplification of a cDNA fragment extending 
from exon 1 to 3 of cyp11a2 showed a 240 base-pair band in the cyp11a2-Spl morphants, 
indicating the loss of exon two (Figure 4.7). A dilution effect of cyp11a2-SplMO was noted at 96 
and 120 hpf, as indicated by the presence of the correctly spliced 396 base-pair band. The 
cyp11a2-Ctl2MO did not disrupt splicing of cyp11a2, as indicated by the single 396 base-pair 
product. 
 
 
 
Figure 4.7 Confirmation of disruption of cyp11a2 splicing 
(A) cyp11a2-SplMO binds to the donor splice site of intron 2, inducing a deletion of exon 2 in 
mature cyp11a2 mRNA. (B) RT-PCR analysis confirmed loss of exon 2 in cyp11a2 morphants 
but not in the controls. MO, indicates cyp11a2-SplMO binding site. Black arrow shows 
transcription initiation site. Black line represents cyp11a2-SplMO binding site. Grey arrows 
indicate the binding sites of the primers used for RT-PCR analysis to confirm missplicing of 
cyp11a2 mRNA. 
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Embryos microinjected with cyp11a2-SplMO developed normally up to 24 hpf. At 52 hpf, 55 % of 
cyp11a2-Spl morphants (n = 193) had delayed absorption of the yolk in contrast to 32 % of the 
controls (n = 182). Pericardial oedema was observed in 6 % of cyp11a2 splice morphants 
compared to 1 % in control injected embryos. As zebrafish embryos grow and develop, the yolk 
is absorbed and metabolised, however, in cyp11a2-Spl morphants the enlarged yolk persisted in 
half the embryos by 96 hpf. In control injected embryos only 10 % showed a slightly enlarged 
yolk at the same time point (data not shown). At 120 hpf injected embryos were classified based 
on their morphological phenotype. In cyp11a2-SplMO injected embryos the prominent phenotype 
was Class II (58 %) followed by Class III (21 %). Approximately, 80 % of cyp11a2 morphants 
(Class II, III and IV) had a large yolk sac. In control injected embryos only Class Ia (56 %) and Ib 
(44 %) phenotypes were observed at 120 hpf (n = 173) (Figure 4.8). Chemical rescues were 
performed by incubating morpholino injected embryos in E3 media supplemented with 50 nM 
pregnenolone. Treated cyp11a2-SplMO injected larvae were classified based on their morphology at 
120 hpf. Sixty-six per cent of cyp11a2 morphants had a normal Class I phenotype (59 % class Ia, 
7 % class I b) at 120 hpf (n = 59). 
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Figure 4.8 Classification of cyp11a2 deficient embryos at 120 hpf 
(A) At 120 hpf larvae were categorised into five different classes depending on the swim 
bladder (black arrow), yolk sac (blue arrow), pericardial sac (red arrow) and head (black 
asterisks) phenotype (Table 4.5). Class Ia (inflated swim bladder) and Ib (not inflated swim 
bladder) represent a wild-type phenotype. (B) Phenotypic spectrum observed in controls, 
untreated cyp11a2-Spl morphants, and cyp11a2-Spl morphants supplemented with 
pregnenolone. 
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4.4.7 Steroid profiles of cyp11a2 deficient embryos 
To determine the effect of Cyp11a2 on pregnenolone synthesis, pregnenolone concentrations 
were measured in cyp11a2-SplMO and cyp11a2-Ctl2MO injected embryos at 10, 22 72, 96 and 
120 hpf. At 10, 22 and 72 hpf there was no difference observed between cyp11a2 deficient 
embryos and controls. At 96 hpf and 120 hpf the cyp11a2-SplMO larvae had 48 % and 80 % less 
pregnenolone when compared to the controls (Figure 4.9).  
 
Cortisol measurements in embryos were also determined at each time point as an indication of 
de novo interrenal steroid hormone production. Both cyp11a2-SplMO and cyp11a2-Ctl2MO injected 
embryos had similar cortisol concentration at 10 and 22 hpf. By 72 hpf, cortisol concentrations 
were 90 % lower in cyp11a2-Spl morphants compared to the controls. This decrease was 
maintained at 96 and 120 hpf with cyp11a2 deficient embryos showing a 70 to 80 % decrease in 
cortisol concentrations (Figure 4.9). Additionally, cortisol was measured from 300 larvae to 
determine if pregnenolone supplementation could restore steroid hormone production. At 
72 hpf, pregnenolone treated cyp11a2-Spl morphants had 1.47 pg per larvae cortisol which was 
comparable to untreated cyp11a2-Ctl2 morphants whose cortisol levels were 1.53 pg per larvae.  
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Figure 4.9 Pregnenolone and cortisol concentrations in cyp11a2 deficient embryos 
(A) Pregnenolone and (B) cortisol concentrations were determined in cyp11a2-SplMO (grey) 
and cyp11a2-Ctl2MO (black) during the first five days of development. Picograms of 
pregnenolone and cortisol per embryos or larvae were calculated from concentrations 
measured by LC-MS/MS from whole zebrafish extracts. Mean ± SD was plotted against 
developmental stages. Grey arrows show interrenal primordial formation (22 hpf), and 
initiation of de novo cortisol synthesis (48 hpf) and active stress response (96 hpf).  
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Figure 4.10 Cortisol concentrations of cyp11a2-Spl morphants supplemented with 
pregnenolone 
 
cyp11a2-Spl morphants were incubated in E3 medium containing 50 nM pregnenolone or 
vehicle from 10 hpf. Cortisol concentrations were measured in 72 hpf zebrafish larvae from 
two independent experiments. Cortisol concentrations expressed as picograms per larvae 
were calculated from concentrations measured by LC-MS/MS in zebrafish extracts. Mean  
SD was plotted against embryo treatment. 
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4.5 Discussion and prospective studies 
It was previously reported that cyp11a1 was the only identified CYP11A1 orthologue in zebrafish. 
However, with the newly identified cyp11a2, the specific functional roles of these enzymes during 
zebrafish development remained to be determined. We have comprehensively characterised both 
cyp11a paralogues in zebrafish. Subsequently, we confirmed previous studies that Cyp11a1 is 
required during gastrulation stages for completion of epiboly and is therefore essential for 
embryo development. Additionally, we have shown that Cyp11a2 is required for pregnenolone 
production in the interrenal gland.  
 
4.5.1 Cyp11a1 has low catalytic activity in vitro  
PCR amplification of cyp11a1 identified amino acid mutations when compared to the ENSEMBL 
annotated sequences. Functional activity analysis performed in mammalian cells identified 
zebrafish Cyp11a1 had 0.1 % of human CYP11A1 activity. This low level activity was confirmed 
with different zebrafish Cyp11a1 sequences amplified from other wild-type strains. In 
comparison, zebrafish Cyp11a2 showed 114 % of human activity. Western blot showed 
decreased levels of Cyp11a1 protein in comparison to Cyp11a2 which may explain the decrease in 
activity. During characterisation of the zebrafish Cyp17a paralogues, we identified Cyp17a1 has 
rapid protein turnover compared to its isozyme Cyp17a2 (Parajes et. al. unpublished). Work is 
continuing to assess the stability of Cyp11a1 by performing in vitro assays with proteasome 
inhibitors, to inhibit Cyp11a1 degradation. Nevertheless, it is plausible that protein stability might 
be a common mechanism of regulating steroid production during early zebrafish development. 
Furthermore, despite the detected low level of in vitro functional activity, transient knockdown 
studies confirmed the importance of Cyp11a1 for zebrafish embryogenesis.  
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4.5.2 Maternal expression of cyp11a1 is essential for embryogenesis 
Our in vivo knockdown investigations confirmed previous studies showing that Cyp11a1 is 
essential for early embryo development (Hsu et al., 2006). The early onset morphological 
phenotype in cyp11a1 deficient embryos is consistent with its early expression pattern and 
highlights the importance of Cyp11a1 activity for early zebrafish development. Pregnenolone is 
the main product of Cyp11a1 and it was confirmed by LC-MS/MS a non-significant decrease in 
pregnenolone per embryo in cyp11a1-ATG morphants compared to controls. Steroid profiles 
were analysed only from embryos which had survived to 10 hpf. It is hypothesised that embryos 
with the most efficient cyp11a1 knockdown were not viable at this stage and therefore it is 
expected that pregnenolone concentrations would be even more decreased in cyp11a1 deficient 
embryos. Pregnenolone can directly bind to microtubule plus end–tracking proteins which 
subsequently help stabilise the microtubules (Weng et al., 2013). Cyp11a1 activity is therefore 
essential for zebrafish development through promotion of epiboly via microtubule 
polymerisation. Although I did not detect cyp11a2 expression during early gastrulation stages, 
injection of the cyp11a2-ATGMO caused a similar abnormal epiboly movement as seen with the 
cyp11a1-ATGMO. These findings were in contrast with the late onset cyp11a2-SplMO phenotype. We 
accredited the different phenotype observed between the translation blocking and splice 
disrupting morpholinos to unspecific binding of the cyp11a2-ATGMO to the cyp11a1 mRNA.  
 
4.5.3 Transition of cyp11a1 to cyp11a2 expression correlates to the 
initiation of de novo steroidogenesis  
The expression of cyp11a1 was strongest in embryos from fertilisation to 24 hpf with minimal 
expression detected at 28 and 48 hpf. This expression is in agreement with previous results 
obtained by RT-PCR (Hu et al., 2004) and microarray analysis (ZF-espresso 0.7.5 alpha, URL: zf-
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espresso.tuebingen.mpg.de). However, other studies detected cyp11a1expression at later stages by 
whole mount in situ hybridisation (Hsu et al., 2003, To et al., 2007). Discrepancies were also 
noted when comparing expression in adult tissues. Our study showed cyp11a1 expression was 
confined to the adult gonads, and was minimally detected or absent in the kidney head 
(containing the interrenal gland) and brain. This result is not consistent with earlier studies which 
detect high cyp11a1 expression in all these tissues (Diotel et al., 2011, Hsu et al., 2003, Tong et al., 
2010). It was speculated that the discrepancies observed with other reported expression data are 
due to non-specific detection of the previously uncharacterised cyp11a2.  
 
We have for the first time characterised the cyp11a1 paralogue gene, cyp11a2. The two zebrafish 
P450scc enzymes share 85 % identity of the coding nucleotide sequence and 80 % at the amino 
acid level. A transition between cyp11a1 and cyp11a2 expression was observed by RT-PCR 
between 28 and 48 hpf. Interestingly, this transition also coincides with development of the 
interrenal and de novo cortisol production. Furthermore, cyp11a2 was maintained as the only 
P450scc enzyme expressed during larval development stages. In adult tissues, cyp11a2 was 
restricted to steroidogenic tissues, including the kidney head, brain and gonads. cyp11a2 is 
expressed in the early larvae when cortisol synthesis begins, and in the adult steroidogenic tissues. 
Coupled with its observed functional in vitro activity, it suggests cyp11a2, rather than cyp11a1, is 
required to initiate and maintain de novo steroidogenesis.  
  
4.5.4 Deficiency in cyp11a2 impairs interrenal steroidogenesis 
The synthesis of cortisol is highly conserved between zebrafish and mammals. As in wild-type 
embryos (Alsop and Vijayan, 2008), the cyp11a2-Spl morphants and controls showed the maternal 
cortisol stores were almost depleted by 24 hpf. At 72 hpf, active steroid hormone synthesis was 
confirmed in control injected embryos by detecting a seven fold increase in whole embryo 
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cortisol levels. At 96 hpf the HPI axis becomes active which corresponded to a three-fold 
increase in cortisol concentration in control larvae. At this time, the larvae are capable of 
synthesising cortisol in response to stress (Alsop and Vijayan, 2008, 2009, To et al., 2007). 
However, Cyp11a2 deficient larvae showed impaired pregnenolone and de novo cortisol synthesis 
at 72, 96 and 120 hpf. At 96 and 120 hpf minimal cortisol was detected, which can be attributed 
to dilution of the morpholino as the larvae grow. Supplementation of cyp11a2 morphants with 
pregnenolone was able to restore cortisol production, confirming that the observed cortisol 
deficiency was from impaired pregnenolone synthesis from a loss of cyp11a2. This clearly shows 
that Cyp11a2 is essential for active steroid hormone biosynthesis in early larvae.  
 
The morphology of cyp11a2-Spl was consistent with other zebrafish morphants which lack 
glucocorticoid production or response. Larvae deficient in cyp11a2 have delayed metabolism of 
the yolk and less frequently pericardial oedema from 52 hpf. By 120 hpf, the phenotype was 
more pronounced compared to the controls. The most severely affected embryos had additional 
craniofacial abnormalities and pericardial oedema. Previous studies show the morpholino 
knockdown of the glucocorticoid receptor (Pikulkaew et al., 2011) or a zebrafish model of 
interrenal insufficiency due to loss of ff1b (orthologue of the mammalian SF1) (Chai et al., 2003) 
have a similar phenotypes. Similarly, the dax1 (SF1 transcription regulator) deficient zebrafish 
(Zhao et al., 2006) and chemical inhibition of P450scc (Chai et al., 2003) are both reported to 
have similar morphological phenotypes.  
 
In contrast to zebrafish models of glucocorticoid resistance and interrenal insufficiency, cyp11a2 
deficient embryos showed no changes in the inflation of the swim bladder. Inflation of the swim 
bladder begins at 96 hpf. At 96 hpf the cyp11a2-SplMO had lost efficacy from being diluted and 
minimal cortisol production can be detected. Cortisol levels were not measured in previous 
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zebrafish models of glucocorticoid deficiencies, so a direct comparison cannot be made. 
However, our study would suggest that low cortisol production is sufficient for inflation of the 
swim bladder, as reported by inflation of the swim bladder at 120 hpf with partial glucocorticoid 
resistance. Notably, supplementation of cyp11a2 deficient embryos with pregnenolone caused an 
increase in swim bladder inflation. This supports the role of glucocorticoids in swim bladder 
inflation. However, it should not be ruled out that the swim bladder inflation maybe a secondary 
phenotype from lethargy and reduced swimming from a decreased metabolic rate. Thus further 
studies are required to determine the role of glucocorticoids in development.  
 
4.6 Conclusion 
By comprehensively characterising the zebrafish P450scc enzymes we were able to demonstrate 
that Cyp11a2, rather than Cyp11a1 is the functional orthologue of human CYP11A1 in larvae 
and adult zebrafish. Both Cyp11a1 and Cy11a2 have distinct functional roles and both are critical 
for zebrafish development. We confirmed that pregnenolone synthesised by Cyp11a1 is 
functionally important for microtubule polymerisation and stabilisation to promote epiboly. 
Additionally, Cyp11a2 is critical for pregnenolone production during de novo steroidogenesis and 
is expressed in steroidogenic tissues in the adults. Overall, we were able to redefine the initiation 
and maintenance of zebrafish steroid hormone synthesis.  
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 GENOMIC DISRUPTION OF FDX1B AND CYP11A2 WITH 5.0
TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES 
5.1 Introduction  
5.1.1 Genomic engineering with TALENs 
Transcription activator-like effectors (TALEs) are naturally occurring proteins from the plant 
pathogenic bacterium Xanthomonas. During infection, the bacterium secretes TALE proteins 
which enter the nucleus and regulate promoter sequences to enhance the bacterial colonisation of 
the plant cell. The TALE recognises specific plant DNA sequences through a central repeating 
domain consisting of 34 amino acids. Nucleotide specificity is achieved by two critical amino 
acids at positions 12 and 13 of the repeating domain; these are known as the repeat variable 
diresidues (RVD) (Figure 5.1). Simultaneously, two groups identified the correlation between the 
two amino acid residues of the RVD and the DNA nucleotide it recognised (Boch et al., 2009, 
Moscou and Bogdanove, 2009). Subsequent studies further refined the nucleotide binding 
specificity code of individual RVDs (Cong et al., 2012, Streubel et al., 2012). By following this 
code, researchers can now engineer specific TALEs to recognise desired nucleotide sequences 
and subject them to genomic editing.  
 
Being able to target specific DNA sequences through the modification of the RVD in the TALE 
has been critical in developing recent genome engineering methodologies. TALEs have been 
fused to protein recombinases (Mercer et al., 2012), as well as transcriptional repressors (Cong et 
al., 2012) or activators (Maeder et al., 2013) to turn off or on endogenous gene expression, 
respectively. Additionally, TALEs have been fused to nucleases to generate transcription 
activator-like effector nucleases or TALENs, which are capable of introducing chromosomal 
breaks (Christian et al., 2010, Li et al., 2011, Mahfouz et al., 2011, Miller et al., 2011). With the 
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straightforward one-to-one RVD to nucleotide association code (NH binds guanine, NG binds 
thymine, NI bind adenine, and HD binds cytosine), TALE DNA-binding domains have rapidly 
become a promising platform to create a variety of molecular tools. 
 
 
 
 
 
 
 
 
Figure 5.1 Transcription Activator-Like Effector Nuclease (TALEN) architecture 
(A) Transcription Activator-Like Effectors (TALEs) contain a central tandem 34 amino acid 
repeating module. Each module is capable of recognising a single DNA nucleotide through 
the repeat variable diresidue (RVD) at amino acid position 12 and 13 (red x). By specifying 
the RVD of each repeating domain specific DNA sequences can be targeted. The RVD to 
nucleotide association code is: NN binds guanine or adenine, NH binds guanine, NG binds 
thymine, NI bind adenine, and HD binds cytosine. (B) TALE nucleases (TALENs) consist 
of specifically assembled TALEs linked to the nuclease domain of the Fok1 restriction 
enzyme (NLS; nuclear localisation signal).  
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5.1.2 Generating targeted DNA breaks using TALENs 
TALENs are becoming an increasing predominant tool in generating genomic modifications 
through their ability to produce loci specific chromosomal breaks. Typically, the TALE is linked 
to the to the DNA cleavage domain of FokI enzyme, to generate the TALEN. As the FokI 
domain requires dimerisation for activity, TALENs function as a pair. Individual TALENs bind 
to each strand of DNA which is separated by a spacer region where the FokI nuclease dimerises. 
Dimerisation of the Fok1 motifs induces nuclease activity resulting in chromosomal breaks, 
which are repaired by the endogenous cellular repair mechanisms. The generation of null alleles 
relies on the error prone non-homologous end joining (NHEJ) for chromosomal repair. The 
insertion or deletion of nucleotides (collectively known as indels) at the site of repair causes 
amino acid changes or frame-shift mutations rendering a non-functional protein (Figure 5.2). 
 
 
 
Figure 5.2 TALEN induced genetic disruption by non-homologous end joining  
TALENs recognise specific DNA sequences through the RVD. Dimerisation of the Fok1 
nuclease domains induces nuclease activity which causes double stranded chromosomal breaks. 
Repair by the error prone non-homologous end joining method results in nucleotide deletions 
(red) or insertions (blue) commonly referred to as indels. Indels cause amino acid changes or 
frame-shift mutations rendering a non-functional protein. 
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5.1.3 Genome editing with TALENs in zebrafish 
Since the first use of TALENs for genomic manipulation (Christian et al., 2010, Miller et al., 
2011), there are a growing number of model organisms and cell types which have been amenable 
by TALENs; and zebrafish has been no exception. Zebrafish lack the conventional genomic 
modifications methods made by homologous recombination in embryonic stem cells which are 
well established in other translational models such as mice. Traditionally, zebrafish studies have 
relied on transient knockdown by targeted antisense morpholino oligonucleotides or mutagenesis 
screens (Eisen and Smith, 2008, Lieschke and Currie, 2007). With recent advances in gene editing 
technology, researchers can now specifically target endogenous zebrafish loci to make genetic 
mutations.  
 
Simultaneously, two independent groups first described the use of TALENs in zebrafish. Sander 
et al. (2011) described the presence of indels generated from TALENs in somatic zebrafish cells, 
while Huang et al. (2011) reported the generation of heritable mutations in zebrafish. Since these 
initial studies, many groups have published optimised strategies and methodologies to 
successfully use TALENs in zebrafish. Different platforms have been developed to enable fast 
assemble of TALEN plasmids including the GoldenGate cloning (Cermak et al., 2011), high-
throughput solid-phase assembly (Reyon et al., 2012), and ligation-independent cloning 
techniques (Schmid-Burgk et al., 2013). Additionally, several groups have confirmed the 
generation of allele disruption in zebrafish due to indels from NHEJ chromosomal repair (Auer 
and Del Bene, 2014). The fast and efficient assembly, together with the site specific genome 
engineering offered by TALENs, has significantly expanded the usefulness of zebrafish as a 
translational model for development and disease studies.  
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5.1.4 Rational for work 
Morpholinos are widely used to study gene function in zebrafish; however, they only provide 
transient knockdown in the early embryo. Therefore, this study aimed to generate loss-of-
function alleles in zebrafish genes fdx1b and cyp11a2 using TALENs. It was hypothesised that 
these lines would show a correlation between the observed morpholino phenotypes and provide 
a useful tool for future experiments investigating the impact of mitochondrial redox regulation 
on steroidogenesis.  
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5.2 Methodology 
5.2.1 GoldenGate TALEN assembly method  
GoldenGate TALEN and TAL Effector Kit 2.0 was first published by Cermak et al. (2011) as a 
method for the easy assembly of custom TALENs. As the name suggests, this assembly method 
is based on GoldenGate cloning principals which uses type II restriction endonucleases (such as 
BsaI and Esp3I), whose recognition sites are distal to their cleavage sites. Additionally, they 
produce nonpalindromic, four nucleotide five-prime overhangs. As the cleavage site and 
recognition site are separated, any desired five-prime overhang can be generated for ligation. 
Furthermore, upon ligation, the enzyme recognition site will be absent; hence ligated products 
cannot be recut allowing restriction digestions and ligations to occur in a single reaction.  
 
5.2.1.a. GoldenGate reaction one 
Each TALEN is created via two rounds of digestion and ligation steps. In the first reaction, ten 
repeat units containing the desired RVDs are cloned into an intermediate pFUS plasmid. Each 
pFUS vector can only be used for 10 repeats, therefore, TALENs with 11 or more repeat units 
require separate ligations into a second pFUS vector. The 20 µL reaction contains 150 ng of the 
appropriate pFUS plasmid, 150 ng of each module plasmids (containing the appropriate RVD for 
the specific position), 1x T4 DNA ligase buffer, 1 µL of T4 DNA ligase, 2 µg BSA and 1 µL of 
BsaI restriction enzyme. The single digest-ligation reaction consisted of 10 cycles of 37 °C for 
five minutes followed by 16 °C for 10 minutes. A final incubation of 50 °C for five minutes and 
enzyme inactivation at 80 °C for five minutes completed the reaction. For each GoldenGate 
reaction, 1 µL of 10 mM ATP and 1 µL of Plasmid-Safe Nuclease (Epicentre Biotechnologies; 
Madison, United States of America) was added and subsequently incubated for one hour at 37 °C 
to digest all unligated plasmids. Next, 5 µL of each reaction was used to transform 50 µL of 
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DH5α gold competent E. coli as per the stranded protocol. Transformations were plated out on 
LB agar plates containing 50 µg/mL of spectinomycin with X-gal and IPTG and incubated 
overnight. White colonies containing RVD modules were screened by colony PCR using 
pCR8_F1 and pCR8_R1 oligonucleotides (Table 5.1) as per the standard protocol. Upon plasmid 
purification, the sequence of RVD amino acids was confirmed by sequencing with pCR8_F1 and 
pCR8_R1 primers (Table 5.1).  
 
 
 
 
 
 
Figure 5.3 GoldenGate TALEN assembly reaction one 
GoldenGate assembly of customised TALENs involves the digestion and ligation of specific 
modules containing the repeating domains into specific plasmids. In reaction one, the type 
IIS restriction endonucleases BsaI is used to create unique overhangs to ligate repeat 
modules containing the desired repeat variable diresidues (RVD) in order. This single step 
reaction involves the generation of up to 10 repeats into an intermediate pFUS plasmids. The 
schematic depicts the ligation of repeat domains one and two containing the required RVDs 
into pFUS-A. For repeat domains between positions 11 and 20 of the TALEN a separate 
reaction is used to ligate them into the intermediate pFUS-B vector.  
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5.2.1.b. GoldenGate reaction two 
The second GoldenGate reaction ligates the intermediate pFUS plasmids into the final 
destination vector containing the last module and the fok1 nuclease coding sequence. After 
digestion with Esp3I, the TALE containing the desired RVD sequences will be ligated in-frame 
with the FokI nuclease domain. The final destination vectors are the second generation 
pCS2TAL3-DD or pCS2TAL3-RR (Dahlem et al., 2012) (Figure 5.4).  
 
 
Table 5.1 Primer sequences for screening TALEN construction plasmids. 
Primer 
Sequence 
(5-prime to 3-prime) 
pCR8_F1 TTGATGCCTGGCATGGCCCT 
pCR8_R1 CGAACCGAACAGGCTTATTGT 
TAL_F1 TTGGCGTCGGCAAACAGTGG 
TAL_R2 GGCGACGAGGTGGTCGTTGG 
SeqTALEN_5-1 CATCGCGCGCAATGCACTGAC 
 
 
In the second reaction 150 ng of each pFUS intermediate vector was added to 150 ng of the pLR 
vector containing the last repeating module and the destination vector (either pCS2+TAL3-DD 
or pCS2+TAL3-RR). These were mixed in a 20 µL reaction contacting 1x T4 DNA ligase buffer, 
1 µL of T4 DNA ligase, and 1 µL of Esp3I restriction enzyme. A single incubation series of 
37 °C for 10 minutes, 16 °C for 15 minutes and 37 °C for 15 minutes was followed by enzyme 
inactivation at 80 °C for five minutes. Five microlitres of each reaction was used to transform 
50 µL of DH5α gold competent E. Coli as per the stranded protocol. Transformations were 
plated out on LB agar plates containing 100 µg/mL of Carbenicillin with X-gal and IPTG and 
incubated overnight at 37 °C. 
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The following day four white colonies were picked to be screened by colony PCR using TAL_F1 
and TAL_R primers (Table 5.1). The PCR cycle consisted of 35 cycles of annealing at 55 °C and 
extension step of three minutes. Reactions were run on a 1 % agarose gel to identify correct 
clones to start an overnight culture for plasmid purification. Following purification, the plasmid 
was sequenced using SeqTALEN 5-1 and TAL_R2 (Table 5.1). After sequencing confirmation of 
the correct order of the RVDs, the final plasmids were stored at -20 °C until required for in vitro 
mRNA generation. 
 
 
 
 
 
Figure 5.4 GoldenGate TALEN assembly reaction two 
Reaction one involves the ligation of the desired repeats into the intermediate pFUS plasmids 
(pFUS-A or pFUS-B). In reaction two, the type IIS restriction endonucleases Esp3I is used to 
create unique overhangs to ligate the pFUS plasmids containing the desired repeat variable 
diresidues (RVDs) in order. They are simultaneously ligated into the final destination vector, 
pCS2+TAL3. The schematic depicts the generation of a single TALEN plasmid of containing 16 
repeat domains in-frame with the fok1-RR domain with a poly adenylation signal (pA). The 
pCS2+ backbone allows for in vitro mRNA synthesis of the TALEN through a SP6 promoter 
prior to injection into the zebrafish embryo.   
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5.2.2 Generation of TALEN RNA for microinjection 
The constructed customised TALEN plasmids were used as templates for in vitro mRNA 
transcription. Prior to mRNA synthesis 5 µg of plasmid DNA was linearised with NotI-HF and 
purified. TALEN mRNA was generated using SP6 polymerase and purified using the GenElute 
Mammalian Total RNA Miniprep Kit. Five microlitres of purified mRNA was run on an agarose 
gel to confirm RNA integrity. 
 
5.2.3 Microinjection of TALEN mRNA  
Microinjection into the single cell embryo is the most effective way to transmit the TALEN 
mRNA into the developing embryo. Upon injection the mRNA will be translated by the 
zebrafish’s endogenous translational machinery to produce the TALEN protein. Initially, single 
cell embryos were microinjected with 50 to 150 pg of TALEN mRNA. After microinjections, 
embryos were screened to identify TALEN induced indels. mRNA concentrations showing over 
50 % of embryos survival were used. 
 
5.2.4 Genotyping by restriction digest 
Initially, detection of indels was performed by loss of restriction site within the TALEN spacer 
region. Injected embryos were genotyped by PCR with primers flanking the predicted cut site and 
subsequent restriction digest of the amplified product. It was assumed that loss of the restriction 
site would be caused by the presence of indels from NHEJ repair of the chromosomal break. 
Genomic DNA was extracted from injected embryos as previously described. PCR amplification 
was performed using Megamix-Blue (Microzone Ltd.), 0.6 µM of specific forward and reverse 
oligonucleotides (Table 5.2) were combined with 3 µL of genomic DNA in a 50 µL reaction 
volume. PCR cycles consisted of an initial denaturing step of 95 °C for five minutes and then 40 
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cycles consisting of 95 °C for 30 seconds, 58 °C for 30 seconds for annealing and extension step 
at 72 °C for 15 seconds. A final step of seven minutes at 72 °C completed the PCR cycle. 
Following the PCR, the amplified product was subjected to a restriction digest. Typically, in a 
25 µL reaction, 2.5 µL of restriction enzyme buffer was added with 1 µL of enzyme with 21.5 µL 
of PCR. After incubation 20 µL was run on an agarose gel for visualisation of the production.  
 
 
 
Table 5.2 Sequences of the primers used for genotyping PCR for fdx1b and cyp11a2 null 
alleles by restriction digest 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
Restriction 
enzyme 
fdx1b 
TALEN F GTGTCTATATTAGGAGCATGCT 
Tsp451 
TALEN R TTCCGTAAGCCAAATCCAGC 
cyp11a2 
TALEN F GGTTGGATTCTATGAAAGTGTGA 
DraI 
TALEN R CCCAACCTCATCCAGAAGG 
 
 
 
5.2.5 Genotyping by high resolution melting curve (HRM) analysis 
High resolution melting curve (HRM) analysis is a PCR method which detects indels, including 
single base-pair changes. HRM was performed using two sets of primers designed around the 
TALEN binding region. fdx1b primer pairs HRM1 forward (F) and reverse (R), and HRM2 
forward (F) and reverse (R), gave products of 110 and 74 base-pairs, respectively. cyp11a2 primer 
pairs HRM1 forward (F) and reverse (R), and HRM2 forward (F) and reverse (R), gave products 
of 143 and 90 base-pairs, respectively (Table 5.3).   
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HRM analysis was performed using 7900HT Fast Real-Time PCR system (Applied Biosystems) 
using 384-well block module. Ten microlitre reactions were performed in duplicate containing 1x 
SYBRGreen Master Mix (Applied Biosystems), 150 nM each of the forward and reverse primer 
and 3 µL of genomic DNA. An initial holding stage for enzyme activation at 95 °C for 10 
minutes was followed by 40 cycles of denaturing at 95 °C for 15 seconds and annealing and 
extending at 60 °C for one minute. Finally, the dissociation phase was performed consisting of 
denaturing at 95 °C for 10 seconds, annealing and extension for one minute at 60 °C, high 
resolution melting at 95 °C for 15 seconds with a ramp rate of 1 % and a final annealing step of 
60 °C for 15 seconds. Amplification was confirmed by analysis of cycle threshold (Ct) values. To 
detect indels, changes in the dissociation curve shape and melting temperature (Tm) of PCR 
products were compared to uninjected wild-type controls. 
 
 
 
Table 5.3 PCR Primers used for genotyping for fdx1b and cyp11a2 null alleles by high 
resolution melting curve analysis.  
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
fdx1b 
HRM1 F CTATATTAGGAGCATGCGAGG 
HRM1 R CATGTCAATCTCTTCATCCACC 
fdx1b 
HRM2 F AGGGCACTCTGGCCTGTTC 
HRM2 R CACCATTGGCTCCAGTTTGTC 
cyp11a2 
HRM1 F AGGTTGGATTCTATGAAAGTGTG 
HRM1 R AGGCAGTCCATGCGTCAATG 
cyp11a2 
HRM2 F GAAAGTGTGAACATCATCAAGCC 
HRM2 R CATGCGTCAATGGTGAGTCTC 
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5.2.6 Visualisation mediated background adaptation assessment 
This method assesses the larvae’s ability to adjust their pigmentation in order to adapt to changes 
in the background environment. Five day old larvae were maintained in a dark environment for 
45 minutes. Following this larvae were kept under fluorescent illumination for at least 20 minutes 
to light-adapt. Larvae were sorted on their melanin pigmentation.   
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5.3 Results 
5.3.1 Strategic design of fdx1b and cyp11a2 TALENs 
TALENs were designed using TAL Effector-Nucleotide Targeter 2.0 (Doyle et al., 2012). Several 
parameters were considered in the design of the TALENs including preference for a thymidine 
nucleotide at the five-prime end of the target site (Moscou and Bogdanove, 2009), presence of a 
unique restriction site within the spacer region, a spacer region of 15 to 24 nucleotides and to 
include 15 to 20 RVDs per TALEN (Cermak et al., 2011). Specifically, fdx1b binding TALENs 
were designed to target the conserved motif 1 region which contains the cystine residues essential 
for haem binding and critical for protein function. Secondly, nucleotide similarity with its 
paralogues fdx1 and fdx1l was also considered in the design. Initially, fdx1b targeting TALEN 1 
and TALEN 2 was comprised of 20 and 17 repeating domains, respectively, and separated by a 
24 base-pair spacer that included a Tsp45I enzymatic restriction site for genotyping (Figure 5.5). 
Alternatively, given cyp11a2 has 80 % nucleotide identity to its paralogue cyp11a1 (Parajes et al., 
2013), the cyp11a2 targeting TALENs were designed in the region which was most dissimilar to 
its paralogue gene. A region was chosen including exon 2 which encodes a conserved β-helix. 
Initial design constraints also meant the cyp11a2 targeting TALENs were designed flanking a DraI 
enzymatic restriction site (Figure 5.5B). Given the similarity between cyp11a1 and cyp11a2, and the 
fact they lie adjacent on chromosome 25, it was essential to ensure specific targeting to cyp11a2 
while considering the best chance to generate a non-functional protein.   
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Figure 5.5 Strategic design of TALENs targeting fdx1b and cyp11a2 
TALEN pairs were designed targeting (A) fdx1b and (B) cyp11a2 using TAL Effector-
Nucleotide Targeter (TALE-NT) 2.0 with constraints described by Cermark et. al. (2011).  
The fdx1b and cyp11a2 TALENs were targeted around Tsp451 and DraI restriction sites, 
respectively (bold and underlined). To minimise off-target effects, homology of fdx1b 
TALEN binding sites were compared to the known paralogues, fdx1 and fdx1l. Similarly, the 
targeted cyp11a2 region was compared to cyp11a1. The homologous nucleotides are 
highlighted in grey.  
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5.3.2 Assembly of customised TALEN repeat arrays 
In total, seven TALENs were generated during this project; four specifically targeting fdx1b and 
three targeting cyp11a2. Each TALEN was constructed by two rounds of digestion and ligation. 
The initial round of TALEN assemble ligates the first 10 repeating domains of each TALEN into 
one intermediate plasmid (pFUS-A) and the remaining domains in a second intermediate plasmid 
(pFUS-B). After the ligation and transformation, eight bacterial colonies from each reaction were 
screened by colony PCR (Figure 5.6). Due to the repetitive nature of the repeats, a smear like 
pattern and low molecular weight laddering is expected when screening. A single positive colony 
was amplified, purified and sequenced to confirm the correct order of RVDs for each plasmid 
(Figure 5.6)  
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Figure 5.6 Confirmation of correct ligation of reaction one of the GoldenGate 
TALEN assembly 
 
(A) A representative agarose gel showing the colony PCR from GoldenGate reaction one. 
Reaction A and B of each TALEN generates the intermediate pFUS plasmids (pFUS-A or 
pFUS-B) which will be further ligated in reaction two to generate either TALEN 1 or 
TALEN 2. Eight colonies from each reaction were screened using pCR8_F1 and pCR8_R1 
primers. The presence of a bright band around the expected molecular weight and a smear 
indicates a correct ligation. (B) Representative sequencing trace shows one 34 amino acid 
repeating domain with and NG RVD. Sequencing of each intermediate pFUS plasmid 
confirmed the order of the RVDs (underlined). 
B 
A 
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Following confirmation of the two intermediate pFUS plasmids, the second round of digestion 
and ligation was performed. After transformation of each ligation reaction, three bacterial 
colonies were screened by colony PCR to confirm the final ligation. Similar to reaction one, the 
presence of a smear pattern typically indicates a correct clone (Figure 5.7). Additional sequencing 
of each TALEN was performed as confirmation (Figure 5.8). After validation of the TALEN 
construction, the final plasmids were used to synthesis mRNA for microinjection into single-cell 
zebrafish embryos. 
 
 
 
 
 
Figure 5.7 Confirmation of TALEN assembly from GoldenGate reaction two 
After the second ligation step three bacterial colonies for TALEN 1 and TALEN 2 were 
screened by colony PCR using TAL_F1 and TAL_R2. PCR products were run on a 1 % 
agarose gel. A representative agarose gel is shown from TALEN 1 and TALEN 2 which 
target the fdx1b locus. Due to the repetitive nature of the TALEN, a smear like pattern with 
a low molecular weight laddering typically indicates the presence of the correct clone. A 
single clone was picked for each TALEN to confirm with sequencing.  
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5.3.3 Microinjection and validation of in vivo TALEN activity by PCR 
digest 
Once the correct sequence for each fdx1b and cyp11a2 TALEN plasmids was confirmed, mRNA 
was synthesised in vitro for microinjection. Paired TALEN mRNAs were injected into single-cell 
embryo with a rhodamine tracer as per the standard injection procedure. Initially, 2 nL injections 
were performed at concentrations of 25, 75 and 150 pg/TALEN/embryo. The following day 
embryos were screened for normal development. High levels of RNA toxicity and abnormal 
fdx1b TALEN 1 
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15 16 17 18 19 20 
RVD residue: NN HD NN NI NN NN NN HD NI HD NG HD NG NN NN HD HD NG NN NG 
Target:  G  C  G  A  G  G  G  C  A  C  T  C  T  G  G  C  C  T  G  T 
 
fdx1b TALEN 2 
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15 16 17 
RVD residue: NG NG NN NG HD NI NI NI HD NI HD NI NG NG HD NG HD 
Target:  T  T  G  T  C  A  A  A  C  A  C  A  T  T  C  T  C   
 
 
cyp11a2  TALEN 1 
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15 16 17  
RVD residue: HD NI NI NN HD HD NG NN NI NI NN NI NG NN HD NG NN 
Target:  C  A  A  G  C  C  T  G  A  A  G  A  T  G  C  T  G 
 
cyp11a2  TALEN 2  
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15 16 17 
RVD residue: NN NN NG NN NI NN NG HD NG HD NG NG NG NN NN NI NG  
Target:  G  G  T  G  A  G  T  C  T  C  T  T  T  G  G  A  T 
 
 
Figure 5.8 Sequencing confirmation of the RVD amino acids for each TALEN 
Sequencing of TALENs after assembly confirmed the order of the repeat variable diresidues 
(RVD) at the positions within the repeating domains. Above are the confirmed RVD 
sequences from the first set of TALEN assembly for fdx1b and cyp11a2, with their position 
within the TALEN and the corresponding nucleotide they recognise.  
Chapter Five: Genomic disruption of fdx1b and cyp11a2 with transcription activator-like effector nucleases 
160 
 
development was observed at the highest concentration of mRNA, therefore, these embryos 
were not used for further analysis. At 72 hpf, genomic DNA was extracted from pools of five 
embryos to determine if the TALEN pair was capable generating indels. This was initially 
performed by restriction digest as described by Bedell et al. (2012).  
 
5.3.3.a. Fdx1b genotyping by restriction digest 
For fdx1b genotyping, fdx1b TALEN forward (F) and reverse (R) primers (Table 5.2) were used 
to produce a product of 133 base-pairs. Tsp451 restriction digest of the PCR product produces a 
97 and a 46 nucleotide fragment in the wild-type allele. Restriction digests showed the presence 
of undigested PCR products, suggesting a loss of restriction site from the generation of indels 
(Figure 5.9). No difference in the proportion of embryos positive for indels was observed 
between the different concentrations of mRNA injected. Remaining larvae from positive clutches 
were grown to adults.  
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Figure 5.9 Confirmation of in vivo fdx1b TALEN activity by restriction digest 
Genomic DNA was extracted from pools of fdx1b TALEN injected embryos at 72 hpf. PCR 
with fdx1b TALEN F and R primers produced a product of 133 base-pairs and subsequent 
digest with Tsp451 generated products of 97 and 46 base-pairs. The presence of undigested 
product (133 base-pairs) in the fdx1b TALEN injected indicates loss of the restriction site 
from indels produced from TALEN activity. 
200 
100 
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Once raised to adults (approximately four months), injected zebrafish were outcrossed to wild-
type fish. Ten to 15 pools of four embryos from each adult were genotyped by PCR and 
restriction digest. No embryos were identified to have genomic disruption of the Tsp451 
restriction site (Figure 5.10). Hence, no adult fish were capable of germ-line transmission of 
indels. Following this, the fdx1b targeting TALENs were redesigned based on optimised design 
strategies. 
 
 
5.3.3.b. Cyp11a2 genotyping by restriction digest 
At 72 hpf genomic DNA was extracted from embryos injected with the cyp11a2 TALEN. PCR 
with cyp11a2 TALEN forward (F) and reverse (R) primers (Table 5.2) amplified a 316 base-pair 
region which would produce two fragments of 60 and 256 base-pair upon treatment with DraI 
 
Figure 5.10 Screening F1 generation for fdx1b indels 
Embryos injected with fdx1b TALENs were raised to adults. Upon sexual maturation they 
were out-crossed with wild-type zebrafish. Pools of four F1 generation embryos were 
screened for indels by PCR and restriction digest to determine adults capable of transmitting 
indels to the F1 generation. Image shows a representative agarose gel of the fdx1b F1 screen. 
All embryos tested showed complete digest of the fdx1b PCR product suggesting a wild-type 
genotype. No adults capable of transmitting indels to the F1 generation were identified.   
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restriction enzyme. At all concentrations of RNA tested, there was no loss of restriction site 
(Figure 5.11). This suggests that the first version of cyp11a2 targeting TALEN was not 
introducing chromosomal breaks and subsequently needed to be redesigned. 
 
 
 
 
5.3.4 Redesign of fdx1b and cyp11a2 TALENs 
We observed that the first versions of TALENs targeting fdx1b and cyp11a2 were not inducing 
indels as anticipated and subsequent redesign was required. During the time when the first 
TALENs were synthesised and tested and when the new TALENs were required, several studies 
were published to optimise TALEN efficiency. During July 2012, two individual groups 
demonstrated that the diresidue asparagine histidine (NH) targets the nucleotide guanosine with 
 
Figure 5.11 Determining cyp11a2 TALEN activity in vivo 
Genomic DNA was extracted from pools of cyp11a2 TALEN injected embryos at 48 hpf. 
PCR with cyp11a2 TALEN F and R primers produced a product of 316 nucleotides and 
subsequent digest with DraI generated products of 256 and 60 base-pairs. No undigested 
product (316 base-pairs) was observed in the cyp11a2 TALEN injected indicates suggesting 
there is no cyp11a2 TALEN activity. 
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more specificity and with good affinity than the previously described asparagine asparagine (NN) 
RVD (Cong et al., 2012, Streubel et al., 2012). Additionally, shorter spacer lengths were 
considered based on the newly proposed optimal distance for FokI dimerisation and nuclease 
activity (Ma et al., 2013). Considering these optimal constraints, new TALENs were generated 
targeting fdx1b and cyp11a2. For fdx1b, TALENs were redesigned to encompass a spacer region of 
15 base-pairs and NN diresidues were replaced by NH to increase specificity and affinity. 
Additionally, only cyp11a2 TALEN 2 was remade to incorporate a smaller spacer region of 15 
nucleotides (Figure 5.12). The second generation TALENs were synthesised as described above 
and the RVDs were confirmed by sequencing (Figure 5.13).  
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Figure 5.12 Redesign of fdx1b and cyp11a2 TALENs 
After initial TALENs were unable to generate indels in vivo, both (A) fdx1b and (B) cyp11a2 
TALENs were redesigned. For fdx1b, specificity was checked by comparing TALEN 
targeting sites with paralogues gene fdx1 and fdx1l. For cyp11a2 the homology with its 
paralogue cyp11a1 was assessed. Homologous nucleotides are shown in grey.  
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5.3.5 Development of high resolution melting curve analysis for 
genotyping   
A genotyping method using high resolution melting curve (HRM) analysis was established to 
detect indels. For HRM, real time PCR is performed using SYBRGreen followed by dissociation 
curve analysis. Changes in the dissociation curve represent changes in the melting temperate of 
the PCR product, which corresponds to differences in nucleotide sequence. To determine if the 
in-house real-time PCR machine and software was sensitive enough to detect individual 
fdx1b TALEN 1  
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15  
RVD residue: HD NG NH NH HD HD NG NH NG NG HD HD NI HD HD  
Target:  C  T  G  G  C  C  T  G  T  T  C  C  A  C  C  
 
fdx1b TALEN 2  
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15 16 17 18 19 20 
RVD residue: NG NG NH NG HD NI NI NI HD NI HD NI NG NG HD NG HD HD NG HD 
Target:  T  T  G  T  C  A  A  A  C  A  C  A  T  T  C  T  C  C  T  C 
 
 
cyp11a2  TALEN 2  
 
Position:  1  2  3  4  5  6  7  8  9  10 11 12 13 14 15 16 17 18 19 20 
RVD residue: HD NG NG NG NH NH NI NG NI NI NG NH NI HD HD NG NG HD NH NH   
Target:  C  T  T  T  G  G  A  T  A  A  T  G  A  C  C  T  T  C  G  G 
 
 
Figure 5.13 Sequencing confirmation of RVD of second generation TALENs 
Sequencing of TALENs after assemble confirmed the order of the repeat variable diresidues 
(RVD) at the positions within the TALEN repeating domains. The confirmed RVD 
sequences from the second round of TALEN assembly are shown for fdx1b and cyp11a2 with 
their position within the TALEN and the corresponding nucleotide sequence they recognise. 
Two new TALENs targeting fdx1b were synthesised. Only TALEN 2 was redesigned for 
cyp11a2 and it was paired with TALEN 1 from the first TALEN assembly.  
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nucleotide changes, a trial HRM was performed using cyp11a2 cDNA extracted from AB and 
Tubingen. From previous Cyp11a2 studies, a SNP was identified in the AB wild-type strain which 
was not present in the Tubingen strain (Chapter 4.0). PCR amplification of 143 nucleotides using 
cyp11a2 HRM1 forward and revere primers confirm specificity by amplification of a single 
dissociation peak when using these primers. Additionally, changes in the dissociation curve and 
subsequent Tm between the two zebrafish strains confirmed the method was sensitive enough to 
detect single base-pair differences (data not shown). All subsequent detection of indels was 
carried out using this method.  
 
5.3.6 Microinjection and validation of in vivo TALEN activity by HRM  
As per the previous TALEN mRNA injections, concentrations of 25 and 75 pg of each TALEN 
mRNA per embryo was microinjected into single cell embryos. After 48 hpf, genomic DNA was 
extracted from pools of five embryos and used for HRM analysis. Two different primers pairs 
were used for each pool of genomic DNA and each sample was performed in duplicate.  
 
5.3.6.a. Confirmation of TALEN induced fdx1b indels  
After fdx1b TALENs were injected, embryos were screened by HRM to determine if the newly 
designed TALENs were capable of generating indels. Genomic DNA was screened using fdx1b 
HRM1 primers and confirmed with HRM2 primers (Table 5.3). A change in the dissociation 
curve was observed in embryos injected with both concentrations of fdx1b TALENs when 
compared with uninjected embryos (Figure 5.14).  
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5.3.6.b. Confirmation of TALEN induced cyp11a2 indels  
HRM was used to determine if the redesigned cyp11a2 TALENs were capable of producing indels 
in the targeted genomic region. Genomic DNA was extracted from pools of injected embryos 
which were then screened for indels by HRM using cyp11a2 HRM1 (Table 5.3). Dissociation 
curves showed two peaks suggesting the presence of indels in the injected embryos. This was in 
contrast to uninjected embryos where only a single peak was observed. Confirmation of changes 
in the dissociation curve was confirmed by a second set of cyp11a2 HRM2 primers.  
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5.3.7 Identification of heritable mutations  
After TALENs were confirmed to successfully induce indels, positive clutches were grown to 
adults. It was anticipated that each adult zebrafish would be a mosaic of different indels as the 
TALEN would cut and repair differently in each cell. Once sexual maturity was reached 
 
 
Figure 5.14 HRM dissociation curves of TALEN injected embryos 
A representative high resolution melting (HRM) dissociation curve of embryos injected with 
TALENs targeting fdx1b. A 110 base-pair fragment of fdx1b was amplified with SybrGreen 
and subjected to dissociation curve analysis. In uninjected embryos a single peak was 
observed suggesting PCR amplification of a single product. In TALEN injected embryos 
two peaks were observed, one corresponding to the wild-type product and a second smaller 
product which is likely the result of generated indels (arrow). The presence of two peaks 
suggests disruption of the wild-type allele. 
TALEN injected uninjected
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(approximately four months) injected adult fish were outcrossed with wild-type fish. Individual 
embryos from these crosses were screened by HRM at 72 hpf to identify adults capable of 
germ-line transmission of indels. F1 generation embryos from positive founder adults were 
grown to adulthood. Adults not capable of producing offspring with disrupted alleles were 
sacrificed.  
 
5.3.7.a. Fdx1b heritable indels 
Using the strategy outlined above, four (from 15 screened) adult zebrafish which were previously 
injected with TALENs targeting fdx1b were capable of germ-line transmission (26.6 %). To 
confirm that the observed changes in the dissociation curve correlated with disruption of fdx1b 
allele an individual embryo was sequenced. A change in sequencing trace was observed within the 
spacer region flanked by the TALENs (Figure 5.15) Clutches of embryos from positive fdx1b 
TALEN injected founder zebrafish were raised (F1 generation).   
 
5.3.7.b. Cyp11a2 heritable indels 
To determine if adults previously injected with cyp11a2 targeting TALENs were capable of 
transmitting indels to the next generation, they were out-crossed with wild-type zebrafish and the 
embryos were screened by HRM. Four female adults were identified (from 22 screened) as 
capable of producing offspring with changes in the cyp11a2 genomic region (18 %). To confirm 
the HRM findings, an individual embryo was sequenced. Heterozygous sequencing traces were 
identified starting from within in the spacer region flanked by the TALENs (Figure 5.15). 
Clutches of larvae from positive founders were raised to adults (F1 generation).   
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5.3.8 Outcrossing and establishing lines harbouring indels 
Due to the mosaic nature of the TALEN injected generation each individual founder fish is 
capable of producing offspring with different indels. Additionally, each individual founder would 
produce a different percentage of off-spring harbouring indels depending on how proficient the 
 
Figure 5.15 Sequencing confirmation of fdx1b and cyp11a2 TALEN induced deletion 
To confirm the presence of mutations in the F1 generation, individual embryos which 
showed a positive or negative peak for indels (A) fdx1b and (B) cyp11a2 was sequenced. The 
arrow indicates the repair site within the spacer region where the TALEN was designed. 
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original TALEN cut and repair was. Clutches from individual founders were grown to adults. 
Heterozygote adults from the F1 generation were identified by extracting genomic DNA from a 
fin clip and performing HRM analysis. 
 
5.3.8.a. Establishing fdx1b null lines 
Fin clipping and subsequent HRM analysis of the F1 generation adults identified 12 fish which 
were heterozygous for individual mutations within fdx1b. To identify the exact indels fdx1b 
genomic DNA was amplified by PCR using fdx1b TALEN forward and reverse primers (Table 
5.2) and six were subjected to sequencing (Figure 5.16). From the six heterozygotes sequenced, 
four different mutations were identified. Line one and two showed the same two base-pair 
deletion and lines four and five had the same 12 base-pair deletion. Line three and line six had 
unique indels. Once the heterozygote F1 adults were identified and confirmed, lines three, four 
and five were maintained by outcrossing to wild-types zebrafish and growing up the offspring (F2 
generation).    
 
5.3.8.b. Establishing Cyp11a2 null lines 
The F1 generation, previously confirmed to contain indels within cyp11a2, were raised to adults 
and subjected to fin clipping and HRM analysis to identify those heterozygote adults. From 43 
adults screened, no fish harbouring cyp11a2 indels was identified. Additionally, only a single 
cyp11a2 founder fish had survived.  
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5.3.9 Genotyping and characterisation of generation fdx1b F2 TALEN 
lines 
After identification of individual heterozygote carrying genomic disruptions in fdx1b, lines three, 
four and five were maintained as heterozygotes for future experiments. These F1 adults were 
A 
   
 
 
 
 
B 
 
  CTCTGGCCTGTTCCACCTGTCACTTGATATTTGAGGAGAATGTGTTTGACAAAC 
1 CTCTGGCCTGTTCC•CCTGTC•CTTGATATTTGAGGAGAATGTGTTTGACAAAC Δ2 
2 CTCTGGCCTGTTCC•CCTGTC•CTTGATATTTGAGGAGAATGTGTTTGACAAAC Δ2 
3 CTCTGGCCTGTTCCAC•••••••TTGTCATTTGAGGAGAATGTGTTTGACAAAC Δ7(Δ12 + 5) 
4 CTCTGGCCTGTTCCACC••••••••••••TTTGAGGAGAATGTGTTTGACAAAC Δ12 
5 CTCTGGCCTGTTCCACC••••••••••••TTTGAGGAGAATGTGTTTGACAAAC Δ12 
6 CTCTGGCCTGTTCCACCTGTC•••••••ATTTGAGGAGAATGTGTTTGACAAAC Δ7 
 
 
Figure 5.16 Sequencing confirmation of F1 heterozygotes for mutations in fdx1b 
Twelve F1 generation adults that were heterozygote for mutations in fdx1b were initially 
identified by high resolution melting curve analysis from fin clips. (A) PCR of the region of 
the where the TALEN was targeted shows the presence of two bands in some fish. 
(B) Sequencing of six lines identify the precise mutations. Outcrossing of these F1 fish was 
performed to establish the F2 generation harbouring the same mutation.  
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outcrossed to wild-type fish and individual F2 clutches harbouring the same indel were raised to 
adults. It was anticipated that indels would be inherited by traditional Mendelian inheritance and 
therefore, 50 % of the F2 generation would be heterozygous. To identify heterozygotes, adult F2 
zebrafish were fin clipped and genotyped by regular PCR. Heterozygotes were identified by PCR 
using TALEN forward and reverse primers (Table 5.2). Heterozygotes were identified and kept 
for future experiments.  
 
 
 
 
 
 
Figure 5.17 Identification of fdx1b null alleles by PCR of F2 generation 
An F2 generation was established for line three, four and five. To identify heterozygous fish, 
adults were screened by PCR from genomic DNA extracted from fin clips. A representative 
agarose gel from screening line three and line five is shown. Wild-type genomic DNA was 
used as a positive PCR control.  
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5.3.10 Preliminary characterisation of fdx1b null zebrafish embryos 
Once F2 heterozygote adults had been identified from each line, they were in-crossed to generate 
fdx1b knockouts. Preliminary data suggest fdx1b null larvae are morphologically indistinguishable 
from wild-type siblings during the first five days of development. When subjected to visually 
mediated background adaptation assessment, 38 of 132 larvae (28.8 %) showed a darker 
appearance after 20 minutes. Genotyping of larva that had pigmentation adaption and no 
pigmentation adaptation showed fdx1b genetic disruption in five out of six larvae without a 
pigmentation change. Only the wild-type or heterozygous allele was present in larva capable of 
background adaption. Larvae were sorted based on their ability to adjust to lighter background 
environments and their steroid hormones were analysed at five days. Preliminary results (n = 1) 
showed fdx1b mutants have cortisol levels of 0.76 pg per larva while their wild-type siblings have 
12.96 pg per larva (Figure 5.18). 
 
Chapter Five: Genomic disruption of fdx1b and cyp11a2 with transcription activator-like effector nucleases 
176 
 
 
  
 
 
Figure 5.18 Phenotypic characterisation of fdx1b null larvae (line five) 
(A) Visual mediated adaption assessment shows fdx1b mutant larvae (Δ fdx1b) are unable to 
contract their melanin granules when exposed to a bright environment when compared with 
wild-type siblings. (B) Phenotype/genotype correlation between larvae showing pigment 
adjustment and no pigment adjustment during visual mediated adaptation. Larvae capable of 
pigmentation adjustment showed either wild-type or heterozygous genotype. Five out of six 
larva with no pigment adjustment were homozygous for a 12 base-pair deletion in fdx1b. Line 
five heterozygotes produce a higher molecular weight band as a result of PCR amplification 
of this locus.  (C) At 120 hpf cortisol concentrations of fdx1b null larvae were 0.76 pg per 
larvae compared to 12.96 pg per larva for their wild-type siblings (n =1). 
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5.4 Discussion and prospective studies 
5.4.1 Using TALENs as an alternative to traditional morpholino 
knockdown studies 
Zebrafish lack the traditional genome knockout methodologies which have been widely used in 
mammalian model organisms since 1989 (Capecchi, 1989). Therefore, gene functional studies in 
the zebrafish have typically relied on antisense morpholino oligonucleotides as an effective, gene-
specific knockdown technology. Morpholinos target the endogenous mRNA and disrupt 
translation or splicing to generate an aberrant protein. However, morpholinos allow for transient 
knockdown only. As the cells divide and the embryo grows, the morpholino becomes diluted and 
used up which allows for functional endogenous expression to be restored during development. 
Additionally, morpholino oligonucleotides are known to be toxic and bind to unstipulated RNAs, 
resulting in non-specific phenotypes (Eisen and Smith, 2008). Common non-specific phenotypes 
include developmental delay, defects in organ asymmetry and pericardial oedema, which are often 
attributed to loss off a specific gene. TALENs are a new genome editing method that allows for 
targeted genetic disruption. In comparison to the traditional morpholino methods, this 
methodology is considered a more reliable and feasible option to determine gene function in 
zebrafish (Schulte-Merker and Stainier, 2014). Generating knockouts omits many of the 
limitations of morpholino knockdowns and should be considered as a method to accurately 
determine the physiological importance of genes of interest in zebrafish. 
 
5.4.2 Designing and optimisation of TALENs targeting fdx1b and 
cyp11a2  
During the TALEN design process it was necessary to consider several features to give the 
highest chance of generating null alleles while limiting off-target effects. For each targeted gene, 
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design considerations included; spacer sequence length, number of repeating domains containing 
the RVD, target site similarity with other genes in the genome, and the inclusion of a unique 
restriction site around the predicted cut site for genotyping.   
 
Given the similarity to its paralogue gene, cyp11a1, target site specificity was of particular 
importance when designing cyp11a2 targeting TALENs. It was suggested that a difference of two 
base-pairs within the targeting sequence was enough to lose TALEN binding ability (Cade et al., 
2012). Given the high homology, a region which was most dissimilar between the two genes was 
chosen to design the TALENs. When compared to cyp11a1 sequence, the successful second 
cyp11a2 TALEN pair had mismatches of 2/17 and 7/20 nucleotides for TALEN 1 and 
TALEN 2, respectively. Given previous studies, these mismatches would allow sufficient 
targeting to cyp11a2, without disrupting cyp11a1.  
 
Optimisation of the spacer region length proved critical for efficient FokI dimerisation and 
subsequent generation of chromosomal breaks. Initial studies reported TALEN induced double 
stranded breaks with spacer regions ranging from 12 to 31 base-pairs (Cermak et al., 2011, Li et 
al., 2011, Miller et al., 2011, Mussolino et al., 2011). Given this, our first generation TALENs 
were synthesised with 24 and 26 spacers regions for fdx1b and cyp11a2, respectively. Neither the 
fdx1b nor cyp11a2 TALENs were able to conclusively show in vivo activity. However, a recent 
study by Ma et al. (2013) reported increased TALEN efficiency in zebrafish embryos when the 
spacer length was between 13 and 19 base-pairs. In the second generation TALENs, the spacer 
regions were shortened to 15 nucleotides for both genes. Subsequently, the newly designed 
TALENs successfully produced chromosomal breaks and subsequent indels within the spacer 
region and consequently disrupted the fdx1b or cyp11a2 coding sequence. 
 
Chapter Five: Genomic disruption of fdx1b and cyp11a2 with transcription activator-like effector nucleases 
179 
 
5.4.3 Optimisation of high resolution melting curve analysis for 
genotyping 
Initial detection of indels relied on the loss of restriction site within the spacer region between 
the two TALENs. However, there are several limitations of genotyping by loss of restriction site. 
Firstly, TALEN design is restricted to flanking locations which harbour a unique restriction site 
in the spacer region. This eliminates TALEN targeting sites which do not fit such requirements. 
Additionally, relying on a loss of restriction site can lead to false negatives being detected if indels 
occur outside of the restriction enzymes recognition domain. Furthermore, detection of false 
positives may also occur due to incomplete digestion of the PCR product. It is likely that false 
positives were detected in the initial screening of the fdx1b targeting TALENs, and would explain 
why no indels were observed in the F1 generation.  
 
Along with optimising TALEN design, new methods to successfully detect indels were also 
established. Apart from restriction digest analysis, other methods including HRM analysis 
(Dahlem et al., 2012), PCR based approaches (Yu et al., 2014), hetero-duplex analysis 
(SURVEYOR assay) (Guschin et al., 2010) or LacZ recovery/disruption assay (Christian et al., 
2010) have all been applied as methods to test for TALEN activity. As an alternative to the loss 
of restriction digest method, HRM analysis was used to detect indels for the second round of 
TALEN injection. Using specific oligonucleotides to generate small PCR products (<300 base-
pairs), single nucleotide mutations can be detected by HRM (Reed and Wittwer, 2004). In the 
initial trial experiments, the detection of a SNP from different zebrafish strains was possible by 
observing changes in dissociation curve. Therefore, HRM provided a more robust and sensitive 
method in which to screen TALEN injected zebrafish. Despite the detection of false negatives 
when using HRM (data not shown), HRM permits a large number of injected embryos to be 
screened for indels in a single efficient reaction (Dahlem et al., 2012). Furthermore, HRM allows 
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TALENs to be targeted more specifically within the desired locus, as it does not rely on the 
presence of a unique restriction site within the spacer region. By implementing the HRM analysis, 
I was able to successfully detect different indels within fdx1b and cyp11a2, thus confirming the 
activity of our TALENs in vivo. 
 
5.4.4 Generating zebrafish Fdx1b null alleles  
To complement our morpholino knockdown studies, TALENs were designed and assembled to 
successfully engineer genomic disruption of fdx1b. Furthermore, through screening and 
out-crossing different lines containing heterozygote alleles were established. Line four and five 
have the same 12 base-pair deletion. This produces an in-frame deletion of a conserved cysteine 
residue required for stabilising the Fe/S cluster. It is predicted this deletion would generate a 
non-functional protein as mutations of any cysteine residues have proven critical for ferredoxin 
activity in vivo (Grinberg et al., 2000). Line three contains a seven base-pair indel generating a 
frame-shift. The mutation is predicted to generate a truncated 135 amino acid pre-protein, where 
there is an additional 34 amino acids after Lys101. This protein would lack conserved motifs two 
and three required for functional activity.  
 
5.4.5 Preliminary data suggests fdx1b knockouts lack glucocorticoid 
production 
In-crossing fdx1b heterozygotes resulted in the generation of fdx1b knockout embryos. 
Preliminary characterisation of the fdx1b knockouts showed no obvious morphological 
differences between fdx1b deficient embryos and wild-type siblings. This is in contrast to our 
fdx1b morpholino studies, which suggest loss of fdx1b gives a morphological phenotype 
consistent with glucocorticoid resistance and adrenal insufficiency (Chapter 3.0). However, 
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preliminary steroid hormone analysis suggests fdx1b knockouts have a cortisol deficiency. This 
biochemical phenotype is consistent with the knockdown phenotype and suggests the 
morphological characteristics are, at least in part, due to non-specific morpholino effects. As 
zebrafish genetic disrupting methods become more prevalent, there are several cases where 
knockout studies do not recapitulate morpholino knockdown data (Law and Sargent, 2014, van 
Impel et al., 2014), and highlight the importance in distinguishing specific from non-specific 
phenotypes in morpholino studies (Schulte-Merker and Stainier, 2014). Further characterisation 
of the of fdx1b knockout larvae is required to determine the physiological importance of fdx1b 
during development.  
 
When five day old larvae were subjected to lighter environments, fdx1b knockout embryos were 
darker in appearance compared to their wild-type siblings. Zebrafish larvae are capable of 
background adaptation, which involves changing their colour to blend into the surrounding 
environment. This rapid and reversible physiological process is functional from 96 hpf and 
involves the distribution or aggregation of melanin within the melanophore (Logan et al., 2006). 
Larvae were separated based on their melanosome pigmentation and collected at 120 hpf for 
steroid analysis. Cortisol concentration in fdx1b knockouts was decreased compared to siblings. 
However, there was some cortisol detected, which may be from false fdx1b knockouts being 
present. Further characterisation of the fdx1b knockout line is required to confirm the phenotype-
genotype correlation.  
 
The fdx1b larvae were darker than wild-type siblings from dispersed melanin pigment in the 
melanosomes. This hyperpigmentation phenotype is likely to be caused by the up-regulation of 
the HPI axis, and subsequent increased expression of pomc. In humans, the POMC protein is 
cleaved to give rise to multiple proteins including, ACTH which increases cortisol production, 
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and α-melanocyte-stimulating hormone (MSH-α), which regulates the production of melanin 
(Figure 5.19). Hyperpigmentation in humans is often associated with a number of diseases 
including adrenal insufficiency and excessive ACTH production (Arlt and Allolio, 2003). In a 
similar way, this pathway has previously been implicated in regulating the camouflage behaviour 
of zebrafish (Wagle et al., 2011, Ziv et al., 2013) and is consistent with larvae deficient in the 
glucocorticoid receptor (Ziv et al., 2013). Although further characterisation of the fdx1b mutant 
lines is required, it is hypothesised the observed decrease in cortisol causes an up-regulation of 
the HPI axis and results in hyperpigmentation. 
 
 
 
 
 
 
 
 
Figure 5.19 Cleavage of pro-opimelanocortin (POMC) protein  
Pro-opiomelanocortin (POMC) is a precursor polypeptide which undergoes cleavage to 
adrenocorticotropic hormone (ATCH), which stimulates cortisol production and melanocyte-
stimulating hormones (MSH), which stimulate the production and release of melanin by 
melanocytes in the skin.  
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5.4.6 Establishing cyp11a2 null lines 
Despite being able to successful to show gene disruption of cyp11a2 and identify founder fish 
capable of transmitting these indels to their offspring, no heterozygote F1 adults were identified. 
The reason for this result is currently under investigation. It is possible that cyp11a2 heterozygotes 
have decreased viability compared to wild-types. CYP11A1 mutations in humans have been 
described patients with adrenal insufficiency and disordered sex development (Hiort et al., 2005, 
Kandari et al., 2006, Katsumata et al., 2002, Kim et al., 2008, Parajes et al., 2012, Parajes et al., 
2011, Rubtsov et al., 2009, Sahakitrungruang et al., 2011, Tajima et al., 2001); however, humans 
who are heterozygotes are reported as healthy and able to reproduce (Miller and Auchus, 2011). 
Therefore, it is unlikely heterozygote cyp11a2 fish show a phenotype; however, further 
characterisation of heterozygous adult zebrafish would be required. Additionally, it is unclear if 
the cyp11a2 TALENs are targeting the highly homologous paralogue cyp11a1. Currently, the off-
target effects generated by our TALENs are unknown. Typically, off-targets mutations can be 
eliminated by out-crossing the founder to wild-types for several generations. Given cyp11a1 and 
cyp11a2 lie adjacent on chromosome 25 it is unlikely these mutations can be eliminated as they are 
closely linked. Embryos recently re-injected with the cyp11a2 targeting TALENs are currently 
being raised and survival rates are being monitored to establish possible off-target effects of the 
cyp11a2 TALENs.  
 
5.5 Conclusions 
In summary, this study has successfully established the use of TALENs for the genome editing of 
zebrafish within our laboratory. Specifically, TALENs were designed and assembled to 
successfully generate chromosomal breaks and subsequent indels which caused genetic disruption 
to the endogenous fdx1b and cyp11a2 genes. The successful generation and future development of 
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the fdx1b and cyp11a2 null alleles will serve as useful tools for investigating the mitochondrial 
redox regulation of steroidogenesis.  
 
In the case of fdx1b, heritable mutations were generated and several lines which contain 
disruption in the fdx1b gene were established. Zebrafish are the only teleost to retain duplicated 
ferredoxins. Due to this uniqueness, I was able to disrupt redox transfer in the late larvae without 
disrupting early development. Over 30 mutants of ferredoxin have been described and explored 
via in vitro assays (Grinberg et al., 2000), however, no in vivo models have been established. The 
generation of the fdx1b null zebrafish is the first ferredoxin in vivo knockout model system and 
preliminary results suggest a direct impact on steroid hormone synthesis. The further 
characterisation of these lines and its use in future studies will allow for direct in vivo analysis of 
redox regulation of steroidogenesis and its impact.  
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 CHARACTERISING THE ROLE OF MITOCHONDRIAL CYP11C1  6.0
6.1 Introduction 
6.1.1 11β-steroid hydroxylase in zebrafish 
Like most teleosts, zebrafish have a single CYP11B homologue, termed cyp11c1. Teleost Cyp11c1 
has conserved motifs required for Cyp11b activity including binding sites for steroids, oxygen, 
and haem (Kusakabe et al., 2002, Wang and Orban, 2007). Specifically, zebrafish cyp11c1 is 
located on chromosome 16 and is expressed as a maternal transcript and maintained throughout 
development (Alsop and Vijayan, 2008). To date, defining the physiological importance of 
Cyp11c1 in teleosts has primarily focused on its role in androgen synthesis. In the testis, Cyp11c1 
hydroxylates testosterone to produce 11-hydroxytestosterone. Subsequent metabolism of 
11-hydroxytestosterone by 11β-Hsd2 generates 11-ketotestosterone, the primary androgen in 
many teleost species including zebrafish (de Waal et al., 2008). The function of Cyp11c1 in 
androgen production has important roles in gonadal differentiation and development (Wang and 
Orban, 2007). Microarray analysis confirmed cyp11c1 is highly expressed in the testis (Sreenivasan 
et al., 2008) and is specifically localised to the androgen producing Leydig cells. Some studies 
have concluded that cyp11c1 is not expressed in the zebrafish ovary (Siegfried and Nusslein-
Volhard, 2008) while others have detected cyp11c1 transcripts by RT-PCR but not in situ 
hybridisation (Wang and Orban, 2007); suggesting cyp11c1 has low levels of expression in the 
ovary.  
 
Cortisol is the primary glucocorticoid in teleosts and requires the 11β-hydroxylation of 
11-deoxycorticol for its production. In zebrafish, cyp11c1 catalyses this final step in cortisol 
synthesis. Expression of cyp11c1 precedes the increase in cortisol levels observed after the 
hatching period (Alsop and Vijayan, 2009), and a study published in 2013 showed morpholino 
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knockdown of cyp11c1 results in 45 % cortisol decrease at 120 hpf (Wilson et al., 2013). However, 
the precise catalytic ability of teleost cyp11c1 remains unknown. Aldosterone is the main 
mineralocorticoid in mammals, but often remains undetected in fish (Bern, 1967, Sandor et al., 
1966), leading to the hypothesis cortisol has both mineralocorticoid and glucocorticoid actions 
(McCormick et al., 2008). Conversely, deoxycorticosterone has been detected in several teleost 
species, suggesting it may be the active mineralocorticoid (Bury and Sturm, 2007, Gilmour, 2005, 
Prunet et al., 2006, Sturm et al., 2005). Whether zebrafish Cyp11c1 has dual 11- and 18- 
hydroxylase and 18-oxidase activity required for aldosterone production remains undetermined. 
Further studies are necessary to determine the contribution of mineralocorticoids and/or 
glucocorticoids in electrolyte homeostasis and energy metabolism in fish. 
 
6.1.2 CRISPR/Cas9 genome editing 
Clustered regularly interspaced short palindromic repeats (CRISPRs) and the CRISPR-associated 
Cas9 uclease, function together as part of an adaptive immune system in bacteria and Achaea 
(Jiang et al., 2013). Naturally, the CRISPR RNA contains sequences complementary to invading 
viral DNA which it recognises and binds to. A second trans-activating RNA guides the Cas9 
nuclease to the CRISPR RNA to direct cleavage of the viral DNA. Therefore, the CRISPR and 
trans-activating RNAs, in combination with the Cas9 protein, acts as an antiviral mechanism for 
the microbe, by introducing DNA breaks in the virus’s genome (Barrangou et al., 2007). This 
CRISPR/Cas9 system has recently been amended for genome editing purposes and is used by 
many laboratories for genomic manipulation in a variety of model systems (Sander and Joung, 
2014).  
 
For genome editing, the Cas9 is guided to the target DNA by a short guide RNA combining both 
the CRISPR RNA and trans-activating RNA sequences. An additional component of the Cas9 
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system is the genomic protospacer-adjacent motif (PAM) located at the three-prime end of the 
DNA target site. This consensus is recognised by the Cas9 protein and signals nuclease activity 
exactly three nucleotides upstream. Although the precise PAM is specific for each Cas9 
orthologue, the most commonly used Cas9 nuclease is from Streptococcus pyogenes which recognises 
the consensus of a single amino acid followed by two guanosine nucleotides (5’-NGG) (Figure 
6.1) (Esvelt et al., 2013, Hsu et al., 2014). By designing specific guide RNAs, the Cas9 nuclease 
can be directed to specific loci to generate chromosomal breaks. In comparison to TALEN 
assembly methods (Chapter 5.0), the desired sequence for the guide can be ordered as a pair of 
oligonucleotides and cloned into a guide RNA expressing plasmid. Due to the quick assembly 
and efficient nuclease activity, the CRISPR/Cas9 system has accelerated the generation of 
transgenic animal models and is becoming the method of choice for genome editing for 
researchers (Gaj et al., 2013).  
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6.1.3 Rational for work 
The zebrafish mitochondrial Cyp11c1 enzyme has critical roles in glucocorticoid and androgen 
production through its 11β-hydroxylase activity. Additionally, its activity is likely to be regulated 
by electron transfer via the mitochondrial redox proteins Fdx1 or Fdx1b. To fully elucidate the 
role of this this enzyme, this study aimed to systematically characterise cyp11c1 in zebrafish. 
Secondly, it aimed to establish the CRISPR/Cas9 methodology to generate cyp11c1 loss-of-
function alleles for future studies. Finally, in order to investigate the role of androgen production 
during zebrafish development this projected aimed to develop a specific and sensitive 
LC-MS/MS methodology to detect zebrafish androgens.  
  
 
Figure 6.1 CRISPR/Cas9 system for genomic engineering 
The Cas9 nuclease is targeted to the genomic loci by a specifically designed guide RNA. The 
guide RNA contains a 20 nucleotide complementary sequence linked to the trans-activating 
RNA sequence which recruits the Cas9 nuclease. Through recognition of the protospacer-
adjacent motif (PAM), 5’ NGG, Cas9 cleaves both strands of DNA three nucleotides 
upstream of this consensus motif (red arrow).  
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6.2 Methodology 
6.2.1 PCR amplification and cloning of cyp11c1 
Specific RT-PCR primers were designed based on the ENSEMBL (Zv9) cyp11c1 sequence 
(ENSDART00000061572). A 1,892 nucleotide fragment containing the cyp11c1 coding sequence 
was amplified with high fidelity Taq polymerase using cyp11c1-F and cyp11c1-XR oligonucleotides 
(Table 6.1) and cDNA from the testis of an adult male zebrafish. After confirmation of the PCR 
product size by agarose gel electrophoresis, the PCR was purified and sequenced. This PCR 
fragment was cloned into pGEMT-easy vector for plasmid amplification and subsequent 
sub-cloning.  
 
 
Table 6.1 Oligonucleotides for the RT-PCR amplification of 11β-hydroxylase from 
zebrafish cDNA 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
cyp11c1 cyp11c1-F CAACAGACAGAGATGGTGA 
 cyp11c1-XRa GAACTCCAGAAGAAGCACAG 
a Reverse oligonucleotides contain a stop codon 
 
 
6.2.2 Alignment and phylogenetic analysis of zebrafish Cyp11c1 
Our Cyp11c1 protein sequence was compared to human (Homo sapiens) CYP11B1 
(ENST00000292427) and CYP11B2 (ENST00000323110) protein sequences, stickleback 
(Gasterosteus aculeatus; ENSGACG00000011657), tilapia (Oreochromis niloticus; 
ENSONIG00000006462) and mouse (Mus musculus; ENSMUSG00000022589). Alignment and 
homology analysis was performed using ClustalW2 software as previously described. 
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6.2.3 In silico KOZAC sequence analysis 
The KOZAC consensus sequence is found on eukaryotic mRNA and is recognised by the 
ribosome as the transcriptional start site. In silico KOZAC sequence prediction was performed 
using the ATGpr program (URL: http://www.hri.co.jp/atgpr) (Salamov et al., 1998), using the 
full-length ENSEMBL cyp11c1 cDNA annotated sequence. 
 
6.2.4 Cloning of additional zebrafish cyp11c1 constructs for in vitro 
studies 
Zebrafish cyp11c1 cDNA was directionally cloned into the pcDNA6-V5 vector which permits 
expression in mammalian cells through the CMV promoter. As the transcription initiation site of 
cyp11c1 was unclear, four separate in-frame ATG transcription initiation sites were used to test 
functional activity. All transcripts were amplified using high fidelity Taq polymerase, using 
different forward primers (Table 6.2) and the cyp11c1-XR reverse oligonucleotide (Table 6.1). The 
full-length 1,892 nucleotide cyp11c1-pGEMTeasy plasmid was used as a template. After 
confirmation of each PCR product size by agarose gel electrophoresis, the PCRs were treated 
with DpnI restriction enzyme to remove residual plasmid template, purified and sequenced. The 
PCR fragments were initially cloned into pGEMT-easy vector for plasmid amplification and 
subsequent sub-cloning.  
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Table 6.2 Additional oligonucleotides used for RT-PCR amplification of cyp11c1 from 
different ATG start sites 
 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
cyp11c1-ATG2 F CAGGATGGTTCGCCCCGA 
cyp11c1-ATG3 F ATGTTCACCGGCAGCAAACAC 
cyp11c1-ATG4 F ATGTTCTTCTTCTGCGCTG 
 
 
All cyp11c1-pGEMTeasy plasmids (i.e. full-length cyp11c1 and cyp11c1-ATG2, cyp11c1-ATG3 and 
cyp11c1-ATG4 constructs) were ligated into pcDNA6 via EcoRI restriction sites. After 
transformation, direction of the inserts was confirmed by colony PCR using T7 (Table 2.1) and 
cyp11c1 e5/6 R primers (Table 6.3). Plasmids in the correct orientation were amplified and 
purified for subsequent experiments.  
 
6.2.5 Characterisation of Cyp11c1 spatial and temporal expression  
The spatial and temporal expression of cyp11c1 was characterised by RT-PCR. A 107 base-pair 
fragment of cyp11c1 cDNA was amplified as previously described using forward (e5 F) and 
reverse (e5/6 R) primers (Table 6.3). The following PCR conditions were used: initial 
denaturation at 95 °C for five minutes, followed by 40 cycles at 95 °C for 30 seconds, 56 °C for 
15 seconds and 72 °C for 60 seconds; and a final incubation at 72 °C for seven minutes. As a 
control for cDNA quality and equal loading a 102 nucleotide fragment of the β-actin gene was 
amplified using e4F and e4R primers (Table 3.3). 
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Table 6.3 Primer sequences used for RT-PCR expression analysis of cyp11c1 
Gene Primer 
Sequence 
(5-prime to 3-prime) 
cyp11c1 
e5 F GATGAACCTGCTGCGCTTCT 
e5/6 R AGCCCAGGTGCTCTCTGTAT 
 
 
6.2.6 Generation of cyp11c1 short guide RNA plasmids  
In order to facilitate Cas9 directed genomic disruption, plasmids for transcribing specific guide 
RNAs were generated. Two individual guides targeting cyp11c1 were synthesised and tested during 
the optimisation of the CRISPR/Cas9 methodology. For each guide, two specific 
oligonucleotides were designed (Table 6.4). Each pair of oligonucleotides was hybridised by 
combining 10 µM of oligonucleotide one and two with 1x Buffer 4 (NEB) in 20 µL of DEPC 
water. The oligonucleotide mix was incubated at 95 °C for ten minutes and cooled to room 
temperature to permit hybridisation. Hybridisation creates overhangs compatible with cloning 
into the BsaI linearised RNA guide synthesis vector, DR274 (Figure 6.2). 
 
 
Table 6.4 Oligonucleotide sequences to generate cyp11c1 genomic targeting guide RNAs 
Genomic target sequence Name 
Sequence 
(5-prime to 3-prime) 
GGCGCGTAACCCTGATGTGC 
Oligo1 TAGGCGCGTAACCCTGATGTGC 
Oligo2 AAACGCACATCAGGGTTACGCG 
GGCGTCTGGAGACCCTCTGA 
Oligo1 TAGGCGTCTGGAGACCCTCTGA 
Oligo2 AAACTCAGAGGGTCTCCAGACG 
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The hybridised oligonucleotides and digested DR274 were ligated together to generate the guide 
RNA template. Seven microlitres of hybridised oligonucleotides and 50 ng of digested DR274 
were combined in a 10 µL reaction with 1x of T4 DNA ligase buffer and 1 µL of T4 DNA ligase. 
The reactions were incubated for 30 minutes at room temperature. Following this, 5 µL was used 
to transform 50 µL of Gold efficiency DH5α competent E. coli as per the standard protocol. 
Transformations were plated on 50 µg/mL kanamycin plates and incubated over night at 37 °C. 
The following day, two individual bacterial colonies were grown for plasmid purification. Each 
plasmid was screened for the inclusion of the specific oligonucleotides by sequencing with M13 
forward primer (Table 2.1).  
 
6.2.7 Genotyping by high resolution melting curve (HRM) analysis 
High resolution melting curve (HRM) analysis was employed for the detection of genetic 
disruption. This method was previously optimised for detection of indels generated by TALENs 
(Chapter 5.0). HRM was performed using a single set of primers designed around the Cas9 cut 
site. For each guide RNA targeting cyp11c1, unique primers were used to detect indels (Table 6.5). 
Specifically, for both guide RNA1 and guide RNA2, primers amplified an 84 nucleotide fragment 
 
Figure 6.2 Hybridisation of oligonucleotides for cloning into DR274 
Hybridisation of oligonucleotides one and two generates five-prime over-hangs compatible 
with BsaI restriction digest. Directional ligation of hybridised oligonucleotides into BsaI 
digested DR274 plasmid, permits the specific cyp11c1 target sequence to be inserted in the 
correct position within the guide RNA.  
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of cyp11c1 for HRM analysis. HRM analysis was performed using 7900HT Fast Real-Time PCR 
system using parameters previously described. 
 
Table 6.5 Sequences of the primers used for genotyping PCR for cyp11c1 indels by high 
resolution melting curve analysis 
 
RNA Primer 
Sequence 
(5-prime to 3-prime) 
gRNA1 
HRM1 F GCCGTGCCGCTGCAATTCG 
HRM1 R TGACGACAGAACCTGCGCG 
gRNA2 
HRM2 F GCGCAGGTTCTGTCGTCA 
HRM2 R GATGGTCCCCTTCAGCAGC 
 
 
 
6.2.8 In vitro mRNA synthesis of cyp11c1 guide RNAs 
Prior to in vitro RNA synthesis, the cyp11c1 guide plasmids were linearised by DraI restriction 
enzyme. After purification, transcription of the guide RNA was performed using a MEGA 
shortscript Kit (Life Technologies) according the manufactures instructions. Specifically, 100 nM 
of template plasmid was combined in a 20 µL reaction with 1x Buffer and 7.5 mM of ATP, GTP, 
CTP and UTP each. Reactions were incubated for three hours at 37 °C. One microlitre of 
TURBO DNase was added to the reaction and incubated for 15 minutes to remove the DNA 
template.  
 
Due to the small size of the guide RNA, it was purified using phenol chloroform liquid-liquid 
extraction, rather than the standard RNA column purification. Specifically, 115 µL of DEPC 
water was added to the RNA with 15 µL of 3 M sodium acetate and mixed. Next, 150 µL of 
phenol/chloroform was added and followed by an equal volume a chloroform. The top aqueous 
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phase containing the RNA was transferred to a new tube. RNA was precipitated by adding two 
volumes of cold 100 % ethanol and mixing. After incubation for one hour at -20 °C, RNA was 
pelleted by centrifugation for 15 minutes at 13 000 rpm at 4 °C. The supernatant was removed 
and the pellet was allowed to air dry. Resuspension in 80 µL of DEPC water typically resulted in 
concentration of 2 µg/µL. One microlitre of guide was run on a 3 % agarose gel to confirm the 
quality of the RNA.  
 
6.2.9 Generation of Cas9 mRNA 
The plasmid to generate cas9 mRNA (MLM3613) was linarised by PmeI restriction enzyme and 
purified. The mRNA was synthesised in vitro using a T7 polymerase mMessage mMachine kit and 
purified using the GenElute Mammalian Total RNA Miniprep Kit, as previously described. cas9 
RNA was aliquoted and stored at -80 °C until required. 
 
6.2.10 Microinjection of CRISPR/Cas9 for genome editing 
Microinjection into the single cell embryo is the most effective way to transmit the cas9 mRNA 
and the cyp11c1 guide RNA into the developing embryo. Ten microlitre microinjection mixes 
were made in DEPC water with 0.05 % phenol red and 2 µL rhodamine dextran. For initial 
injections a titration of the guide RNA was performed using 10 pg, 20 pg and 50 pg of RNA per 
embryo with 50 pg per embryo of cas9 mRNA. After microinjection, the cas9 mRNA will be 
translated by the endogenous translational machinery to produce the Cas9 nuclease protein.   
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6.3 Results 
6.3.1 Phylogenetic analysis 
Alignment of teleost Cyp11b-like proteins, the single mouse Cyp11b protein and human the 
CYP11B1 and CYP11B2 protein sequences was performed in silico to elucidate the evolution and 
conserved functional domains of the zebrafish Cyp11c1 enzyme. Evolutionary analysis revealed 
that teleost Cyp11c1 enzymes grouped together on their own clade distinct from other mammals 
(Figure 6.3). 
 
 
 
 
 
 
 
 
Figure 6.3 Evolution of Cyp11b-like proteins 
Maximum likelihood phylogenetic analyses of vertebrate Cyp11b-like protein sequences were 
conducted using the PhyML software under the SH-like likelihood-ratio test parameters. 
Scaled phylogenetic tree was drawn with TreeDyn software. Branch support values are 
represented in %. Human CYP11B1 and CYP11B2 are represented as 11B1 and 11B2, 
respectively.  
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The zebrafish Cyp11c1 protein showed typical cytochrome P450 functional domains, including 
the redox-interaction domain, oxygen-binding and the ExxR motif (Kusakabe et al., 2002, Wang 
and Orban, 2007). In comparison to the human orthologues, zebrafish shares the highest protein 
identity with CYP11B2 (42 %); which is required for mineralocorticoid production in humans. 
Protein sequence alignment showed conservation of amino acids in teleost Cyp11c1 sequences 
that are functionally important for CYP11B2 activity. Additionally, zebrafish Cyp11c1 had 67 % 
identity with tilapia and shared a long five-prime signalling peptide, which was well conserved 
between the two species (Figure 6.4). 
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Figure 6.4 ClustalW alignment of Cyp11c1 homologues 
The protein sequence of human CYP11B1 and CYP11B2, were aligned with the Cyp11c1 
proteins from tilapia, stickleback, zebrafish and mouse. CYP11B and Cyp11c enzymes were 
aligned using ClustalW under default parameters. Black lines and arrows annotate -helixes 
and -sheets, respectively, of the predicated secondary protein structure (Belkina et al., 2001) 
The haem-binding domain is highlighted in red, the oxygen-binding region in brown, the 
meander in light grey, and the ExxR and W(R/K)xxR in blue. Residues which support 
CYP11B1 activity are highlighted in purple and predicted residues participating in redox 
interaction are coloured in orange (Parajes et al., 2010).  
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6.3.2 Characterisation of cyp11c1 expression 
The expression of the cyp11c1 was investigated during early zebrafish development and in adult 
zebrafish tissues (Figure 6.5). cyp11c1 showed low levels of expression from zygote to 
segmentation periods (from one-cell stage up to 22-24 hpf). From 28 hpf expression became 
more prominent and was maintained to 120 hpf. In adults, expression was detected in all tissues 
tested with the predominant being the testis and the kidney head. No sexual dimorphism in the 
expression pattern was observed. 
 
 
 
 
 
Figure 6.5 Spatial and temporal expression of zebrafish cyp11c1 transcripts 
Expression of cyp11c1 was characterised in zebrafish embryos and larvae (A) and in adult 
tissues (B). Beta actin was used as a loading control. 
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6.3.3 Cyp11c1 functional in vitro assays 
To determine the functional activity of the zebrafish Cyp11c1 protein in comparison to human 
orthologues, catalytic conversion assays were performed using 11-deoxycortisol as the substrate. 
Initially, experiments were performed using cDNA encoding a 628 amino acid protein as 
annotated on the ENSEMBL genome browser (ENSDART00000061572). Functional activity 
showed the transcripts initiating from this start site (Met 1) had 1.2 % of enzymatic activity 
compared to human wild-type CYP11B1 (Figure 6.6).  
 
Sequence homology with human CYP11B orthologues and other previous reports (Wang and 
Orban, 2007), predict a shorter Cyp11c1 protein which lacks amino acids at the amino terminus. 
Therefore, three other in-frame start methionine residues (Met 2, Met 3 or Met 4) were evaluated. 
Firstly, in silico KOZAK sequence analysis was performed to determine possible translation 
initiation sites. Met 1 and Met 4 were predicted to have strong KOZAK consensus sequences 
(cxxATGG and AxxATGt) with a reliability of 75% and 30 %, respectively. Further analysis 
using five-prime cap analysis gene expression (CAGE) data both Met 1 and Met 4 were shown to 
produce transcripts (personal communication). The three additional cyp11c1 sequences with different 
start methionine amino acids were cloned and predicted to encode pre-proteins of 592, 565 or 
518 amino acids. Catalytic activity using 11-deoxycortisol as the substrate revealed the three 
additional Cyp11c1 proteins all had similar functional activity compared to human CYP11B1. 
Specifically, Cyp11c1 Met 2, Met 3 and Met 4 proteins had 116 %, 139 % and 129 % activity of 
the human homologue, respectively (Figure 6.6).  
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Figure 6.6 Catalytic conversion of 11-deoxycortisol to cortisol by Cyp11c1 
(A) Comparison of the zebrafish Cyp11c1 with human CYP11B1 and CYP11B2 revealed a 
longer amino terminal sequence. Four full-length zebrafish cyp11c1 sequences were cloned 
using a different methionine start amino acid (termed Met 1, Met 2, Met 3 or Met 4). (B) 
COS7 cells were transfected with human CYP11B1 or zebrafish Cyp11c1 with different start 
sites (Met 1, Met 2, Met 3 or Met 4). Cells were then incubated with 11-deoxycortisol for 
conversion to cortisol. Zebrafish Cyp11c1 Met 1 had 1.2 % (± 0.34) activity compared to 
human CYP11B1. While zebrafish Cyp11c1 Met 2, Met 3 or Met 4 had 115.8 % (± 16.20),  
139.4 % (± 63.24) and 128.5 % (± 29.67) activity of the human paralogue, respectively. 
Experiments were performed in triplicate-triplicate and the mean ± SD is shown for each 
protein. Statistical significance was determined by ANOVA following Dunnett's multiple 
comparisons test **p<0.01. 
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6.3.4 Generating cyp11c1 null alleles using CRISPR/Cas9 
6.3.4.a. Strategic design of guide RNAs 
To generate Cyp11c1 loss-of-function alleles, the CRISPR/Cas9 system was used. The Cyp11c1 
CRISPR guide RNAs were designed using the ZiFiT Targeter software (URL: 
http://zifit.partners.org), which is a web tool that identifies guide RNA target sites within a 
particular sequence, while recognising potential off-target sites in the specified organism (Sander 
et al., 2010, Sander et al., 2007). The output lists possible CRISPR guides in order of their quality 
score ranging from 0 to 100 %, which indicates the on-target activity of each guide. Exon 10 of 
zebrafish cyp11c1 was used to identify potential guides. Two guides were synthesised and tested. 
The first guide RNA (gRNA 1) gave a quality score of 92 %, and was predicted to have 24 off-
targets sites in zebrafish; four of which were located in genes. The second guide (gRNA 2) had a 
quality score of 66 % and was estimated to have 135 off-target binding sites; 35 of which were 
contained in exons. Neither gRNA 1, nor gRNA 2 were predicted to non-specifically bind genes 
located on chromosome 16 where cyp11c1 is located; thus allowing for potential off-target effects 
to be outbred.  
 
6.3.4.b. Construction and synthesis of short guide RNAs 
Two guide RNAs targeting cyp11c1 were constructed by hybridisation of specific oligonucleotides 
and ligated into DR274 plasmid. The DR274 plasmid contains additional sequence which directs 
the Cas9 protein to the specific chromosomal locus. Each guide RNA was co-injected with 
mRNA transcribing Cas9 protein. Initial microinjections were performed with 10, 20 and 50 pg 
of guide RNA with 50 pg of cas9 mRNA. Embryos were monitored for RNA toxicity, abnormal 
development and screened by HRM for indels. RNA toxicity was observed at 50 pg of guide 
RNA with 80 % of embryos showing abnormal development. At 72 hpf, 36 larvae from each 
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injection pool were screened for indels using HRM analysis. No indels were detected from 
gRNA 1 at any concentration. The second guide, gRNA 2, produced changes in the melting 
curve indicative of indels at all concentration tested, ranging from 50 % of 10 pg injected larvae 
to 85 % of 50 pg injected larvae (Figure 6.7). Embryos injected with 10 pg of gRNA 2 were 
raised for further screening.  
 
 
 
Figure 6.7 HRM analysis of larva injected with cyp11c1 targeting guide RNA 2 
A high resolution melting (HRM) curve obtained from a cyp11c1 fragment amplified from 
genomic DNA extracted from a larva injected with guide RNA 2 (gRNA 2) and cas9 mRNA. 
An 84 base-pair fragment of cyp11c1 was amplified with SybrGreen and subjected to 
dissociation curve analysis. In uninjected embryos a single peak was observed indicating 
amplification of a single product. In gRNA 2/cas9 injected embryos, two peaks were 
observed; one corresponding to the wild-type product and a second smaller product due to 
the generation of indels (arrow). The presence of two peaks suggests disruption of the wild-
type allele. 
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6.3.5 Optimisation of androgen detection by LC-MS/MS 
By using the core LC-MS/MS facility at the Centre for Endocrinology, Diabetes and Metabolism 
at the University of Birmingham a method was confirmed for the simultaneous detection of 
androgens. Initially, individual androgens were analysed to determine chromatographic peaks and 
analysed using the TargetLynx software. An androgen mixture containing androstenedione, 
testosterone, 11β-hydoxyandrostenedione, 11-ketoandrostenedione, 11-ketotestosterone, 
11β-hydroxytestosterone, dihydrotestosterone and 5α-androstanedione was then run to 
determine if individual analytes could be resolved. Chromatographic peaks for each analyte were 
resolved in a short LC-MS/MS method of less than three minutes (Figure 6.8). 
 
 
 
Figure 6.8 Chromatogram showing optimise solution of the zebrafish androgens 
A LC-MS/MS method was develop to identify androgens androstenedione (OA),11β-
hydroxyandrostenedione (OHA), 11-ketoandrostenedione (OA), 11-ketotestosterone (11-KT), 
testosterone (T), 11β-hydroxytestosterone  (OHT), dihydrotestosterone (DHT) and 
5α-androstanedione (5α-dione). The main metabolites involved in zebrafish androgen 
production are shown in black.  
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6.4 Discussion and prospective studies 
Our previous work exploring zebrafish as a model for steroidogenic physiology and disease has 
highlighted the importance of meticulous characterisation of the system before further exploring 
more complex physiological questions (Parajes et al., 2013). Therefore, this study aimed to 
comprehensively characterise the zebrafish CYP11B isozyme, Cyp11c1, and establish methods to 
assess its function in vivo and in vitro.  
 
6.4.1 Zebrafish Cyp11c1 shares homology with human aldosterone 
synthase 
The classical 11β-hydroxylase enzyme in humans, CYP11B1, hydroxylates 11-deoxycortisol to 
produce cortisol, as well as deoxycorticosterone to corticosterone. The production of 
mineralocorticoids requires the additional 18-hydroxylase and 18-oxidase activities of aldosterone 
synthase (CYP11B2) to generate aldosterone from corticosterone. Like most teleosts, zebrafish 
have a single cyp11b-like homologue, termed cyp11c1. Protein alignment with teleost Cyp11c1 and 
the human orthologues, CYP11B1 and CYP11B2, showed Cyp11c1 shares most protein identity 
with CYP11B2. Human CYP11B1 and CYP11B2 share 95 % identity (Kawamoto et al., 1990), 
however, specific amino acids are required for their catalytic activities. Mutation of Leu301, 
Glu302 and Ala320 in human CYP11B2 to the corresponding amino acids of CYP11B1 (Pro301, 
Asp302 and Val320, respectively), increases the 11β-hydroxylase activity of CYP11B2. 
Subsequently, this increases cortisol production from 5 % to 85 % (Bottner et al., 1998). 
Additionally, these substitutions impair aldosterone synthesis by up to 13 % of wild-type 
CYP11B2, thus indicating these amino acids are important for efficient cortisol production. The 
amino acid alignment reveals zebrafish Cyp11c1 shares homology with human CYP11B2 at these 
functional specifying amino acid positions. Although the critical amino acids for aldosterone 
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synthesis are conserved in Cyp11c1, it is generally accepted that teleost lack the ability to 
synthesise mineralocorticoids, and that the primary function of this protein is 11β-hydroxylase 
activity.  
 
Even within mammals there are significant differences in Cyp11b enzymes. It is hypothesised 
that Cyp11b2 is the ancestral gene which is capable of synthesising mineralocorticoids and 
glucocorticoids. However, within the mammalian linage Cyp11b has undergone one or more 
duplication events leading to diverse functions (Colombo et al., 2006). A single bovine enzyme 
was identified which catalyses 11-deoxycortisol to cortisol and all three steps required to convert 
deoxycorticosterone to aldosterone (Ogishima et al., 1989, Sato et al., 1978). Conversely, rats (but 
not mice) have three Cyp11b-like functional genes (Mellon et al., 1995). Neither the crystal 
structure for CYP11B1 or CYP11B2 has been deduced, making structural-functional correlations 
difficult. Out sequence homology analysis of the zebrafish Cyp11c1 was not sufficient to 
understand the functional capabilities of this enzyme; therefore, functional in vitro assays were 
performed. 
 
6.4.2 Functional characterisation of predicated Cyp11c1 proteins 
Protein sequence alignment of the annotated Cyp11c1 revealed a long amino terminus in 
comparison to the human CYP11B sequences. This region of the protein contains the 
mitochondrial signalling peptide which is cleaved once the protein is imported into the 
mitochondria. Although this sequence is conserved with other teleosts, other studies based on 
homology analysis suggest that M111 (Met 4) of the annotated sequence is the start methionine 
(Wang and Orban, 2007). In silico analysis of the amino terminal nucleotide sequence identified 
KOZAK consensus sites to initiate transcription at Met 1 and Met 4. Furthermore, analysis of 
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five-prime CAGE tags also supported transcription from Met 1 and Met 4, suggesting cyp11c1 has 
at least two alternative start sites.  
 
We tested the functional capabilities of all four proteins in comparison to the human orthologue 
CYP11B1. In assessing their ability to convert 11-deoxycortisol to cortisol Met 1 showed 1 % 
conversion activity compared to human. This suggests the additional amino terminus residues of 
the 628 amino acid protein transcribed from Met 1 renders targeting sequence non-functional. 
The stability of different Cyp11c1 products will be assessed by Western blot using carboxyl 
terminal V5 tags. Additionally, by tagging a fluorescent protein with the different amino terminal 
mitochondrial import sequences, we can visualise the effectiveness of directing proteins to the 
mitochondria. In vivo functional studies suggest blocking translation from the annotated 
methionine (Met 1) by morpholino inhibits de novo glucocorticoid production in zebrafish (Wilson 
et al., 2013), and suggests the 628 amino acid protein is capable of glucocorticoid production.    
 
The three shorter Cyp11c1 proteins exhibited catalytic activities equivalent to human CYP11B1. 
Despite Cyp11c1 having conserved amino acids which are predicted to promote aldosterone 
synthesis rather than glucocorticoid production, this enzyme is capable of producing cortisol in 
vitro. As it has retained its 11β-hydroxylase activity, it would be anticipated it could also generate 
corticosterone from deoxycorticosterone. However, further in vitro studies are required to 
determine the mineralocorticoid producing capabilities of this enzyme. Taken together the 
homology alignments, KOZAC consensus identification and in vitro data, it is suggested that 
Met 4 of Cyp11c1 encodes a functional 518 amino acid protein which allows for Cyp11c1 to 
enter the mitochondria for glucocorticoid synthesis.  
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6.4.3 Spatial and temporal expression of cyp11c1 is consistent with its 
functional activities 
Characterisation of the spatial and temporal expression of Cyp11c1 is required when employing 
zebrafish as a model for biological processes and human disease. Expression of cyp11c1 was 
detected from early stages of development and it was up-regulated between 24 and 28 hpf. This 
coincides with the expression of other steroidogenic genes including cyp11a2 (Parajes et al., 2013). 
This result is consistent with previous reported microarray studies and reflects its role in de novo 
glucocorticoid production during larva development (Alsop and Vijayan, 2009). Although 
expression of cyp11c1 was detected in all adult tissues tested, its highest expression was observed 
in the kidney head and testis. This expression reflects the role of Cyp11c1 in glucocorticoid and 
possible mineralocorticoid production in the interrenal and androgen synthesis in the testis of 
adults.   
 
6.4.4 Generating cyp11c1 null zebrafish line by CRISPR/Cas9 
6.4.4.a. Implementation of the CRISPR/Cas9 system for genomic engineering 
Recently, Hwang et al. (2013b) published the first report of successful implementation of the 
CRISPR/Cas9 system zebrafish. The co-injection of in vitro transcribed guide RNA and cas9 
mRNA into one-cell stage embryos led to targeted chromosomal breaks and sequence indels. 
Additionally, transmission rates of indels ranged from 42 to 100 % (Hwang et al., 2013a, Hwang 
et al., 2013b); establishing it as the most efficient genome editing method to date. Due to the 
recent developments in creating targeted genomic modifications in zebrafish, this study aimed to 
generate cyp11c1 loss-of-function alleles by implementing the CRISPR/Cas9 system.   
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In comparison to TALENs, CRISPR guide RNAs are considerably easier and quicker to 
generate. Unlike Zinc Finger Nucleases and TALENS which preceded this method, the 
CRISPR/Cas9 system relies on RNA rather than proteins to recognise genomic DNA. The 
efficiency to generate somatic mutations in zebrafish with the CRISPR/Cas9 system is, on 
average, 30 %; which is comparable to TALENs (Blackburn et al., 2013). Higher indel 
frequencies have been reported with injection of Cas9 protein rather than mRNA (Gagnon et al., 
2014), suggesting higher rates of genetic disruptions could be achieved in the future. 
Furthermore, a unique advantage of the CRISPR/Cas9 system is the ability to target multiple 
genomic loci at once. Jao et al. (2013), simultaneously targeted five loci in zebrafish embryos, 
eliminating the need for complicated breeding strategies to make multiple changes, and 
highlighting the power of this new method. 
 
One current limitation of the CRISPR/Cas9 systems is the uncertainty of Cas9 to induce off-
target cleavage events and subsequent production of unwanted indels. Several studies 
investigating the specificity of Cas9 have found it variable and difficult to predict the off-target 
cleavage events with a given guide RNA sequence (Cho et al., 2014, Fu et al., 2013, Hsu et al., 
2013, Pattanayak et al., 2013a). Variants of the Cas9 protein (Shen et al., 2014), length of the 
guide RNA (Fu et al., 2014) and modification of the guide RNA architecture (Hsu et al., 2013) 
have all been used to increase the effectiveness and specificity of the CRISPR/Cas9 system. Due 
to the infancy of this technology, optimisation of the method is still a current topic in establishing 
it as a routine biotechnology tool.   
 
6.4.4.b. The genetic disruption of cyp11c1 
For further investigation into the role of Cyp11c1 in zebrafish and to compare to previously 
described morpholino studies (Wilson et al., 2013) we generated a cyp11c1 disrupted allele. The 
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CRISPR guide RNAs were targeted to exon 10, which contains the conserved CYP ExxR motif 
and predicted amino acids involved in redox partner interaction. Two separate guide RNAs 
targeting cyp11c1 were trialled. The first guide (gRNA 1) was unsuccessful in generating indels in 
embryos when analysed by HRM. However, up to 85 % of embryos microinjected with the 
second guide (gRNA 2) showed disrupted melting curves by HRM analysis. At the time of this 
manuscript preparation the CRISPR/Cas9 injected zebrafish were being raised to adults. Upon 
reaching sexual maturity, adults capable of transmitting indels to offspring will be determined. 
Furthermore, lines harbouring heterozygous alleles from the second generation will be 
established for future experiments.  
 
6.4.5 Development of LC-MS/MS methodology to identify zebrafish 
androgens 
Other than cortisol production, Cyp11c1 is also required for the biosynthesis of zebrafish 
androgens. Generally, steroid quantification in fish relies on enzyme immunoassays which can 
lack specificity and sensitivity. In collaboration with Dr. Angela Taylor and the core LC-MS/MS 
facility at the Centre for Endocrinology, Diabetes and Metabolism at the University of 
Birmingham, we were able to detect simultaneously zebrafish androgens from a purified mixture. 
The main products from zebrafish testis are 11β-hydroxyandrostenedione, 11-
ketoandrostenedione, and 11-ketotestosterone (de Waal et al., 2008) and a corresponding peaks 
of each analyte were clearly resolved with our method. Future work will involve optimisation of 
the extraction of androgens from zebrafish embryos and larvae to determine concentrations of 
androgens during development and in adult tissues. This will give further insight into the role of 
androgens during development and in specific tissues, and also provide a biochemical analysis of 
future studies of zebrafish steroidogenic genes. 
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A quantitative method for these specific androgens is not limited to zebrafish studies. In humans, 
11β-hydroxyandrostenedione and 11β-hydroxytestosterone are synthesised in the adrenals. 
Interestingly, 11β-hydroxyandrostenedione is the second most abundant androgen in the adrenal 
vein of women but, its physiological functions remain unknown (Bloem et al., 2013). Both 11β-
hydroxyandrostenedione and 11β-hydroxytestosterone can by generated from the CYP11B 
isoforms, suggesting that CYP11B1 and CYP11B2 have a role in adrenal derived androgens 
(Swart et al., 2013). Furthermore, the hydroxyl- and keto-metabolites of androstenedione and 
testosterone are capable of androgen receptor activation in humans (Yazawa et al 2008) and is 
proposed to have physiological consequences in castration resistant prostate cancer (Bloem et al., 
2013).  
 
6.4.6 Summary 
CYP11B orthologues have been well conserved during the evolution of vertebrates, including 
within the teleost linage. Therefore, the characterisation of this family of enzymes from lower 
species will help in understanding the evolution and divergence of this family. The zebrafish 
enzyme, Cyp11c1, is capable of synthesising cortisol (Wilson et al., 2013) and thus provides a 
promising and genetically amenable model system to study conserved endocrine mechanisms, 
including the mitochondrial redox regulation of steroidogenesis.  
 
The CYP11B family of proteins are mitochondrial CYP enzymes and therefore rely on electron 
transfer from ferredoxin for catalytic activity. Our previous studies show the zebrafish 
ferredoxin, Fdx1b, is required for cortisol production during zebrafish development (Chapter 
3.0). It was postulated that through its electron transfer interaction with Cyp11c1, Fdx1b can 
influence glucocorticoid and androgen production in zebrafish. For further investigation several 
methods to characterise the role of Cyp11c1 during zebrafish development were developed. 
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These included in vitro assays to investigate functional activity, LC-MS/MS method to 
simultaneously detect the main zebrafish androgens and implementation of the CRISPR/Cas9 
system to generate a cyp11c1 knockout line. Overall, the detailed characterisation of Cyp11c1 and 
the implementation novel methods will provide insight into the regulation of glucocorticoid and 
androgen production in zebrafish.  
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 GENERAL DISCUSSION AND PROSPECTIVE STUDIES 7.0
7.1 Characterising steroidogenic enzymes in zebrafish  
Basic biomedical research relies on the study of systems which have similar physiological 
characteristics to humans. Traditionally, this has led to mammals, particularly rodents, being the 
most widely used models in medical research. Since first being pioneered as a model organism by 
George Streisinger (Streisinger et al., 1981), zebrafish have become a popular resource for 
developmental and molecular biologists. In recent years, zebrafish have become increasingly used 
for exploring human diseases and have extended their utility into translational research, cancer, 
toxicology and drug discovery (Ablain and Zon, 2013). Zebrafish represent an important model 
to provide significant insights into the conserved role of steroid hormones during early 
development, with implications in stress research, ageing and the pathophysiology of common 
diseases.  
 
This project aimed to establish zebrafish as an in vivo model for endocrine development and 
steroidogenic disorders. This required comprehensive characterisation of zebrafish steroidogenic 
genes. A detail review of the literature identified discrepancies in the expression and functional 
characterisation of the zebrafish side-chain cleavage paralogue, cyp11a1. In chapter three we 
redefined the initiation and maintenance of interrenal steroid hormone production, through 
characterisation of the cyp11a2 paralogue. Temporal expression of each zebrafish cyp11a gene was 
paralogue specific; with only cyp11a2 being expressed after the interrenal had formed. Through 
the development of a LC-MS/MS method to quantify cortisol and pregnenolone from whole 
zebrafish embryos and larvae extracts, we were able to identify that the Cyp11a isozymes have 
similar enzymatic functions; that is, they are both required for pregnenolone synthesis. Overall, 
our data revised previous findings and identified cyp11a2 as the functional equivalent of human 
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CYP11A1, as it is required for de novo steroidogenesis in zebrafish larvae. Additionally, this data 
highlighted the need for meticulous characterisation of the steroidogenic pathway prior to 
employing zebrafish as model in translational research of adrenal disease. 
 
In chapter six the work in characterising the 11β-hydroxylase homologue, cyp11c1, was 
highlighted. Through in silico analysis and homology alignments I identified two alternative start 
sites for cyp11c1. Further in vitro functional analysis revealed only the shorter transcript had 
equivalent 11β-hydroxylase activity compared to human. The functional characterisation of 
zebrafish cyp11c1 is still in its infancy. By testing in vitro Cyp11c1’s conversion of androstenedione, 
testosterone and deoxycorticosterone, further information about the functional characteristics of 
this enzyme with regards to androgen and mineralocorticoid production will be revealed. To date, 
human CYP11B1 and CYP11B2 proteins have not been crystallised, therefore, the study and 
comparison with the zebrafish Cyp11c1 will provide insight into functional amino acids required 
for specific catalytic activity. 
 
7.2 The study of mitochondria redox reactions in vivo 
Previous in vitro studies established FDX1 can influence steroid hormone production through 
regulating CYP enzymatic activity. Since the relevance of in vitro findings is constantly being 
questioned, the need for in vivo model systems is often required (Langheinrich, 2003). This study 
aimed to develop zebrafish as an in vivo model to investigate mitochondrial redox reactions. This 
would provide insight into the influence of redox reactions on mitochondrial steroidogenic CYP 
enzymes and determine the consequences within a whole organism. During initial 
characterisation of the mitochondrial steroidogenesis redox pathway, two Fdx1 zebrafish 
paralogues were identified. Chapter three details the protein sequence comparison, spatial and 
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temporal expression and relevance of their functional roles during zebrafish development. Upon 
observation that fdx1b expression reflects that of the zebrafish side-chain cleavage paralogue, 
cyp11a2, it was hypothesised Fdx1b has a functional role in steroid hormone production. 
Functional characterisation through antisense morpholino knockdown coupled with steroid 
analysis by LC-MS/MS showed Fdx1b is the ferredoxin required for cortisol production in 
larvae.  
 
It remains to be further elucidated as to why zebrafish Fdx1 cannot compensate for the loss of 
Fdx1b. We hypothesise that zebrafish Fdx1b specifically interact with steroidogenic CYP 
enzymes while Fdx1 is required for other processes such as bile acid synthesis and vitamin D 
metabolism (via Cyp24A1 and Cyp27A homologues) (Goldstone et al., 2010). Ferredoxin genes 
have bacterial origins and are well conserved through evolution; to such an extent there are 
several examples where bacterial CYPs can accept electrons from mammalian FDX1 (Ewen et 
al., 2012). Through collaboration with Professor Rita Bernhardt (Institute of Biochemistry, 
University of the Saarland, Germany) the interaction affinities and the electron transfer rates 
between each zebrafish ferredoxin and the mitochondrial CYP enzymes are currently being 
explored. This will provide an understanding of the mitochondrial redox regulation in zebrafish, 
and will also give additional insight about the specific regulation of individual CYP enzymes by 
their redox partners. 
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7.3 Establishing zebrafish as a model for endocrine disease 
and development  
7.3.1 Genome engineering in zebrafish 
Traditional molecular biology involves the study of genes outside the context of the genome. 
However, recent genomic engineering methodologies allow direct editing or modulation of the 
DNA sequence in their endogenous context. This has created an exciting new era in biological 
research which is capable of transforming basic biology, biotechnology and medical fields. There 
is little doubt that the recent advances in genome editing methods, such as TALENs and the 
CRISPR/Cas9 system will have profound consequences for disease treatments.  
 
One of the major limitations for loss-of-function studies in zebrafish was the lack of targeted 
genome editing tools. Traditionally, the laboratory mouse is the most widely used in vivo model 
system primarily due to the ease of genetic manipulation of the embryonic stem-cells (Schartl, 
2014). Now, with the development of the TALEN and CRISPR/Cas9 strategies it is the first 
time specific gene targeting can be achieved in zebrafish (Grunwald, 2013). Therefore, to develop 
zebrafish as a tool to investigate endocrine development and disease, several knockout lines were 
generated using these methods. Chapter five details the methodology undertaken to establish, 
troubleshoot and optimise the successful implantation of TALENs in zebrafish. Soon after the 
successful use of TALENs was first published in zebrafish (Cermak et al., 2011, Huang et al., 
2011), I began generating TALENs to target fdx1b and cyp11a2 using a commercially available 
assembly kit. As the field of genomic editing by TALENs developed, optimised strategies for 
design and indel detection became apparent and proved critical for our studies. The initial 
TALENs were unsuccessful in generating indels in fdx1b and cyp11a2. Nevertheless, 
incorporation of optimised methodologies allowed for successful generation of genomic lesions 
in both genes.  
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Although, the cyp11a2 knockout zebrafish still require confirmation of germ-line indels, several 
different fdx1b knockout lines have already been established. These, fdx1b lines await further 
characterisation. Based on expression patterns of the zebrafish ferredoxin genes and the loss of 
cortisol observed in fdx1b morphants, it was hypothesised zebrafish Fdx1b specifically interacts 
with steroidogenic CYP enzymes. Therefore, by using TALENs I have generated a unique 
steroidogenic mitochondrial redox pathway specific knockout. This is in contrast to traditional 
tissue or global knockout models and allows for the first time the ability to investigate the role of 
redox regulation on steroidogenesis in vivo, without disruption of early zebrafish development or 
other mitochondrial redox regulated processes. 
 
Chapter six describes the successful implementation of the CRISPR/Cas9 system in zebrafish to 
genetically disrupt the cyp11c1 coding sequence. Similar to cyp11a2, the cyp11c1 knockout line 
requires confirmation of germ-line indels. Once individual knockout lines are established we will 
be able to compare and contrast the physiological impact of cyp11a2, cyp11c1 and fdx1b 
deficiencies and the effects on adrenal insufficiency.  
 
Due to its simplicity of assembly and efficiency of inducing chromosomal lesions, the 
CRISPR/Cas9 system has taken over TALENs as the technique of choice for genome editing.  
However, both TALENs and CRISPRs all have unique advantages and limitations which need to 
be considered in the application and interpretation of genome engineering studies. From a 
practical standpoint, CRISPRs are easier to implement than TALENs. TALENs must be 
constructed individually through timely assembly of the individual modules. In comparison, 
CRISPRs require the exchange of 20 nucleotide sequence of the guide RNA. This can be simply 
ordered as a pair of oligonucleotides. The CRISPR/Cas9 system is suggested to be more effective 
in targeting the genome in comparison to other methods, however, such comparisons requires 
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systematic analysis and will only be truly reflective as these methods become optimised. One 
major concern in the field is the generation of off-target mutations within the cell causing 
unwarranted genomic disruption. Despite efforts to predict and identify the off target effects of 
these systems, no conclusive guidelines have been established. Further characterisation of our 
knockout lines and out-breeding for several more generations will insure off-target effects are 
mitigated.  
 
7.3.2 Development of zebrafish whole system steroid assays 
Traditionally, immunoassays have been used for the quantification of plasma steroid hormones in 
adult teleost fish or from whole embryo/larva extracts. However, one limitation of steroid 
hormone immunoassays is cross-reactivity with structurally related compounds (Krasowski et al., 
2014). LC-MS/MS is an alternative method of steroid hormone analysis which provides 
improved specificity and increased sensitivity. In order to investigate the systemic effects of 
modified steroidogenesis in zebrafish we developed and optimised a LC-MS/MS to measure 
cortisol and pregnenolone from whole zebrafish embryos and larvae (Parajes et al., 2013). Using 
this methodology we were able to establish pregnenolone and cortisol concentrations during the 
first five days of zebrafish development (data not shown) as well as confirm steroid profiles of 
fdx1, fdx1b, cyp11a1 and cyp11a2 deficient embryos.  
 
As the mitochondrial CYP enzyme Cyp11c1 is involved in androgen production, a sensitive 
method to measure specific androgens was required. To provide a biochemical readout for 
androgen synthesis, we developed a LC-MS/MS method to identify the primary androgens in 
zebrafish. Work is now continuing to optimise the extraction method from whole zebrafish. 
From other studies in our laboratory we confirmed the androgen receptor is required for early 
development. It would be beneficial to determine the composition of androgens during zebrafish 
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development; an achievement not currently available with immunoassay due to cross-reactivity 
between the steroids.  
 
The use of LC-MS/MS methodology to investigate the steroid hormone profiles in zebrafish will 
enhance the usefulness of zebrafish as a model for endocrine development, physiology and 
pathophysiology. Furthermore, the ability to accurately identify steroids from whole embryo 
extracts will provide information about the role of hormones during development. Additionally, 
coupled with the genome editing techniques, zebrafish can be used to establish the systemic 
effects, both morphologically and biochemically of genetic alterations; an achievement not 
possible with in vitro assays.  
 
7.4 The future of zebrafish in endocrine research 
Throughout this project we have established zebrafish as an in vivo model to study mitochondrial 
redox regulation of steroidogenesis. However, the usefulness of zebrafish as a model for 
endocrine research goes beyond their applications in developmental and molecular biology 
applications. Genomic engineering in zebrafish provides the ability to specifically generate precise 
mutations which are present in human endocrine pathologies. The engineering of clinically 
relevant mutations in zebrafish will provide useful advantages compared to other systems. These 
zebrafish could be used in studying genotype/phenotype correlations, molecular mechanisms of 
disease and disease pathology. Additionally, high-throughput drug screening offers the potential 
to identify novel therapeutic agents which can be developed as disease treatments.  
 
The comprehensive characterisation of zebrafish steroidogenic genes, use of novel genome 
editing methods and the development of steroid analytical methods, have helped establish 
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zebrafish as a model to study the role of steroid hormone in development and disease. By 
focusing on mitochondrial steroidogenesis reactions, this study has provided insights into the 
mechanism of mitochondrial redox regulation. Importantly, this data forms the basis for future 
studies using zebrafish as a comprehensive in vivo model in translational research of adrenal 
diseases.  
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 APPENDIX 8.0
8.1 Appendix One: Redefining Cytochrome P450 side-chain 
cleavage activity in zebrafish 
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